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MgSO4    Magnesium sulfate  
MHz    Megahertz 
mL    Milliliter  
MMC    Methyl malonyl chloride  
mmol    Millimole 
Mn(OAc)3   Manganese(III) acetate 
MO    Molecular orbital 
MS    Molecular sieves 
MsOAc   Methanesulfonyl acetate 
Myoc-OLF   Myocilin olfactomedin domain 
N2    Nitrogen  
NaBH4    Sodium borohydride 
NaH    Sodium hydride  
NaHCO3   Sodium bicarbonate 
NaOAc   Sodium acetate 
Na2SO4   Sodium sulfate 
Naphth              Naphthalene 
NEt3    Triethylamine  
Ni(OTf)2   Nickel(II) trifluoromethanesulfonate 
NMR    Nuclear magnetic resonance 
Nphth    Phthalimido 
o    Ortho 
O2    Oxygen 
Obs.    Observed 
OLED    Organic light-emitting diode  
p    Para 
PAF    Platelet activating factor  
PAA    p-Anisaldehyde 
Pd    Palladium  
Pd/C    Palladium on carbon 
PdCl2    Palladium(II) chloride 
Pd(OAc)2   Palladium(II) acetate 
PFK    Perfluorokerosene 
Ph    Phenyl 
Pip    Piperdine 
PKCβ    Protein kinase Cβ 
PMA    Phosphomolybdic acid 
POCl3    Phosphoryl trichloride 
PPA    Polyphosphoric acid 
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ppm    Parts-per-million  
PQ    Pyrrolo[3,2,1-ij]quinoline 
Pr    Propyl 
PtCl2    Platinum(II) chloride 
PtCl4    Platinum(IV) chloride  
PtO2    Platinum(IV) oxide 
q    Quartet 
qd     Quartet of doublets 
qn    Quintet 





RT Room temperature 
Ru3(CO)12 Triruthenium dodecacarbonyl 
s Singlet or strong 
SAR Structure-activity relationship 
Sc(OTf)3 Scandium(III) triflate 
SIRT1 Sirtuin 1 
SnCl4 Tin(IV) chloride 
SO Spyro Orange 
SPR Surface Plasmon Resonance 
t  Triplet 
t-Butyl Tert-butyl 
t-BuOOH Tert-butyl hydroperoxide 
td Triplet of doublets 
TBDPS Tert-butyldiphenylsilyl 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
THI Tetrahydroindolizine 
THQ Tetrahydroquinoline  
Ti(i-PrO)3Cl Chlorotitanium triisopropoxide 
TIPB 1,3,5-triisopropylbenzene 
TLC Thin-layer chromatography  
p-TsOH p-Toluenesulfonic acid 
UV Ultraviolet 
w weak 
Yb(OTf)3 Ytterbium(III) trifluoromethanesulfonate 
Y(OTf)3 Yttrium(III) triflate 
ZnI2 Zinc iodide 







Nature’s biodiversity is complex and filled with beauty and wonder which are all 
observable on the macroscopic scale. This exquisiteness of nature’s intricacies are mirrored 
on the molecular level such that substances, large or small, are assembled to serve as 
signaling molecules, protective agents, and fundamental composites of higher-order 
frameworks for the operation and survival of life. Over the years, chemists have isolated 
and synthesized these molecules, known as natural products,1 to understand and evaluate 
their functions in biology2–10 and potential for medicinal applications.11–20  
Although bioactive natural products demonstrate medicinal promise,21 poor 
pharmacological effects require further derivatization because semisynthesis is not 
sufficient to refine adverse pharmacokinetics. For some active molecules, isolation results 
in poor yields.22 In addition to small quantity isolation, many natural products, reflecting 
the immense complexity of biology itself, pose difficult synthetic challenges to organic 
chemists because of skeletal heterogeneity, stereochemical complexity, and substitution 
divergence.23,24 As a result of these synthetic obstacles to natural product utilization,  
improvements are needed in current chemical approaches, and new innovative 
methodologies for synthesis and chemical space exploration are necessary.   
Pharmaceutically relevant frameworks, natural products, and synthetic biologically 
active molecules are comprised of polycarbocyclic and heterocyclic scaffolds. 
Traditionally, cycloadditions, transannular transformations, and annulation reactions serve 
as powerful methods for polycyclic formation. In order to assemble diverse polycycles, 
donor-acceptor cyclopropanes are useful, versatile synthetic equivalents for C-C bond 
formations. By taking advantage of the strain within these unique polarized systems, 
differing molecular architectures can be accessed directly to perform contemporary organic 
synthesis. Moreover, the donor-acceptor cyclopropanes initially utilized in these studies 
provided a fundamental basis for new methods to synthesize other relevant scaffolds. 
Unique, efficient, Lewis acid-catalyzed intramolecular cyclization strategies for the 
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construction of functionalized polycycles using Friedel-Crafts-type alkylation sequences 
are presented to expand the reaction repertoire of the molecular architect. Generally, 
products were formed from commercially-available starting materials in high yields with 
broad scope. The methodologies were demonstrated to be modular, operationally simple, 
and amenable to different substitution patterns and functional groups to afford 
tetrahydroindolizines, heteroaromatic cyclohexenones, hydropyrido[1,2-a]indoles, 
pyrrolo[1,2-a]indoles, pyrrolo[3,2,1-ij]quinolines, pyrrolizines, and 
tetrahydrobenzo[ij]quinolizines. To demonstrate the utility of the methodologies devised, 
progress toward, (±)-rhazinicine, a natural product, is discussed. 
This dissertation is organized into six chapters: (1) an introduction, paradoxical 
stress and molecular strain’s utility in synthesis;  (2) annulation reactions for the formation 
of heteroaromatic cyclohexenones; (3) hydropyrido[1,2-a]indole formation via an In(III)-
catalyzed cyclopropane ring-opening/Friedel-Crafts alkylation sequence; (4) 
tetrahydroindolizine formation and progress toward the total synthesis of (±)-rhazinicine 
(5) pyrrolo[1,2-a]indole synthesis using a Michael-type Friedel-Crafts cyclization  









CHAPTER 1  PARADOXICAL STRESS: EXPLOITING STRAIN 
FOR SYNTHETIC UTILITY  
 Stress is an inevitable part of life that results from an adaptive response to the 
pressures of work, family, environment, and any threat that induces disharmony or 
dysphoria. Defined by Hans Selye in 1936 as “the non-specific response of the body to any 
demand for change,” stress can arise as a psychological phenomenon that is counter to 
completing tasks and goals, whether it is a real or perceived change.25–27 The mere mention 
of the word stress can induce neurosis! Ask anyone about his or her personal experiences, 
and he or she will quickly be capable of conjuring a stressful memory or experience. 
Unique to its peculiar nature, stress is paradoxical,28 a combination of a psychological 
positives and negatives. Distress, the negative concept, can debilitate, impair, and stymie 
overall performance and productivity, but eustress, the positive equivalent, can improve 
performance, productivity, creativity, self-esteem and health.29,30 While one’s response to 
his/her environment is not always predictable, it is previous experiences, anecdotal 
evidence, and drive for inner harmonic balance that increases the eustress to distress ratio 
and improve the odds of success. If one desires to succeed in an ever-changing society, 
stress management is critical to the daily functions and interactions of the individual. 
Harnessing and relieving this psychophysiological tension can foster accomplishment, 
productivity, and drive, consequently, turning something unfortunate into an opportunity. 
To alleviate strain, “the stressee” can meditate, involve himself or herself in enjoyment, 
express his/her feelings, relax, and exercise to promote calmness and stability. 
Interestingly, this human experience is relatable to the molecular world. 
1.1 Molecular Stress 
 Molecules can be examined through the eyes of anthropomorphism. When 
molecular structure is probed, bonded electrons constitute the skeleton/framework of 
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molecules. As suggested by Kirby, bonding electrons act as a “rudimentary nervous 
system” and respond to perturbations caused by other atoms; therefore, this relay of 
perturbation is governed by distance and geometry at local centers.31 Hence, molecules can 
inherently react and acknowledge external pressures contained within their environment 
through vibrational degrees of freedom, angle alteration, bond scission, bond formation, 
and polarization. Moreover, molecules cope with strain induced by themselves, which is 
characterized by less than optimal geometric arrangement(s)—the individualized, “internal 
pressure” caused by molecular movement and steric relationships that induces strained 
forms, conformational isomerism, and instability when a higher energy conformer is 
compared to the ground state. As a direct result, in accordance with the eustress 
perspective, chemists can exploit this stress for beneficial synthetic outcomes to discover 
new reactivity for strained molecules.    
1.2 Eustress from the Chemical Perspective 
 Methodologies can be designed to improve performance and productivity. To the 
chemist, improved performance and productivity translates into mild conditions, high 
yields, chemoselectivity, regioselectivity, regiospecificity, diastereoselectivity, 
diastereospecificity, enantioselectivity, enantiospecificity, and atom economy. For 
synthetic creativity and molecular design, the use of strained systems may enhance 
modularity development, diversification in coverage of chemical space, and simplicity. 
Chemists employ these fundamental tenets of organic synthesis when applying catalysts 
and reagents to relieve stress in strained carbocyclic and heterocyclic systems to access 
new reactivity and diverse structures that are often difficult to obtain through traditional 
routes. Depending on the molecular architecture, selectivity, and amenability of a synthetic 
step, the reactivity is predicated on an exercise the molecule undergoes to achieve greater 
structural relaxation and stability. It is this dominant thermodynamic driving force and 
propensity that is one of the underlying principles observed in ring strained compounds. 
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1.3 Ring Strain in Cycloalkanes 
 Chemists view strain as structural stress that raises the internal energy of a 
compound when the strained molecule is compared to a reference state.32 This increased 
energy may be a direct consequence of conformational distortions, nonoptimal bonding, 
and nonideal angles that are absent from the reference. Most of the research presented in 
this dissertation explores the reactivity of the most strained cycloalkane—cyclopropane. 
Understanding its unique reactivity as it pertains to other strained carbocycles requires an 
understanding of cyclopropane’s structure because thermodynamics alone is inadequate to 
explain the reactivity of cyclopropanes and strain energy similar to that in cyclobutane.33 
Below are basic cycloalkane systems with corresponding strain energies in Figure 1.1.34–36  
 
Figure 1.1: Strain energies of cycloalkanes 
 
  Because of the cyclic arrangement of cycloalkanes, the stress that these systems 
experience contribute substantially to ring strain, which is described by its subcomponents, 
Baeyer strain (angle strain) and Pitzer strain (torsional strain in the context of a ring).37 
Staggered and anti-orientations are the preferable spatial orientations and can result low in 
torsional strain energy. Out of all the alkanes represented in Figure 1.1, only cyclohexane 
achieves the staggered, favorable conformation in two chair-like forms as determined by 
conformational analysis. The chair form’s spatial arrangement consists of staggered bonds 
where the axis of rotation is not aligned such that two atoms or groups have a dihedral 
angle of 60˚.  Large and small angle strain occurs when the C-C-C network deviates from 
the ideal tetrahedral angle of 109.5˚ for a sp3 hybridized carbon atom. Interestingly, the 
cyclohexane chair’s carbons adopt an angle close to 109.5˚, ensuing zero strain energy 
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(Figure 1.2). For cyclopropane, the ring ideality exhibited by the cyclohexane cannot be 
attained because of planarity. 
 
Figure 1.2: Cyclohexane chair forms and Newman projection 
   
 The carbon skeleton of cyclopropane is geometrically constrained to a plane, which 
institutes disfavored coplanar eclipsed C-C bonds (Figure 1.3). Therefore, the majority of 
cyclopropane’s strain arises from its Baeyer strain, since bonds attempt to accommodate 
three 60˚ angles, ca. 49˚ less than the desired 109.5˚. Because of the equilateral triangle 
angle constraints, cyclopropane’s C-C bonds are bent and exist as an intermediate between 
π- and σ-bonds, known as “τ bonds,” since the internuclear angle (<60˚) is substantially 
less than the 109.5˚ interorbital angle.38–41 Originally conceived by Förester,42 the refined 
valence bond Coulson-Moffitt model advanced this notion by showing a ring constructed 
from sp3 hybridized –CH2- groups 22˚ outward from the C-C nuclear baseline, causing a 
20% deficiency in orbital overlap in reference to C-C bonding in ethane (Figure 1.4).33,39,43–
45  
 
Figure 1.3: Torsional strain in cyclopropane 
 
 To accommodate small ring angles, Greenberg et. al 46,47 predicted greater s 
character (32%) in the C-H bonds in 1978.48,49 Then, Walsh, in a separate publication, 
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derived a molecular orbital (MO) picture of cyclopropane that accounts for the unusual 
reactivity of cyclopropanes not observed in other cycloalkanes (Figure 1.4). Walsh’s MO 
model describes three mathematical linear combinations of sp2 hybridized atomic orbitals 
(AO) of lowest energy as the basis set that constitutes the σ-bond network ψ1.50–53 By using 
three p-AOs, two other linear combinations of equal energy yield ψ2 and ψ3. 
 
Figure 1.4: Coulson-Moffit and Walsh models for cyclopropane 
 
  From the derived combinations, orbital overlap is reduced because of the inward 
directionality of ψ1, and “quasi π-character” is imparted from ψ2 and ψ3. Both models, 
Walsh and Coulson-Moffit, account for the substantial angle strain attributed to diminished 
orbital overlap. For these reasons, a thermodynamic bias for ring-opening is inherent and 
acts as a driving force for bond cleavage when the cyclopropane is activated. The π-
character and large electron density adjacent to the C-C axis54 makes cyclopropane useful 
for various transformations with chemical reagents, (e.g., catalysts, nucleophiles, 
electrophiles, radicals), heat, and light. Presenting a myriad of synthetic opportunities, 
cyclopropanes are versatile building blocks for organic chemists and can be used to 
assemble a broad range of carbocyclic and heterocyclic scaffolds.33,55–59 
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1.4 The Push-Pull Effect in Donor-Acceptor Cyclopropanes 
 Often synthesized from carbenes, carbenoids, or other equivalents and 
corresponding olefins,60–62 cyclopropanes are relatively stable and resistant to bond 
scission unless they are activated. This activation is accomplished by polarizing one or 
more of the C-C bonds through the attachment of electron-donating (donor, D) and electron 
accepting (acceptor, A) as substituents  (Figure 1.5). Classically, electron-withdrawing 
functionalities, such as the carbonyl, sulfonyl, and nitro groups, operate as acceptors, and 
moieties with electron-rich aryl groups, such as heteroatoms, alkyl, or alkenyl groups, act 
as donors. Common arrangements for the donor and acceptor groups about the 
cyclopropane ring are shown in Figure 1.5. For this initial discussion, the substituent 
placement for the donor and acceptor groups to be considered are geminal (1-1) and vicinal 
positioning (1-2).  
 
Figure 1.5: Common donor-acceptor arrangements in cyclopropanes 
 
Vicinally-positioned donor and acceptor groups act in a tunable, push-pull fashion, 
resulting in enhanced polarization of the C-C bond between the donor and acceptor groups 
(Figure 1.6).63,64 In contrast, donor and acceptor groups positioned geminally are not as 
‘synergistic’ as vicinal substitution for bond polarization,56,65 but gem-donor-acceptor (D-




Figure 1.6: Push-pull effect in vic- and gem-disubstituted cyclopropanes 
 
 The push-pull effect induces polarization, resulting in multiple pathways for 
versatility in product formation. If heterolytic ring opening occurs, a 1,3-zwitterionic 
intermediate forms such that its stability and reactivity are dependent on the reaction 
conditions; meaning, this dipole reacts with electrophiles, nucleophiles, and dipolarophiles 
(Figure 1.7). As a result, donor-acceptor cyclopropanes serve as convenient synthetic 
equivalents that are purposive for synthesizing compounds with dissonant charge patterns. 
The umpolung of polarity in the carbon center provides an alternative route to complex 
structures not accessible by other methods.67 Many donor-acceptor cyclopropane ring-
opening reactions proceed through a synchronous route involving nucleophilic attack on 
the electron-deficient carbon with a concurrent ring-opening. Another pathway for ring-
opening is homolytic cleavage via a diradical intermediate that forms independent of a 
substituents’ nature.  In the case of dipolarophiles, a formal cycloaddition is purported to 
proceed through a stepwise polar mechanism. This predictable behavior has led to 
extensive application of vicinal donor-acceptor cyclopropanes in modern organic 
chemistry, prompting researchers to better understand the ring polarization.  
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Figure 1.7: Reactivity of vic-donor-acceptor cyclopropanes 
 
 In order to quantify the polarizing effect of donor and acceptor substituents, 
Schneider and Werz conducted a systematic theoretical investigation by calculating ring 
enlargement activation barriers for 72 donor-acceptor cyclopropane combinations (Figure 
1.8).64 As anticipated, smaller transition energies were observed with good donor (e.g., 
NMe2, OMe, aryl, alkyl) and acceptor substituents (e.g., NO, CHS, CHO). For most 
systems, the donor has greater impact on the transition state energy than the acceptor. If an 
additional acceptor and/or donor group is added geminally, the transition state energies 
further decrease without significant influence on reaction enthalpies. According to the 
calculations of Schneider and Werz, increasing solvent polarity (toluene, DCM, DMSO) 
lowers the activation barrier of their NMe2/CHO model by 3-10 kcal/mol.  Hence, 
Schneider and Werz predicted that specific combinations of donor and acceptor 
substituents readily promote ring-expansion with or without catalyst while other 
combinations offer less C-C bond polarization. Of note, this study involved a synchronous 
polar ring-enlargement mechanism as opposed to a heterolytic ring-opening that causes 
larger transition state energies. Similarly, when intermediates involving diradicals were 




Figure 1.8: Schneider and Werz' donor-acceptor computational insights 
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1.5 Donor-Acceptor Cyclopropane Design and Synthetic Utility 
 The incorporation of the intramolecular design for donor-acceptor cyclopropanes 
was established in the late 1960s and early 1970s. During this period, Stork68–71 and 
Grieco72 pioneered the application of cyclopropyl ketones with alkyl donors as useful 
precursors for acid-promoted, intramolecular cation-olefin cyclizations. Corey reported the 
first example of a total synthesis using the Stork cyclopropane cyclization method in the 
synthesis of (±)-cedrone and (±)-cedrol.73 Danishefsky published numerous examples of 
intramolecular nucleophilic ring-opening cyclizations to form functionalized carbocycles 
and heterocycles.74 Wenkert later showcased the utility of stronger donor groups, including 
heteroatom donors,75 and in 1980, Hirsch and Reissig coined the term “donor-acceptor 
cyclopropane” for vic-structures76 with both cohorts being recognized for this early 
renaissance in donor-acceptor cyclopropane chemistry.77 These seminal examples 
established a foundation for almost 40 years of work devoted to intramolecular reactions 
of donor-acceptor cyclopropanes. Trushkov noted this breadth of chemistry in the 
dedication article to O.M. Nefedov:78 
 “Acceptor and donor together bring a magic force to the three-membered ring. This 
ring is inimitable under the sky, reacts with radicals, nucleophiles, electrophiles, redox 
agents, alkenes, imines, aldehydes, conjugated dienes. It dimerizes, reacts with nitrones, 
nitriles, and alkynes, and so forth, and so on….” 
 Initially, most of the chemistry encompassed ring cleavage with electrophiles and 
nucleophiles.56,65 Within the last 15 years, the number of Lewis acid-catalyzed 
cycloadditions and annulation transformations with D-A cyclopropanes have soared.78 
Further application of these unique Michael acceptors in [3+2]- and [3+3]-cycloadditions 
and annulations affirms the proficient production of cyclic compounds intermolecularly 
with compounds containing double and triple bonds (e.g., allenes, nitrones, alkenes, 
aldehydes, imines, nitriles, ketones) to afford five- and six-membered constructs.77,79–81 
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Trushkov’s outline of important donor-acceptor reactivity before 2008 is presented in 
Figure 1.9.78  
 
Figure 1.9: Trushkov's overview of donor-acceptor cyclopropane chemistry prior to 
2008 
 
These reactive donor-acceptor units can also undergo cycloisomerizations, umpolung 
reactions, rearrangements, ring-opening lactonizations, ring-opening lactamizations, and 
cyclodimerizations to form diverse scaffolds (Figure 1.10).82 Some developed asymmetric 
protocols in which donor-acceptor cyclopropane synthons performed well with high 
stereoselectivity, regioselectivity, and chemoselectivity and were applied to natural 
product syntheses.82–92 Due to the characteristic reactivity and synthetic potential of donor-
acceptor cyclopropanes, these polarized carbocycles have garnered a considerable amount 
of attention and have invigorated a resurgence of the application of donor-acceptor 
cyclopropane chemical reactivity described by Werz as the “new golden age for donor-
acceptor cyclopropanes,”77 prompting a large number of important extensive reviews on 
the synthesis and reactivity of D-A cyclopropanes in the last decade. 
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Figure 1.10:xTransformations for donor-acceptor cyclopropanes with resulting 
products formed 
 
1.6  Current Reviews on D-A Cyclopropanes 
 In 2003, Reissig discussed synthetic applications of vicinally-substituted donor-
acceptor cyclopropane derivatives as intermediates in natural product synthesis with an 
emphasis on cyclopropane bond scission.56 Subsequently, in 2005, Pagenkopf et al. noted 
advancements in the formation and usage of donor-acceptor cyclopropanes as 
dipolarophiles for 1,3-dipolar cycloadditions.65 In 2009, Waser studied intramolecular 
ring-opening cyclizations with emphasis on the formal homo-Nazarov cyclization.93 
Likewise, Kerr and Carson published a tutorial review on methods for formation of 
functionalized heterocycles from ring-expansion reactions of cyclopropanes in 2009.80 
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Then, in 2010, Kerr described intramolecular cycloadditions of donor-acceptor 
cyclopropanes and transformations of the resulting adducts to natural product targets.81 In 
2011, Trushkov et al. published an account article which included [3+2]-cycloadditions, 
reductive ring-openings, nucleophilic ring-openings/ring-closures, and acid induced ring-
openings.78 Within the same year, Waser94 et al. published a paper on the synthesis and 
reactivity of heteroatom substituted donor-acceptor cyclopropanes while Reisman95 et al. 
focused on the application of the Buchner reaction for total synthesis. Moreover in 2012, 
Qin96 and Wang97 separately disclosed an overview of versatile, activated cyclopropanes 
in natural product synthesis. Afterwards, in 2013, Njardarson and Mack reported new 
advancements in expansions of three- and four-membered rings by using metal catalysts.98 
In 2014, Cavitt and France82 reviewed recent intramolecular chemistry for donor-acceptor 
cyclopropanes; Werz’77 review justified the assertion of a new forefront for donor-acceptor 
cyclopropane chemistry; Waser presented more progress in the field and included 
cyclobutanes; Snieckus99 reported on the employment of alkenyl and alkylidene 
substituents; Grandi100 covered Nazarov-like cyclization reactions reported during 2009-
2013. In 2015, Kerr101 introduced another comprehensive overview of intermolecular and 
intramolecular annulations using donor-acceptor cyclopropanes to form carbocycles, and  
Tomilov102 discussed the dimerization reactions of donor-acceptor cyclopropanes.  
1.7 Dissertation Overview 
 This dissertation centers on novel intramolecular chemistry of vic-donor-acceptor-
acceptor cyclopropanes (D-A-A) 1-5 and vic-donor-donor-acceptor-acceptor 
cyclopropanes (D-D-A-A) 1-6 to form disparate heterocyclic scaffolds (Figure 1.11). 
While particular emphasis is placed on intermolecular reactivity in the literature, research 
studies on intramolecular transformations have recently become more frequent owing to 
the benefits of intramolecularity for ring-opening cyclization reactions. The advantages of 
intramolecular reactivity over intermolecular include increased local concentration, milder 
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reaction conditions, improved control of diastereoselectivity, and rapid formation of 
polycyclic structures. Notably, the work presented in this dissertation has assisted in 
ushering in this new golden age and expanding the repertoire of methodologies for the 
molecular architect by examining the reactivity of different donor-acceptor combinations 
to construct distinct structures difficult to procure by other synthetic means.  
 In addition to our contributions to the growing field of donor-acceptor cyclopropane 
chemistry, we used structural and mechanistic rationale based on donor-acceptor 
cyclopropane chemistry as a guide and inspiration for new Friedel-Crafts-type alkylation 
methodologies to access other valuable frameworks. Initially, we were interested in 
improving protocols reported for our target scaffolds and devising new strategies to access 
differing molecular skeletons. Because some protocols required harsh reaction conditions, 
long reaction times, and high temperatures, we sought to reduce the number of cumbersome 
steps and to incorporate robust transformations using readily accessible, commercially-
available, cheap starting materials. If we were to achieve our goals, it was critical to choose 
reactive systems that were electronically tunable to provide an array of carbocycles and 
heterocycles. By adding additional polarization to vic-donor-acceptor cyclopropanes, we 
realized or goals, by even more than we had originally anticipated. From the donor-
acceptor cyclopropane strategy, we synthesized heteroaromatic ring-fused cyclohexenones 
1-8 (Chapter 2), hydropyrido[1,2-a]indoles 1-9 (Chapter 3), and tetrahydroindolizines 1-
10 (Chapter 4) (Figure 1.11). 
 As explained earlier, cyclopropanes have an inherent π-character and can be viewed 
as reactive quasi π-systems. Removing one carbon unit and keeping the double bond 
character would form Michael-type acceptor compounds 1-7 (Figure 1.11). We inferred 
that subjecting the polarized Michael-type precursors to Lewis acid would form five-
membered constructs (pyrrolo[1,2-a]indoles 1-11 and pyrrolizines 1-13) (Chapter 5). From 
1-7, we postulated that pyrrolo[3,2,1-ij]quinolines 1-12 would be synthesized if the indole 
2-position were replaced with a poor leaving group such that aromatization could be 
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established only by electrophilic aromatic substitution at the indole C7-position (Chapter 
6). Furthermore, using this same Friedel-Crafts approach tetrahydropyrrolo[3,2,1-
ij]quinolines 1-14 and tetrahydrobenzo[ij]quinolizines 1-15 were hypothesized to form 
accordingly (Chapter 6).  Given the results presented in this dissertation, our diversity-
oriented strategy was successful since we covered a significant portion of chemical space 
from common starting resources. The subsequent chapters will provide a more in-depth 








CHAPTER 2  SYNTHESIS OF HETEROAROMATIC RING-
FUSED CYCLOHEXENONES VIA INDIUM(III) CATALYSIS  
 The late 20th century work of Corey, Stork, and Danishefsky demonstrated that 
activated carbonyl cyclopropanes were useful for forming unique polycyclics 
intramolecularly in one step by ring-opening and subsequent cyclization (Figure 
2.1).71,73,103  
 
Figure 2.1: Early reports by Stork, Corey, and Danishefsky’s including donor-
acceptor-acceptor cyclopropanes 
 
 For similar transformations, Waser postulated three general ring enlargement 
modes (Figure 2.2).93 Endo 1 is feasible if the electron withdrawing substituent(s) is outside 
the ring. After cyclization, two ring carbons form the carbocycle. Endo 2 proceeds where 
all of the ring carbons are amalgamated into the fused system, and finally, exo cyclization 
results from the incorporation of one carbon unit into the cyclized product. Due to poor 
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orbital alignment, Waser inferred that a concerted process is highly unlikely, but a stepwise 
mechanism with a dipolar intermediate is more plausible.104 Given the ring enlargement 
modes, the endo(1) process is considered to be analogous to the well-known Nazarov 
cyclization if one examines the π-character of vinyl cyclopropyl ketones. The term “homo-
Nazarov” was first mentioned in Ra’s dissertation outside of the cyclopropane context in 
1990.105 Yadav’s synthetic protocol106 in 2008 coined the ring enlargement with vinyl-type 
cyclopropyl ketones the “homo-Nazarov” cyclization.  
 
Figure 2.2: Waser’s modes of cyclization for substituted cylopropanes 
 
 The homo-Nazarov’s well-known and highly popular parent reaction, which was 
discovered in 1941, was named after Ivan Nikolaench Nazarov (1906-1957)—the Nazarov 
cyclization.107,108  This concerted electrocyclic reaction, governed by Woodward-Hoffman 
principles,109–112  which forms a transient pentadienyl cation under acidic conditions, is 
recognized as a powerful transformation for synthesizing five-membered rings.113 Up to 
2008, examples of the analogous reaction for six-membered constructs were few. Through 
the lens of cyclopropanes, the Nazarov reaction converts to the homo-Nazarov reaction 
because of one additional carbon unit and the differing mechanistic pathway for 
cyclization. As a result of the versatility of donor-acceptor cyclopropanes as reactive 
species for C-C bond formation, the application of the homo-Nazarov cyclization for 
synthesizing cyclic structures has increased the number of routes, approaches, and 
possibilities to access materials, therapeutics, and natural products difficult to obtain by 
other means.  
 Mechanistically, under acidic conditions, carbonyl cyclopropanes 2-9 open to form 
a cyclic oxyallyl cation in a stepwise manner to afford six-atom cyclic systems 2-10. 
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Contrary to the classical Nazarov reaction, the formal homo-Nazarov reaction is not FMO-
controlled, but a similar oxyallyl cation is purported to be an intermediate (Figure 
2.3).113,114 The term “formal” is used to indicate that specificity is not imparted by standard 
Woodward Hoffmann electrocyclic predictions, principles the classic Nazarov reaction 
adheres to for cyclization. “Formal” would be removed if the cyclopropane system were to 
cyclize in a manner governed by frontier molecular orbital (FMO) theory to impart 
stereoselectivity in product formation.94 Although earlier representative examples of the 
formal homo-Nazarov methodology underlying principles of ring-enlargements from 
donor-acceptor cyclopropanes were reported in 1980, the term “formal” was not included 
in the description of the methodology at that time.  
 
Figure 2.3: The Nazarov reaction and the formal homo-Nazarov reaction 
 
2.1 Earlier Examples of the Formal Homo-Nazarov Reaction 
Applying the underlying precept of the formal homo-Nazarov reaction, Murphy 
and Wattanasin used arylaroyl cyclopropanes 2-11 to synthesize tetralone derivatives 2-12 
for a 14-18% yield in 1980. Electron-rich benzenes were ketone substituents on the 
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cyclopropane. Upon treatment with acid (SnCl4, TFA, or BF3•Et2O) at room temperature, 
ring-opening resulted in the formation of a benzylcarbocation intermediate and ring 
closure. When electron-donating groups were replaced with hydrogen in either ring, C-C 
bond scission was slow, and carbinol 2-13 and tetrahydrofuran 2-14 products formed. 
Adducts were observed when both rings were substituted with donor, activating groups—
settling the mechanistic debate at the time. Although this approach was effective for 
assembling their target compounds, four equivalents of SnCl4 were used, and long reaction 
times were recorded for product formation (Figure 2.4).115,116  
 
Figure 2.4: Murphy’s formation of tetralones 
 
In 1988, further exploration of this chemistry was reported by Tsuge and co-
workers, who used 1-alkenyl cyclopropyl ketone 2-15 and excess polyphosphoric acid in 
benzene under reflux to synthesize 6-membered constructs similar to 2-16 (Figure 2.5).117 
For the representative example, 63% yield was obtained after 30 hours at 80 °C. Depending 
on the 1-alkenyl cyclopropyl ketones’ substitution patterns, the reaction furnished other 
side products, which may have been a result of the quantity of acid used. Drawbacks for 
this approach were narrow scope (five out of the sixteen precursors gave the desired 
cyclohexenones), low to moderate yields (15-63%), and harsh reaction conditions (long 
reaction times and stoichiometric acid). Hence, the development and application of this 
methodology was limited.   
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Figure 2.5: A representative example of Tsuge’s synthesis of an aryl cyclohexenone 
 
Further expansion of the formal homo-Nazarov methodology occurred in 2005 
when Otto et al. reported on heteroaryl-substituted cyclopropyl ketones’ reactivity, which 
was similar to that of 1-alkenyl cyclopropyl ketones (Figure 2.6).118 This protocol was the 
first formal homo-Nazarov cyclization example with heteroaryl cyclopropyl ketones to 
furnish [b]-annelated cyclohexenones. 2-Thienyl cyclopropyl ketone 2-17 and 2-furyl 
cyclopropyl ketone 2-18 yielded 54% and 95%, respectively, when subjected to acidic 
workup. If 2-furyl and 2-thienyl reactions were exposed to basic conditions, alcohols were 
obtained in a 40% yield for 2-furyl and a 70% yield for 2-thienyl.   
 
Figure 2.6: Otto’s heteroaromatic formal homo-Nazarov reaction 
 
Eventually, in 2008, this six-membered ring annulation was named the 
heteroaromatic homo-Nazarov cyclization by Kumar and Yadav, and the scope was 
expanded considerably.106 Heteroaryl 2-silylmethyl substituted cyclopropanes reacted with 
4.0 equiv. of SnCl4 in 1,2-dichloroethane at 80 °C. Precursors 2-23 and 2-24 afforded 2- or 
3-substituted heteroaromatic cyclohexenones 2-25 and 2-26 in 80-85% yield (Figure 2.7), 
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exquisitely establishing β-silyl groups as good stabilizing substituents for carbenium 
intermediates for this protocol.  
 
Figure 2.7: Yadav and Kumar’s heteroaromatic formal homo-Nazarov reaction 
 
Within the same year, Waser divulged a catalytic formal homo-Nazarov cyclization 
of activated cyclopropanes using p-TsOH to yield fused ring systems, similar to those in 
Tsuge’s report (Figure 2.8).119  
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Figure 2.8: Waser’s formal homo-Nazarov cyclization 
 
Waser experimentally investigated the mechanism for a Brønsted acid-catalyzed 
process because a pKa dependence suggested a stepwise route with cationic intermediates, 
and Waser wanted to improve the methodology (Figure 2.9). Waser discovered that the 
reaction was first-order for the acid catalyst concentration, which indicated catalyst 
involvement in the ring-opening step.  However, when attempting to verify this 
mechanistic postulation, Waser was not initially successful in trapping his model substrate 
2-27, shown in Figure 2.8. 
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Figure 2.9: Waser’s mechanism for the formal homo-Nazarov cyclization 
 
As an alternative to support the formation of the cationic intermediates, Waser treated 
cyclohexene cyclopropyl ketone 2-27 with water and other nucleophiles, but cyclized 2-28 
was observed only. In order to slow the rate, 2-37 was assembled. Standard reaction 
conditions caused 2-37 to react in a similar time to 2-27, and no cyclized product for 2-37 
was formed. When catalytic TsOH•H2O (20 mol%) in acetonitrile was used, 
polymerization occurred (Figure 2.10). Conditions with 5 vol% of water formed carbinol 
2-38; this result supported the plausibility of carbocationic intermediates. Therefore, if ring 
scission is facile, cyclized products form, but when cleavage is slow, polymerization and 
nucleophilic attack products becomes more favorable. Following the work of Kumar, 
Yadav, and Waser, Frontier published a Lewis acid-catalyzed approach to  heteroaromatic 
ring-fused cyclopentanones from heteroaryl vinyl ketones—commonly known as the 
heteroaromatic Nazarov cyclization.120 In order to fashion a relatively simple procedure for 
heteroaryl cyclohexenones assembled in previous protocols, we drew upon Frontier’s work 
for inspiration.  
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Figure 2.10: Waser’s cyclohexene cyclopropyl ketone trials 
 
2.2 Hypothesis and Synthetic Rationale for Heteroaromatic Cyclohexanone 
Synthesis 
Frontier and co-workers explored the effects of tuning the electronics of the 
Nazarov cyclization reaction. When they placed electron-donating and electron-
withdrawing functionalities in different localities on the pentadienone substrates and used 
a catalytic amount of acid, greater selectivity and reactivity were observed (Figure 2.11).120  
 
Figure 2.11: Frontier’s catalytic Nazarov cyclization of heteroaromatic alkenyl        
ketones  
 
From Frontier’s findings, our group proposed that classical, vic-substituted donor-acceptor 
cyclopropanes could be further polarized with a secondary gem-acceptor group and a 
stabilizing donor group in order to promote the formal homo-Nazarov cyclization.120–122 
The application of donor-acceptor-acceptor (D-A-A) cyclopropanes 2-41 is vast for other 
chemical transformations (Figure 2.12).123–135  
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Figure 2.12: vic-Donor-acceptor-acceptor cyclopropane reactivity 
 
If a metal coordinating ligand such as an ester in the α-position as the secondary substituent 
is used, localizing the charge density can further polarize the cyclic oxyallyl cation, which 
increases the charge predictability and reactivity of intermediate 2-42 designs (Figure 
2.13). 
 
Figure 2.13: Intermediate predictability 
 
For these reasons, milder reaction conditions with good yields are plausible for alkenyl and 
heteroaryl substituted ketones. The application of this chemistry could lead to a significant 
expansion in the reaction scope for the formal homo-Nazarov reaction. Consequently, the 
methods and protocols developed can be utilized for a diverse array of synthetic 
applications.   
The first example as “proof of concept” was reported by France et al. in 2010.  
Using 30 mol% In(OTf)3 in DCM at 25 °C, Patil and co-workers reported an efficient 
protocol for the formal homo-Nazarov cyclization of alkenyl cyclopropyl ketones 2-43 
which furnished methylene cyclohexenols 2-44 and cyclohexenones 2-45 (Figure 2.14).136 
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For this work, simple alkenes without an α-heteroatom worked, whereas Waser’s 
carbocyclic precursors afforded polymerization or carbinols but not the desired product. 
The research of Patil et al. was the first publication demonstrating the utility of D-A-A 
cyclopropanes in which the formal homo-Nazarov cyclization formed cyclohexenones and 
cyclohexenols using catalytic In(OTf)3. With this concept in mind, the France group 
published a related method for the heteroaromatic formal homo-Nazarov cyclization.137 
 
Figure 2.14: France’s formal homo-Nazarov cyclization for methylene cyclohexenols 
           and cyclohexenones 
 
Heteroaromatics are key structural components in the core of many natural 
products, biologics, and medicinally active molecules.138–143 Given their substantial 
chemical importance and relevance, heteroaromatics are convenient synthetic equivalents 
for increasing structural complexity.144–146 Organic chemists continue to develop efficient 
methods for their synthesis and incorporation into materials, polymers, and medicines.147–
151 We made use of the underexplored heteroaromatic formal homo-Nazarov ring closure 
to generate six-membered appendages to form assorted heteroaromatics. 
 To the best of our knowledge, as mentioned previously, only three examples of the 
heteroaromatic homo-Nazarov cyclization existed before our published protocol. Yadav106 
synthesized 4-silylmethyl/hydroxymethyl-substituted 2,3-heteroaromatic ring-fused 
cyclohexanones; Otto118 made 4,5-dihydrobenzo[b]thiophen-7(6H)-one and 4,5-
dihydrobenzo[b]furan-7(6H)-one, and Waser94 cyclized  a 2-indolyl substrate with p-
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TsOH. After a review of the literature mentioned, a rapid method for generating 
heteroaromatic ring-fused cyclohexanones under mild conditions was warranted for 
expansion of the reaction scope. Our approach was applied to these donor-acceptor-
acceptor cyclopropanes with heteroaromatics 2-46 to generate heteroaryl ring-fused 
cyclohexanones 2-47. 
 
Figure 2.15: Heteroaromatic formal homo-Nazarov cyclization with donor-acceptor- 
acceptor cyclopropanes 
 
2.3 Precursor Assembly and Reaction Optimization for Heteroaryl Cyclopropyl 
Ketones 
 For the initial investigation, we synthesized 2- and 3-heteroaryl cyclopropyl ketone 
precursors 2-51 in three steps, as shown in Figure 2.16. Prepared from their commercially-
available heteroaromatic carboxylic acid in situ, 2- and 3-substituted heteroaromatic acid 
chlorides 2-48 and lithium 1-methoxyethen-1-olate were used to form β-ketoesters 2-49. 
Diazotization61,62,152 generated α-diazoesters 2-50. Finally, Rh2esp2 (dirhodium α,α,α’,α’-
tetramethyl-1,3-benzenedipropanoate)-catalyzed cyclopropanation153 with the 
corresponding olefins afforded heteroaromatic cyclopropyl ketones 2-51. 
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Figure 2.16: Heteroaryl cyclopropyl ketone synthesis 
 
 Because thiophene is known for its stability in the presence of Lewis acids and 
usage in past protocols,154 2-thienyl cyclopropyl ketone 2-52 served as the main substrate 
for optimization using indium(III) catalysis previously reported by the France group for 
the alkenyl formal homo-Nazarov cyclization.136 When we subjected 2-52 to 30 mol% 
In(OTf)3, 2-53 formed with 88% yield in 2.5 hours (Table 2.1, entry 1), affirming our 
hypothesis for donor-acceptor-acceptor cyclopropanes as feasible participants in the 
heteroaromatic formal homo-Nazarov cyclization. Markedly, catalyst loading was lowered 
to 1 mol% and yielded 77% of the product with an increased reaction time of 6.5 hours 
(Table 2.1, entry 3). In the same manner, InCl3 furnished the product, although the reaction 
time was longer (4.5 hours), and the yield was lower (78%) (Table 2.1, entry 4). In the end, 
5 mol% In(OTf)3 resulted in the 2,3-ringfused cyclohexanone 2-53 having a yield of 86%, 
a yield comparable to that of (achieved by) the 30 mol% loading (Table 2.1, entry 2). In 
order to improve the reaction outcomes, we examined the effects of LiClO4 as an additive 
because previous protocols had successfully implemented the reagent in Sc(OTf)3- and 
In(OTf)3-catalyzed Friedel-Crafts acylations
155–157 and Nazarov cyclizations120,122. This 
proved to be futile since 1.0 equiv. of LiClO4 with InCl3 and In(OTf)3 salts resulted in poor 
conversion. Ultimately, 5 mol% In(OTf)3 in dichloromethane (DCM) at room temperature 
was chosen as the optimal condition.  
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Table 2.1: Reaction Optimization for Heteroaryl Cyclohexenones 
 
2.4 Results and Discussion 
 With the optimized reaction conditions established, we investigated 2- and 3-
substituted heteroaryl cyclopropyl ketones for their reactivity for indium(III) catalysis to 
ascertain scope and reactivity limits. In order to probe the 2-position versus the 3-position 
for thiophene precursors 2-52  and 2-56, we subjected 3-thienyl precursor 2-56 to the 
optimized conditions, which afforded cyclohexanone 2-57 in 73% yield with 1.7:1 dr 
(Table 2.2, entry 3). The diastereomeric ratios were based off of cis/trans isomers.  
Comparatively, this yield was lower than its 2-thienyl cogener 2-53 (86% with 1.5:1 dr) 
(Table 2.2, entry 1). Conversely, 3-furanyl substrate 2-58 (Table 2.2, entry 4) produced 
cyclohexanone 2-59 in 73% yield with 1.1:1 dr as opposed to its 2-substituted counterpart 
2-55 in 67% yield with 1.1:1 dr (Table 2.2, entry 2).  However, 2-substituted furyl precursor 
was heated to reflux in 1,2-dichloroethane at 84 ˚C because room temperature conditions 
gave a 28% yield with other side-products not observable at the elevated temperature. It is 
likely that the additional heat provided enough energy for the desired transition state barrier 
to be surpassed for the six-membered product. In the case of the 2-thienyl and 2-furyl 
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substrates, electrophilic aromatic substitution readily occurs at the 3-position, which is 
typically uncommon for these heteroaromatics, but not for systems with this particular 
arrangement. The N-methyl-2-indolyl cyclopropane 2-60 and N-methyl-3-indolyl 2-64 
substrates formed their corresponding annulated products 2-61 and 2-62 in 63% yield with 
1.2:1 dr (Table 2.2, entry 5) and 61% yield with 1.2:1 dr (Table 2.3, entry 2) respectively.  
 32 
Table 2.2: Heteroaromatic Formal Homo-Nazarov Cyclizations 
 
To our delight, 2-benzofuran 2-62 cyclized in 91% yield with 1.4:1 dr (Table 2.3, entry 1), 
and 3-benzofuran 2-66 cyclized in 71% yield with 1.2:1 dr (Table 2.3, entry 3). Attributable 
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to mild reaction conditions, competing polymerization of the benzofurans was minimized 
or avoided, highlighting the versatility of our protocol when matched to other reports in 
which benzofuran-derived substrates were unsuccessful for the ring closure under acidic 
conditions. 
 Until this work, 2,3-ring-fused heteroaromatics were investigated only for formal 
homo-Nazarov ring enlargement. According to our postulation, we envisioned that 3,4-
heteroaryl cyclohexanones could be formed as well. Therefore, we designed a 3-substituted 
cyclopropyl ketone with the 2-position blocked, as in 2-bromo thienyl cyclopropane 2-68, 
such that the 4-position is available for electrophilic attack. As anticipated, 3,4-fused 
heteroaryl cyclohexanone 2-69 formed in 56% yield (Table 2.3, entry 4) and represents the 
first example of its kind using a donor-acceptor-acceptor cyclopropane precursor. 
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Table 2.3: Heteroaromatic Formal Homo-Nazarov Cyclizations 
 
 Continuing to expand the reaction scope, we examined donor substituents which 
stabilize positive charge build-up. Phenyl precursors 2-70 and 2-72 formed ring-fused 
cyclohexanones 2-71 and 2-73 in 81% with 2.3:1 dr and 83% yield with 1.2:1 dr, 
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respectively (Table 2.3, entry 5 and Table 2.4, entry 1), with the elevated temperature. 
When we increased the donation with an additional gem-methyl group at the benzylic 
position to form a tertiary stabilized center, as in α-methyl styrene derivative 2-74, the 2-
75 product was formed in 71% yield with 2.0:1 dr (Table 2.4, entry 2) under standard 
conditions (no heat) with a shorter reaction time (4.5 hours). Presumably, in addition to the 
electronic effect described, a steric effect could have also contributed to the cyclization 
result, unlike the phenyl substrate 2-70 which required heating for product formation.  
Likewise, indanyl precursor 2-76 afforded tetracycle 2-77 in 87% yield (Table 2.4, entry 
3). Enlightened by Yadav’s report that silyl moieties provide additional stability through 
the donating β-silyl effect for the formal homo-Nazarov cyclization,106 we synthesized 
TBDPS substrate 2-78; the methylsilyl cyclopropane furnished 2-79 in 71% yield with 
2.4:1 dr (Table 2.4, entry 4).  
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Table 2.4: Effects of Cyclopropyl Substituents on the Cyclization 
 
 After demonstrating that heteroaryl donor-acceptor-acceptor cyclopropanes are 
adequate reactants for the homo-Nazarov cyclization in which disparate heteroaromatic 
ring-fused cyclohexanones are generated, we sought to decrease the number of steps for 
product formation. Since the Rh(II)-catalyzed cyclopropanation and In(III)-catalyzed ring 
enlargement readily proceed in dichloromethane at room temperature, we explored a one-
pot procedure by conducting two control reactions. We stirred α-diazoester 2-80 with 5 
mol% In(OTf)3; the diazo was stable and degradation was minimal in the presence of the 
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Lewis acid. Then, we monitored 4-methoxy styrene stability with Rh2esp2 and In(OTf)3. 
For an active ~20 mol% indium catalyst loading, 1 mol% of Rh2esp2 and 0.2 mol% of 
In(OTf)3 in dichloromethane at 0 °C as the initial reaction conditions gave a 56% yield of 
the desired ring-fused cyclohexanone 2-82, which is higher than the two-step process and 
equates to a yield of approximately 75%  for each individual step (Figure 2.17).    
 




 In summary, the original hypothesis for the heteroaromatic formal homo-Nazarov 
reaction using donor-acceptor-acceptor cyclopropanes was verified through experimental 
results. Heteroaryl donor-acceptor-acceptor cyclopropanes gave better yields (56-91%) 
under milder conditions to form functionalized heteroaryl ring-fused cyclohexenones. 
Furthermore, we demonstrated the viability of a one-pot protocol. As a consequence of the 
ubiquity of heteroaromatics in natural products and medicinally relevant compounds, this 
efficient methodology could be utilized and included in synthetic routes for compounds 
containing fused heteroaromatic cyclohexenones.  
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France, S. A Catalytic Homo-Nazarov Cyclization Protocol for the Synthesis of 
Heteroaromatic Ring-Fused Cyclohexanones. Org. Lett. 2011, 13, 1952–1955. 
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2.7 Experimental Information 
2.7.1 Synthetic Methods for Heteroaromatic Cyclohexenone Preparation 
 Infrared (IR) spectra were obtained using a Nicolet 4700 FTIR with an ATR 
attachment from SmartOrbit Thermoelectronic Corp. Proton and carbon nuclear magnetic 
resonance spectra (1H NMR and 13C NMR) were recorded on a Varian Mercury Vx 300 
spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm; 
13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, bs = broad singlet, d = doublet, dd = doublet of doublets, dt = 
doublet of triplets, dq = doublet of quartets, ddd = doublet of doublet of doublets, ddt = 
doublet of doublet of triplets, dtd = doublet of triplet of doublets, t = triplet, bt = broad 
triplet, td = triplet of doublets, q = quartet, qd = quartet of doublets, qn = quintet, m = 
multiplet), coupling constants (Hz), and integration. Mass spectra were obtained with a 
VG-70SE instrument.  
 Chromatographic purification was performed as flash chromatography using 
Dynamic Adsorbents silica gel (32-65µm), using the solvents indicated as eluent with 0.1-
0.5 bar pressure. For quantitative flash chromatography technical grades solvents were 
used. Analytical thin-layer chromatography (TLC) was performed on EMD silica gel 60 
F254 TLC glass plates. Visualization was accomplished with UV light, aqueous basic 
potassium permanganate (KMnO4) solution, iodine, aqueous acidic 
dinitrophenylhydrazine (DNP) solution, aqueous acidic p-anisaldehyde (PAA) solution, 
and ethanol solution of phosphomolybdic acid (PMA) followed by heating.   
 Yields refer to isolated yields of analytically pure material unless otherwise noted. 
All reactions were carried out in oven-dried glassware under an atmosphere of N2, unless 
stated otherwise. Tetrahydrofuran and diethyl ether were distilled from a 
sodium/benzophenone ketyl under N2 and stored in a Schlenk flask. 1,2-Dichloroethane 
and dichloromethane were purified by distillation from calcium hydride under N2 prior to 
 40 
use. Acetonitrile was dried by fractional distillation over CaH2. Benzene was purified by 
drying with CaH2. Lithium bis(trimethylsilyl)amide (LiHMDS) was purchased from 
Sigma-Aldrich as a 1.0 M solution in THF.  N-Butyllithium was purchased from Sigma-
Aldrich as a 2.5 M solution in hexanes.  T-Butyllithium was purchased from Sigma-Aldrich 
as a 1.0 M solution in hexanes.   Nitromethane was distilled over CaH2 and stored under 
nitrogen under 4 Å molecular sieves. All other reagents were purchased from Acros, 
Sigma-Aldrich, Fluka, VWR, Merck, Alfa Aesar, TCI and Strem (for metal catalysts) and 
used without further purification unless otherwise noted. Compounds  2-49 were made with 
a modified Warner’s method.158  β-Ketoester for compound 2-58 was prepared with a 
modified version of Frontier’s method.120  Compound 2-66 was prepared with Kanda’s 
protocol.159 Compounds synthesized and not reported in the literature until our publication 
are listed below. Dr. Lien H. Phun and Dr. Dadasaheb V. Patil synthesized the precursors 
as well. 
2.7.2 General Procedure for α-Diazo Esters 
 In a flame dried flask containing a solution of the β-ketoester in acetonitrile (0.2 
M), NEt3 (1.2 equiv.) was added.  After vigorous stirring for 5 minutes, tosyl azide (1.2 
equiv.) was added, and the reaction was stirred for 3 hours.  After complete disappearance 
of the starting material, the mixture was concentrated in vacuo and purified by column 
chromatography, which furnished the desired diazo compound.136 
 
Methyl 2-diazo-3-oxo-3-(thiophen-2-yl)propanoate (2-50a):  According to the general 
procedure, to a solution of the 2-thienyl β-ketoester  (1.50 g, 8.14 mmol) in acetonitrile, 
NEt3 (1.4 mL, 9.77 mmol) and tosyl azide (1.93 g, 9.77 mmol) were added. Column 
chromatography (10% EtOAc/Hex, Rf= 0.25) furnished the diazo as a bright yellow oil 
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(1.20 g, 69.5%). 1H NMR (CDCl3, 300 MHz) δ ppm  8.06 (dd, J = 3.91, 1.12 Hz, 1H), 7.66 
(dd, J = 4.99, 1.12 Hz, 1H), 7.26 (s, 1H), 7.12 (dd, J = 4.98, 3.92 Hz, 1H), 3.92-3.82 (s, 
3H) ppm.  13C NMR (CDCl3, 75 MHz) δ ppm 176.3, 161.1, 141.2, 133.8, 127.6, 52.2 ppm.  
IR: 3100 (m), 2947 (m), 2146 (s, N2 stretch), 1721 (s), 1712 (s), 1692 (s), 1617 (s), 1604 
(s), 1433 (m), 1299 (s) cm-1.  HRMS(ESI) M/Z+ Calc. 210.0099, Obs. 210.0095. 
 
Methyl 2-diazo-3-(furan-2-yl)-3-oxopropanoate (2-50b): According to the general 
procedure, to a solution of the 2-furyl β-ketoester (0.75 g, 4.46 mmol) in acetonitrile NEt3 
(0.75 mL, 5.35 mmol) and tosyl azide (1.06 g, 5.35 mmol) were added. Column 
chromatography (10% EtOAc/Hex, Rf = 0.20) gave the diazo as a bright yellow oil (0.614 
g, 71.0%).  1H NMR (CDCl3, 300 MHz) δ ppm 7.62-7.44 (m, 1H), 7.28-7.20 (m, 1H), 6.72-
6.19 (m, 1H) 3.90-3.82 (s, 3H).  13C NMR (CDCl3, 75 MHz) δ ppm 170.7, 161.5, 150.4, 
146.0, 145.9, 119.4, 112.3, 52.5.   IR: 3102 (w), 2953 (w), 2140 (s, N2), 1717 (s), 1584 (s), 
1514 (m), 1434 (m), 1410 (w) cm-1.  HRMS(ESI) M/Z+ Calc. 194.0328, Obs. 194.0323. 
 
 
Methyl 3-(benzofuran-2-yl)-2-diazo-3-oxopropanoate (2-50c):   According to the 
general procedure, to a solution of the 2-benzofuryl β-ketoester (0.76 g, 3.50 mmol) in 
acetonitrile NEt3 (0.60 mL, 4.22 mmol) and tosyl azide (0.81 g, 4.22 mmol) were added. 
Column chromatography (10% EtOAc/Hex, Rf = 0.20) afforded the diazo as a bright yellow 
oil (0.48 g, 57.0%). 1H NMR (CDCl3, 300 MHz) δ ppm  8.77 (s, 1H), 8.17 (ddd, J = 4.15, 
2.91, 0.69 Hz, 1H), 7.83 (d, J = 8.34 Hz, 1H), 7.65-7.45 (m, 1H), 7.42-7.28 (m, 1H), 3.93-
3.80 (m, 1H)  13C NMR (CDCl3, 75 MHz) δ ppm 172.1, 161.4, 155.0, 150.5, 128.3, 126.8, 
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123.9, 123.4, 115.1, 112.2, 52.6.  IR:  3129 (w), 2950 (w), 1737 (s), 1671 (s), 1555 (s), 
1446 (m), 1316 (w), 1246 (m), 1123 (s), 1088 (m) cm-1.  HRMS(ESI) M/Z+ Calc. 
244.0484, Obs. 244.0479. 
2.7.3 General Procedure for Heteroaryl Cyclopropyl Ketones 
 In a flame dried flask containing a solution of Rh2esp2 (0.1 mol%) in DCM (0.2 M) 
at 0 °C the corresponding alkene (1.0 equiv.).  After stirring the catalyst and olefin for 5 
minutes, a solution of the α-diazo ester (0.2 M) was added in one shot, and the mixture was 
then  stirred for an additional 10 minutes at 0 °C.  At this time, the ice bath was removed, 
and the reaction was allowed to warm up to room temperature.  After two hours, the 
reaction was quenched with saturated thiourea (aqueous) and allowed to stir for 30 minutes.  
The mixture was transferred to a separatory funnel and extracted with CH2Cl2 (3x).  The 
organic layer was washed with brine, dried with Na2SO4, and concentrated, and column 
chromatography afforded the desired cyclopropyl heteroaryl ketones. 
 
Methyl 2-phenyl-1-(thiophene-2-carbonyl)cyclopropanecarboxylate (2-70):  
According to the general procedure, to a solution of Rh2esp2 (0.83 mg, 0.1 mol%) in 
dichloromethane, styrene (0.113 g, 1.09 mmol) was added, followed by a solution of the 
α-diazo ester  (0.30 g, 1.43 mmol). The reaction was quenched and column 
chromatography (10% EtOAc/Hex) afforded 2-70 as a solid (0.198 g, 81%). 1H NMR 
(CDCl3, 300 MHz) δ ppm 7.72 (d, J = 1.13 Hz, 1H), 7.71 (d, J = 1.13 Hz, 1H), 7.67 (d, J 
= 1.12 Hz, 1H), 7.65 (d, J = 1.12 Hz, 1H), 3.49 (dd, J = 8.98, 8.32 Hz, 1H), 3.30 (s, 3H), 
2.38 (dd, J = 8.10, 5.05 Hz, 1H), 1.67 (dd, J = 9.17, 5.04 Hz, 1H)  13C NMR (CDCl3, 75 
MHz) δ ppm 186.2, 168.7, 143.0, 134.7, 133.9, 132.5, 129.0, 128.1, 127.5, 127.2, 52.3, 
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42.5, 30.4, 19.4 ppm.  IR:  3036 (w), 2947 (w), 1745 (s), 1656 (s), 1409 (s), 1271 (s), 1141 
(s), 1197 (s), 1040 (s), 957 (s) cm-1. HRMS(ESI) M/Z+ Calc. 286.0670, Obs. 286.0697.    
2.7.4 Catalyst Screening for Heteroaromatic Cyclohexenone Formation 
 To a flame dried flask containing the indium catalyst with the appropriate loading 
(1, 5, or 30 mol%) in anhydrous CH2Cl2 (0.2 M) was added cyclopropane 2-52. The 
reaction was monitored via TLC, and upon complete disappearance of the starting material, 
the reaction was quenched with H2O.  The mixture was extracted with CH2Cl2 and dried 
with Na2SO4, and column chromatography (10% EtOAc/Hex) provided 2-53. 
2.7.5 General Procedure for the Lewis Acid-catalyzed Formal Homo-Nazarov 
Cyclization for Heteroaromatic Cyclopropyl Ketones  
 To a flame dried flask containing In(OTf)3 (5 mol%) in anhydrous CH2Cl2 (0.2M) 
was added the corresponding cyclopropane.  The reaction was monitored via TLC, and 
upon complete disappearance of the starting material, the reaction was quenched with H2O.  
The mixture was extracted with CH2Cl2 and dried with Na2SO4, and column 
chromatography provided the fused heteroaromatic cyclohexanones. 













CHAPTER 3  IN(III)-CATALYZED RING-OPENING/FRIEDEL-
CRAFTS ALKYLATION SEQUENCE FOR HYDROPYRIDO[1,2-
A]INDOLE ASSEMBLY 
 The hydropyrido-[1,2-a]indole core, a 6-5-6 tricycle, is arguably one of the most 
privileged scaffolds in the indole alkaloid family. This 6-5-6 indolic skeleton and its C(6)-
oxidized cogeners 3-7 are common structural motifs in natural products, marketed 
therapeutics, and other useful compounds (Figure 3.1).142,148,160–167 Organic chemists have 
devised numerous approaches and strategies to specifically construct the indole 
derivatives.168–172 Typically, routes append a piperidine ring onto an indole framework to 
form the hydropyrido-[1,2-a]indole tricycle through the following synthetic means:173 
acid-promoted cyclizations,174,175 cycloadditions,176–180 Pauson-Khand reactions,181 radical 
cyclizations,162,182–186 nucleophilic substitutions,187,188 transition metal-catalyzed C-C bond 
formations,189–195 transition metal-catalyzed oxidative C-H/N-H cyclizations,196 
condensations,197–201 and domino reactions.173  Depictive examples of each reaction type 
are presented below. 
 
Figure 3.1: Hydropyrido[1,2-a]indole core in natural products 
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3.1 Common Transformations for Pyridoindole Formation 
 In 2004, Letica Perez-Serrano et al. published the first examples of using the 
Pauson-Khand reaction for indole chemistry in order to synthesize diverse tetracyclics 3-
9, 3-10, and 3-11 in a small number of steps (Figure 3.2).  With Co2(CO)8 as the active 
catalyst over molecular sieves, 1,2-fused, 2,3-fused and 3,3a,4-fused systems were 
constructed. Various reaction conditions were explored to give good yields of 
intermediates potentially applicable for natural alkaloid synthesis and derivatization.181  
 
Figure 3.2: Pauson-Khand ring closure for pyridoindole derivatives 
 
 Haider and Käferböck published a method on the construction of annulated 
carbazoles 3-13 by intramolecular, inverse electron demand Diels-Alder (IEDDA)  
reactions in 2004 (Figure 3.3). Educts 3-12 were synthesized and heated in 1,3,5-
triisopropylbenzene (TIPB) at 232 °C for 15 hours to 14 days.  After [4+2] cycloaddition, 




Figure 3.3: Inverse-electron-demand Diels-Alder reaction for annulated carbazoles 
 
  In 2006, Tanaka et al. synthesized 3-anilino-4-(3-indolyl)maleimide derivative 3-
16 for inhibition of protein kinase Cβ (PKCβ) for diabetes studies (Figure 3.4).  To obtain 
a more potent and selective inhibitor, they assembled conformationally-restricted 
tetrahydropyrido[1,2-a]indole 3-16. Acetal 3-14 underwent an acid-catalyzed ring closure 
to form pyrido[1,2-a]indole 3-15 in 95% yield after trifluoroacetic acid (TFA) exposure in 
water and hydrogenation with palladium on carbon.174 
 




 Khdour et al. designed a new methide reductive alkylating agent 3-17 to study 
quinone methide chemistry in 2006 (Figure 3.5). Cyclopropyl quinone methide 3-17 was 
formed from pyrido[1,2-a]indole 3-18. In the synthetic route, one of the important steps to 
generating the pyrido[1,2-a]indole arose from condensation of indole 3-19  under basic 
conditions with γ-butyrolactone followed by acidification with polyphosphoric acid to 
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afford 3-20, a necessary precursor for the synthesis of 3-18. The condensation provided a 
direct route for appending the six-membered piperidine ring to the indole.198 
 
Figure 3.5: Intermolecular condensation for cyclopropyl quinone methide synthesis 
 
 In 2008, Kerr reported the first total synthesis of (±)-mersicarpine 3-23. In order to 
assemble the hydropyrido[1,2-a]indole framework, he implemented a malonic radical ring 
closure (Figure 3.6). 3-21 was subjected to Mn(OAc)3 in acetic acid at reflux after 1,4-
addition to give a 60% yield of 3-22. Other substrates and conditions were examined for 
optimization of the radical cyclization. With this cyclization method, Kerr and co-workers 
were able to rapidly assemble the desired skeleton for the natural product.162  
 
Figure 3.6: Kerr’s Mn(III)-radical cyclization for the synthesis of (±)-mersicarpine 
 
 In the same year as Kerr’s mersicarpine report, Morales and Pagenkopf published 
the shortest total synthesis of (±)-goniomitine 3-26 using a donor-acceptor cyclopropane 
[3+2] cyclization to give 5.2% yield of the target in 17 steps (Figure 3.7). This report 
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highlighted the fact that microwaves could be used to enhance reactivity to decrease 
reaction times. In order to form tetracycle 3-25, Kerr subjected nitrile 3-24 to POCl3 in 
toluene followed by sodium borohydride in methanol. Nitrile 3-25 was afforded in 84% 
yield.187 
 
Figure 3.7: Morales and Pagenkopf’s nucleophilic substitution for tetracycle        
         formation  
 
 In 2008, Li et al. published a protocol for the synthesis of fused substituted indoles 
from N-(2-alkynylphenyl)lactams 3-27 by using a PtCl4/PtCl2-catalyzed 
cylcoisomerization with molecular oxygen in 1,2-dichloroethane at reflux (Figure 3.8). 
Various moieties were tolerated at the terminus of the γ-lactam precursors and benzene 
ring to furnish differing sizes and substitutions for the indoles in 33-89% yield. For the 
transformation, a Pt-catalyzed cyclization, 1,2-acyl migration, and 1,2-migration of R1 to 
the platinum carbenoid formed indoles 3-28 and 3-29.189 
 
Figure 3.8: PtCl4/PtCl2-catalyzed cycloisomerization for hydropyrido[1,2-a]indole      
         synthesis 
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 In 2009, Du et al. reported a unique N-heterocyclic carbene-catalyzed domino 
cyclization to generate 6-5-6 tricyclic hydropyrido[1,2-a]indoles (Figure 3.9). Using 
formylcyclopropane 1,1-diesters 3-31, they formed hydropyrido[1,2-a]indoles 3-33 from 
halogenated indoles 3-30 and N-heterocyclic carbene 3-32 by using a domino ring-
opening/redox amidation/cyclization sequence. Aryl and alkyl groups were tolerated about 
the cyclopropane ring, and halogens, donating alkyl and methoxy groups were substituted 
on the indole’s benzene ring. Although the conversions were high for 3-30, the isolated 
yields were lower (33-76%).173  
 
Figure 3.9: Wang’s N-heterocyclic carbene-catalyzed domino ring-opening/redox  
         amidation/cyclization reaction 
 
 In 2015, Zhou et al. published a one-pot rhodium(III)-catalyzed intramolecular 
redox-neutral annulation of tethered alkynes formed pyrido[1,2-a]indoles 3-35 (Figure 
3.10). Alkyne 3-34 was treated with a dirhodium catalyst with cesium acetate, acetic acid, 
and 1,2-dichloroethane at 70 ˚C  reacted for 6 hours; then, dioxane/HCl mixture was added 
and reacted at 60 ˚C for an additional 4 hours to give pyridoindoles 3-35 in 52-70% yield.   
This redox-neutral protocol utilized mild reaction conditions and encompassed a broad 
substrate scope since electron-releasing and electron-accepting groups were well tolerated. 
Without any oxidant, the reactivity occurs with a reversal in regioselectivity for the 
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pyrido[1,2-a]indole systems. To demonstrate that the method was translational, the group 
applied the rhodium(III)-catalyzed C-H activation/annulation protocol for the formal total 
synthesis of (±)-goniomitine 3-26.196 
 
Figure 3.10: Li’s rhodium(III)-catalyzed redox-neutral annulation protocol  
 
3.2 Hypothesis and Synthetic Rationale for Hydropyrido[1,2-a]indole Synthesis 
 Many of the strategies above require multistep processes to obtain the 
hydropyrido[1,2-a]indole framework because the reaction scope maybe limited due to the 
reagents employed for the transformation. Therefore, the discovery of a new, efficient 
method for a facile chemical process for the construction of hydropyrido[1,2-a]indoles is 
a formidable challenge for synthetic chemists. From our previous protocols, we envisaged 
the rapid formation of the 6-5-6 tricycle using donor-acceptor-acceptor and donor-donor-
acceptor-acceptor cyclopropanes.    
 In a previous publication, Patil et al. disclosed the synthesis of methylene 
cyclohexenols and cyclohexenones in good to high yields (up to 93%) from alkenyl 
cyclopropyl ketones that bore an additional α-coordinating electron withdrawing group 
(such as an ester) as reactive donor-acceptor-acceptor cyclopropanes for the formal homo-
Nazarov cyclization (Figure 3.11, Scheme 1).136 Later, the France group divulged another 
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Lewis acid-catalyzed approach for heteroaromatic ring-fused cyclohexanones in moderate 
to good yields (56-91%) via the formal homo-Nazarov cyclization by using heteroaryl 
cyclopropyl ketones (Figure 3.11, Scheme 2).137  
 
Figure 3.11: France’s Lewis acid-catalyzed cyclopropane ring-opening/cyclization               
earlier reports 
 
 As a direct result of this unique reactivity for cyclopropyl ketone donor-acceptor-
acceptor cyclopropanes, the synthesis of hydropyrido[1,2-a]indoles 3-42 was envisioned 
to arise from a Lewis acid-catalyzed ring enlargement (Figure 3.12). We aimed to construct 
hydropyrido[1,2-a]indoles from indolyl-donor-acceptor-acceptor cyclopropanes 3-41 such 
that the indole would act as a π-nucleophile upon Lewis acid activation of the 
cyclopropanes. Therefore, cyclopropane bond scission would afford an aza-cationic 
intermediate to give annelated six-membered lactams. Precursor 3-43 was used as the 
model substrate. We supposed that the p-methoxyaryl group would stabilize charge buildup 
at the benzylic position upon ring-opening.  If bond scission occurred heterolytically, as in 
Figure 3.12, the indole would participate as a π-nucleophile202 for an intramolecular 
Friedel-Crafts alkylation.123 Subsequent rearomatization would form 3-42, incorporating a 
nitrogen atom into the newly formed ring, generating the lactam functionality of 
hydropyrido[1,2-a]indole-6(7H)-ones 3-42. Given our previous successful protocols, we 
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anticipated high yields, mild reaction conditions, and variety in functionalization. We 
synthesized precursors, optimized the reaction conditions, and determined the reaction 
scope. 
 
Figure 3.12: Hypothesis and mechanistic rationale for the formation of    
hydropyrido[1,2-a]indoles 
 
3.3 Precursor Assembly and Reaction Conditions for Hydropyrido[1,2-a]indoles 
 We prepared the cyclization precursors in three steps starting with commercially-
available indoles 3-44 and methyl malonyl chloride (MMC). N-Acylation under basic 
conditions afforded β-amidoesters 3-45. Subsequent diazo transfer62,152,153 gave 1,3-
dicarbonyl compound 3-46. Rh(II)-catalyzed cyclopropanation62,153 with Rh2esp2 in the 
presence of the requisite alkene afforded methyl 1-(1H-indole-carbonyl)-1-
cyclopropanecarboxylates 3-47 in good yields (up to 70%) over three steps.  Since In(OTf)3 
was an effective catalyst for ring-opening cyclizations in our previous report,  30 mol% 
In(OTf)3 in dichloromethane at room temperature was implemented as the initial reaction 
condition. To our delight, 3-48 was formed in 99% yield with 2.6:1 trans:cis dr (as 




Figure 3.13: Precursor assembly for hydropyrido[1,2-a]indoles 
 
3.4 Results and Discussion  
To probe electronic effects, we examined differing donors and electron-
withdrawing moieties about the aryl ring of the cyclopropane. Like precursor 3-43, 2-
methoxy phenyl precursor 3-49 provided 3-50 in 95% yield with 3.2:1 dr (trans:cis ratio) 
(Table 3.1, entry 2). When phenyl derivative 3-51 was subjected to the same reaction 
conditions at room temperature, starting material was recovered after t>24 hours, and none 
of the desired product 3-52 was formed. Upon reflux in 1,2-dichloroethane with 30 mol% 
In(OTf)3, 3-51 furnished 3-52 in 52% yield with 2.6:1 dr (Table 3.1, entry 3). Other 
withdrawing-substituted precursors 3-53, 3-55, and 3-57 did not cyclize at room 
temperature either, but the desired product was observed in 1,2-dichloroethane after reflux. 
4-Fluorophenyl 3-53 and 4-chlorophenyl 3-55 cyclopropanes gave tricycles 3-54 and 3-56 
in 48% yield with 2.6:1 dr and 50% yield with 1.9:1 dr, respectively (Table 3.1, entries 4 
and 5). 4-Nitro derivative 3-57 formed trace amounts of cyclized product 3-58 as 
determined by crude 1H NMR (Table 3.2, entry 1). From these observations, ortho- and 
para-substituted donors are favorable substituents for the ring-opening/Friedel-Crafts 
alkylation sequence. As we anticipated, deactivating, electron-withdrawing substituents, 
viz. fluoro, chloro, and nitro had lower yields, whereas the activating substituents (o-and-
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p-methoxy subunits) have a higher yields and a greater stabilizing effect. Some of these 
results reflect the stabilities of benzylic carbocations.203,204  Although nitro is too 
withdrawing, the fluoro and chloro product yields are reasonable, and these halogens 
provide a chemical handle for further derivatization. 
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Table 3.1: Electronic Effects with Differing Benzenoids 
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The next step to exploring the reactivity was to utilize a heteroaromatic as a donor 
substituent. Furyl cyclopropane 3-59 gave cyclized product 3-60 in near quantitative yield 
(99%) with 4.5:1 dr (Table 3.2, entry 2) at room temperature. This was an exciting finding 
because furyl-based products had formerly been shown to polymerize. Other donor groups 
were investigated. α-Methyl styrene 3-61 readily reacted at room temperature as well to 
afford 3-62 in 94% with 1.1:1 dr (Table 3.2, entry 3) with a greater accelerating effect. 
Compared to the phenyl derivative 3-51, 3-61 displayed enhanced reactivity, presumably 
due to the additional strain caused by the methyl group and the increased stability from a 
benzylic carbocation to a 3˚ benzylic carbocation. Moreover, a quaternary stereocenter was 




Table 3.2: Donor and Acceptor Effects 
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 In accordance with the increased reaction rate, high yield, and additional stability 
provided by alkyl donation to an intermittent benzylic carbonium, gem-disubstituted alkyl 
groups at the donor position of the cyclopropane were employed. Since 3˚ carbocations 
and benzylic carbocations are proportional in energy, cyclized products should be formed 
from the geminal precursors. To explore this premise, we assembled  3-63 (2-ethyl-butene 
derivative), 3-65 (methylene cyclopentane), and 3-67 (methylene cyclohexane) and 
subjected 3-63 to 30 mol% In(OTf)3 at room temperature, but no product was afforded. 
When heated in 1,2-dichloroethane at reflux with 30 mol% In(OTf)3, 3-63, 3-65, and 3-67 
afforded hydropyrido[1,2-a]indoles 3-64 (85% yield, Table 3.2, entry 4), 3-66 (88% yield, 
Table 3.2, entry 5), and 3-68 (79% yield, Table 3.3, entry 1). The products mentioned so 
far are synthetic accomplishments in that 1) spirocyclics (e.g., 3-66 and 3-68) can be made 
from 1,1-disubstituted alkenes, 2) alkyl group utilization for this methodology used to be 
limited to Tsuge’s protocol,117 and 3) many hydropyrido[1,2-a]indole natural products 
have gem-dialkyl substituents at C(9). 
Continuing with donor group examinations, we investigated the use of a 2-
silymethyl group for additional stabilization as reported in Yadav’s recent work106 which 
used 2-silylmethyl-substituted heteroaromatic cyclopropanes for the formation of tricyclo-
2,3-heteroaromatics. 2-silylmethyl cyclopropane 3-69 reacted to form 3-70 in 82% with 
one observable diastereomer (Table 3.3, entry 2).  According to Yadav’s postulation,106 the 
silyl group stabilized the carbocation upon ring-opening through anchimeric assistance 
from a silyl group.205–208 This stabilizing hyperconjugative effect promoted ring 
enlargement in Yadav’s case, and we postulated that it would be effective in our case. 
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Table 3.3: Substrate Scope 
 
After investigating aryl, alkyl, and silyl moieties as reactive subunits, we probed 
heteroatom-donating groups, in particular, oxygen, sulfur, nitrogen groups, for their 
effectiveness. When phthalimido 3-71, a masked amine, was substituted as the stabilizing 
group, 3-72 was obtained in 55% yield with 4.8:1 dr (Table 3.3, entry 3). Vinyl phenyl 
thioether derivative 3-73 gave 3-74 in 81% yield with 6.3:1 dr (Table 3.3, entry 4).  
Unfortunately, when we attempted to synthesize the dihydrofuran and Cbz-protected ring-
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fused piperdinyl cyclopropanes, cyclopropanes were not synthesized with our Rh(II)-
catalyzed cyclopropanation general procedure. β,γ-unsaturated carbonyl compounds 3-75 
and 3-76 in Figure 3.14 were obtained for dihydropyran and Cbz-protected 
tetrahydropyridine. Therefore, we were not able to investigate the reactivity of the desired 
cyclopropane precursors for our protocol.  
 
Figure 3.14: β,γ-unsaturated-δ-heteroatom 1,3-dicarbonyl amides obtained from the 
                Rh(II)-catalyzed method 
 
Given these findings, we attempted to ascertain the flexibility of our protocol if the 
3-methyl indole were altered to other tolerable moieties that would be useful for natural 
product applications. 3-77 (derived from 1H-indole) affirmed that 3-substitution on the 
indole was not necessary for cyclization because 3-78 was formed in 99% yield with 1.1:1 
dr (Table 3.4, entry 1). 3-(2-Bromoethyl)-1-H-indole cyclopropane 3-79 afforded 3-80 in 
99% yield with 2.7:1 dr (Table 3.4, entry 2) with the bromine remaining intact throughout 
the cyclization and workup. This bromine group provides another chemical site for further 
functionalization. Similarly, phthalimid-protected tryptamine derivative 3-81 generated 3-
82 in 76% yield with 2.8:1 dr (Table 3.4, entry 3), which can be deprotected to give a free 
amine. Finally, methyl 3-(1H-indol-3-yl)propanoate derivative 3-83 provided 3-84 in 88% 









 In summary, an efficient catalytic ring-opening/Friedel-Crafts alkylation sequence 
procedure for hydropyrido[1,2-a]indole-6(7H)-ones was designed. Product yields ranged 
from 48-99% in four steps from readily accessible indoles and olefins. This Friedel-Crafts 
alkylation transformation is modular, atom economical, and robust, allowing for a variety 
of functionalized products to be formed. Attributable to the valued products formed, our 
method is applicable to highly efficient constructions of complex skeletons of natural 
products and biologically-active molecules.   
3.6 Research Participants 
This research was conducted with Dr. Dadasaheb V. Patil and Paul Grzybowski. They 
made the precursors and the final products.  
This work was published in Chemical Communications:  Patil, D. V.; Cavitt, M. A.; 
Grzybowski, P.; France, S. An Efficient Synthesis of hydropyrido[1,2-a]indole-6(7H)-
Ones via an In(III)-Catalyzed Tandem Cyclopropane Ring-opening/Friedel-Crafts 
Alkylation Sequence. Chem. Commun. Camb. U. K. 2011, 47, 10278–10280. 
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3.7 Experimental Information 
3.7.1 Synthetic Methods for Hydropyrido[1,2-a]indole Preparation 
 All reactions were carried out in pre-dried glassware from the oven, and any 
additional moisture was removed by flame drying the reaction vessel.  Each reaction 
proceeded under a nitrogen atmosphere, and dry solvents were used, unless stated 
otherwise. Tetrahydrofuran and diethyl ether were distilled from a sodium/benzophenone 
ketyl under nitrogen and stored in a Schlenk flask. 1,2-Dichloroethane and 
dichloromethane were purified by distillation from calcium hydride under N2 prior to use. 
Acetonitrile was dried by fractional distillation over CaH2. Benzene was purified by drying 
with CaH2. All other reagents were purchased from Acros, Sigma-Aldrich, Fluka, VWR, 
Merck, Alfa Aesar, TCI and Strem (for metal catalysts) and used without further 
purification.  
 Chromatographic purification was performed as flash chromatography with 
Dynamic Adsorbents silica gel (32-65µm) and solvents indicated as eluent with 0.1-0.5 bar 
pressure. For quantitative flash chromatography, technical grade solvents were utilized. 
Analytical thin-layer chromatography (TLC) was performed on EMD silica gel 60 F254 
TLC glass plates. Visualization was accomplished with UV light, aqueous basic potassium 
permanganate (KMnO4) solution, iodine, aqueous acidic dinitrophenylhydrazine (DNP) 
solution, aqueous acidic p-anisaldehyde (PAA) solution, and an ethanol solution of 
phosphomolybdic acid (PMA) followed by heating. Each yield refers to isolated 
analytically pure material.  
 Infrared (IR) spectra were obtained using a Nicolet 4700 FTIR with an ATR 
attachment from SmartOrbit Thermoelectronic Corp. The IR bands are characterized as 
weak (w), medium (m), and strong (s). Proton and carbon nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) were recorded on a Varian Mercury Vx 300 spectrometer 
or a Varian Mercury Vx 400 spectrometer with solvent resonances as the internal standard 
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(1H NMR: CDCl3 at 7.26 ppm; 
13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported 
as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, dd = doublet of 
doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, t = triplet, m = 
multiplet), coupling constants (Hz), and integration. Mass spectra were obtained using a 
VG-70SE instrument. Compounds synthesized and not reported in the literature until our 
publication are listed below. Dr. Dadasaheb V. Patil and Paul Grzybowski synthesized the 
precursors and the final products as well. 
 
3.7.2 Preparation of β-Amide Esters 3-45 
 A heterogeneous solution of sodium hydride (1.1 equiv.) and THF (20 mL) was 
formed and cooled to 0 °C.  In a separate flask, the desired indole (1.0 equiv.) was dissolved 
in 30 mL of THF and syringed into the basic solution. After 30 minutes, methyl-3-chloro-
3-oxopropanoate (1.1 equiv.) was slowly added. The reaction was stirred for 14 hours at 
room temperature. The reaction mixture was quenched with water. The organic layer was 
separated, and the aqueous layer was extracted three times with EtOAc.  The combined 
organic layers were washed with brine, dried with anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure.  The residue was purified by silica gel flash column 
chromatography for product isolation.  
 
 
Methyl 3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (3-45a): The general procedure 
was followed using sodium hydride (0.624 g, 26.0 mmol), 3-methyl-1H-indole (3.01 g, 
22.9 mmol), methyl-3-chloro-3-oxopropanoate (3.0 mL, 28.0 mmol), and THF (120 mL). 
After 12 hours, the reaction was quenched, and column chromatography (20% EtOAc/Hex, 
Rf = 0.26 and Rf = 0.15 for keto and enol tautomers) gave 3-45a as a light brown solid (3.60 
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g, 68%). 1H NMR (300 MHz, CDCl3) δ ppm 8.43 (d, J = 7.1 Hz, 1H), 7.52 – 7.47 (m, 1H), 
7.41 – 7.28 (m, 2H), 7.10 (s, 1H), 3.92 (s, 2H), 3.79 (s, 3H), 2.27 (s, J = 1.3 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ ppm 166.8, 163.4, 136.0, 131.5, 125.5, 124.0, 121.4, 119.7, 
118.9, 116.7, 52.9, 43.6, 9.7. IR: 3051.9 (w), 2937.6 (w), 1747.0 (s), 1685.1 (s), 1604.1 
(w), 1447.0 (s), 1375.5 (s), 1232.6 (m), 1070.7 (m), 913.5 (m), 732.6 (s) cm-1. HRMS (ESI) 
M/Z+ Calc. 231.0895, Obs. 231.0895. 
 
Methyl 3-(3-(2-bromoethyl)-1H-indol-1-yl)-3-oxopropanoate (3-45b):209 A mixture of 
potassium carbonate (0.116 g, 0.840 mmol) and 3-(2-bromoethyl)-1H-indole (0.400 g, 1.78 
mmol), methyl-3-chloro-3-oxopropanoate (0.30 mL, 2.80 mmol) and acetonitrile (25 mL) 
were heated to reflux. After 12 hours, the reaction mixture was cooled, filtered and dried 
in vacuo.  The residue was dissolved in EtOAc/Hex (1:2.5). The organic layer was 
separated, and the aqueous layer was extracted three times with EtOAc. The combined 
organic layers were dried with anhydrous sodium sulfate, filtered, and concentrated. 
Column chromatography (20% EtOAc/Hex, Rf = 0.35) formed 3-45b as a yellowish brown 
solid (0.559 g, 97%). 1H NMR (300 MHz, CDCl3) δ ppm 8.41 (d, J = 7.8 Hz, 1H), 7.47 (d, 
J = 7.6 Hz, 1H), 7.40 – 7.24 (m, 2H), 7.22 (s, 1H), 3.92 (s, 2H), 3.76 (s, 3H), 3.61 (t, J = 
7.2 Hz, 2H), 3.22 (t, J = 7.2 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ ppm 166.5, 163.5, 
135.7, 129.8, 125.6, 123.9, 122.1, 120.4, 118.4, 116.7, 52.7, 43.3, 31.1, 28.5. IR: 3091.7 
(w), 2940.7 (w), 2878.8 (w), 1760.1 (s), 1657.8 (s), 1615.6 (s), 1535.5 (s), 1440.9 (s), 
1239.4 (s), 1191.4 (s), 1040.8 (m), 820.8 (m), 777.4 (m) cm-1. HRMS (ESI) M/Z+ Calc. 




45c): The general procedure was followed using sodium hydride (0.298 g, 12.4 mmol), 2-
(2-(1H-indol-3-yl)ethyl)isoindoline-1,3-dione210 (2.23 g, 7.69 mmol), methyl-3-chloro-3-
oxopropanoate (1.4 mL, 13.1 mmol), and THF (10 mL). After 12 hours, the reaction was 
quenched, and column chromatography (30% EtOAc/Hex, Rf = 0.17) generated 3-45c as a 
brown solid (1.84 g, 62%). 1H NMR (300 MHz, CDCl3) δ ppm 8.41 (d, J = 7.7 Hz, 1H), 
7.88 – 7.77 (m, 2H), 7.75 – 7.67 (m, 2H), 7.64 (d, J = 7.7 Hz, 1H), 7.40 – 7.27 (m, 3H), 
4.04 (t, J = 7.2 Hz, 2H), 3.96 (s, 2H), 3.78 (s, 3H), 3.10 (t, J = 7.4 Hz, 2H). 13C NMR (75 
MHz, CDCl3) δ ppm 171.0, 168.3, 167.2, 166.7, 163.7, 136.0, 134.1, 131.9, 130.4, 125.7, 
124.2, 123.3, 121.9, 120.0, 118.9, 116.8, 52.9, 52.8, 43.4, 40.5, 37.2, 24.1. IR: 2937.6 (w), 
1742.2 (s), 1703.2 (s), 1691.8 (s), 1599.3 (w), 1456.5 (m), 1383.6 (m), 1329.9 (m), 1210.0 
(m), 1153.5 (s), 1008.8 (m), 923.1 (w), 719.7 (s) cm-1. HRMS (ESI) M/Z+ Calc. 390.1216, 
Obs. 390.1213. 
 
Methyl 3-(3-(2-methoxy-2-oxoethyl)-1H-indol-1-yl)-3-oxopropanoate (3-45d): The 
general procedure was followed with sodium hydride (0.460 g, 19.2 mmol), methyl 2-(1H-
indol-3-yl)acetate (2.92 g, 15.4 mmol), methyl-3-chloro-3-oxopropanoate (2.0 mL, 18.7 
mmol), and THF (90 mL). After 12 hours, the reaction was quenched, and column 
chromatography (30% EtOAc/Hex, Rf = 0.24) afforded 3-45d as a dark brown solid (2.36 
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g, 53%). 1H NMR (300 MHz, CDCl3) δ ppm 8.43 (d, J = 8.0 Hz, 1H), 7.57 – 7.49 (m, 1H), 
7.43 – 7.27 (m, 3H), 3.96 (s, 2H), 3.79 (s, 3H), 3.73 (s, 2H), 3.72 (s, 3H). 13C NMR (75 
MHz, CDCl3) δ ppm 171.0, 166.6, 163.6, 135.8, 130.1, 125.8, 124.2, 123.1, 118.9, 116.8, 
116.0, 52.8, 52.2, 43.4, 30.6. IR: 3009.3 (w), 2952.1 (w), 1737.4 (s), 1703.2 (s), 1595.1 
(m), 1366.0 (s), 1265.7 9 (m), 1204.7 (s), 1148.4 (s), 1015.7 (m), 909.4 (m), 728.3 (s) cm-
1. HRMS (ESI) M/Z+ Calc. 289.0950, Obs. 289.0945.  
 
Methyl 3-(1H-indol-1-yl)-3-oxopropanoate (3-45e): 1H-Indole (503 mg, 4.30 mmol), 
methyl 3-chloro-3-oxopropanoate (620 uL, 5.61 mmol), and toluene (15 mL) were charged 
to a round bottom flask equipped with a stir bar. The reaction mixture was heated to a 
reflux for 12 hours. The toluene was removed by vacuum, and the crude material was 
purified directly by flash column chromatography (15% EtOAc/Hex, Rf= 0.35), yielding 
3-45e as a yellow-brown oil (550 mg, 59%). 1H NMR (300 MHz, CDCl3) δ ppm 8.44 (d, 
J = 8.1 Hz, 1H), 7.56 – 7.51 (m, 1H), 7.38 – 7.23 (m, 3H), 6.61 (dd, J = 3.8, 0.8 Hz, 1H), 
3.91 (s,2H), 3.74 (s, 3H). 13C NMR (75 MHz, CDCl3) δ ppm 166.5, 163.8, 135.4, 130.2, 
125.1, 124.5, 123.9, 120.7,116.3, 109.8, 52.6, 43.1. IR: 3109.7 (w), 3152.9 (w), 3036.6 
(w), 2953.6 (w), 2850.7 (w), 1737.9 (m), 1703.1 (s), 1691.8 (m), 1529.04 (w), 1472.2 (w), 
1450.6 (m), 1383.1 (m), 1346.9 (s), 1261.2 (m), 1204.9 (s), 1150.2 (s), 1015.7 (m), 925.7 
(m), 747.3 (s), 715.2 (m), 689.3 (m) cm-1. HRMS (ESI) M/Z+ Calc.217.0739, Obs. 
217.0738. 
3.7.3 Formation of Diazo Compounds 3-46 
 The β-amide ester (1.0 equiv.) was dissolved in acetonitrile. Triethylamine (1.2 
equiv.) was added to the reaction mixture and stirred for 10 minutes. Tosyl azide (1.2 equiv) 
was placed in the reaction flask. The mixture was stirred at room temperature for 12 hours 
and concentrated under reduced pressure. The resulting residue was purified by silica gel 
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flash chromatography to afford the diazo compound.  
 
Methyl 2-diazo-3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (3-46a): The general 
procedure was followed using methyl 3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (1.50 
g, 6.49 mmol), triethylamine (1.2 mL, 8.61 mmol), tosyl azide (1.55 g. 7.86 mmol), and 
acetonitrile (15 mL). After 24 hours, the reaction mixture was concentrated, and column 
chromatography (20% EtOAc/Hex, Rf= 0.41) afforded 3-46a as a yellow solid (1.55 g, 
93%). 1H NMR (300 MHz, CDCl3) δ ppm 8.17 (d, J = 8.6 Hz, 1H), 7.51 – 7.47 (m, 1H), 
7.39 – 7.26 (m, 2H), 7.11 (s, 1H), 3.85 (s, 3H), 2.28 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 
ppm 161.5, 158.9, 136.0, 131.7, 124.8, 123.7, 123.3, 118.9, 117.7, 115.7, 69.7, 52.6, 9.7. 
IR: 3047.1 (w), 2956.6 (w), 2918.5 (w), 2132.7 (s), 1708.9 (s), 1651.7 (s), 1601.0  (m), 
1466.0 (s), 1349.6 (s), 1302.9 (s), 1254.3(s), 1127.9(s), 1046.9 (s), 865.9 (m), 732.7 (s) cm-
1. HRMS (ESI) M/Z+ Calc. 257.0800, Obs. 257.0805. 
 
Methyl 3-(3-(2-bromoethyl)-1H-indol-1-yl)-2-diazo-3-oxopropanoate (3-46b): The 
general procedure was followed using methyl 3-(3-(2-bromoethyl)-1H-indol-1-yl)-3-
oxopropanoate (0.679 g, 2.09 mmol), triethylamine (0.350 g, 2.51 mmol), tosyl azide 
(0.561 g, 2.85 mmol), and acetonitrile (15 mL). After 10 hours, the reaction mixture was 
concentrated, and column chromatography (20% EtOAc/Hex, Rf= 0.50) gave 3-46b as a 
yellow oil (0.540 g, 74%). 1H NMR (300 MHz, CDCl3) δ 8.15 (d, J = 8.0 Hz, 1H), 7.47 (d, 
J = 7.6 Hz, 1H), 7.36 – 7.23 (m, 2H), 7.22 (s, 1H), 3.81 (s, 3H), 3.61 (t, J = 7.3 Hz, 2H), 
3.23 (t, J = 7.2 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 161.2, 159.1, 136.0, 130.1, 125.0, 
124.2, 123.8, 118.7, 118.5, 115.8, 70.1, 52.7, 31.2, 28.7. IR: 3018.6 (w), 2947.1, (w), 
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2142.0 (s), 1732.7 (s), 1656.5 (s), 1604.1 (w), 1451.7 (s), 1380.4 (s), 1306.8 (s), 1251. 7 
(m), 1056. 4 (m), 861.2 (w), 734.3 (s), 708. 8 (m) cm-1. HRMS (ESI) M/Z+ Calc. 349.0062, 
Obs. 349.0061. 
 
Methyl 2-diazo-3-(1H-indol-1-yl)-3-oxopropanoate (3-46c): The general procedure was 
followed using methyl 3-(1H-indol-1-yl)-3-oxopropanoate (3.00 g, 13.8 mmol), 
triethylamine (2.6 mL, 18.5 mmol), tosyl azide (3.69 g, 18.7 mmol), and acetonitrile (50 
mL). After 18 hours, the reaction mixture was concentrated, and column chromatography 
(10% EtOAc/Hex, Rf= 0.35) afforded 3-46c as a yellow oil (3.15 g, 94%). 1H NMR (300 
MHz, CDCl3) δ ppm 8.22 – 8.16 (m, 1H), 7.59 – 7.53 (m, 1H), 7.40 – 7.23 (m, 3H), 6.61 
(dd, J = 3.8, 0.7 Hz, 1H), 3.83 (s, 3H). 13C NMR (75 MHz, CDCl3) δ ppm 161.3, 159.5, 
135.7, 130.6, 127.4, 126.7, 124.7, 123.8, 120.9, 115.5, 108.2, 52.7. IR: 3162.8 (w), 3053.2 
(w), 2953.6 (w), 2140.3 (s), 1710.8 (s), 1721.3 (s), 1657.8 (s), 1649.7 (s), 1529.0 (w), 
1451.1 (s), 1380.5 (s), 1342.4 (s), 1298.4 (s), 1244.9 (m), 1139.5 (m), 1121.6 (m), 1090.6 
(m), 1067.0 (m), 945.5 (w), 883.1 (m), 859.7 (m), 746.5 (s), 640.3 (w) cm-1. HRMS (ESI) 
M/Z+ Calc. 243.0644, Obs. 243.0640. 
3.7.4 Cyclopropane Synthesis and β,γ-Unsaturated-δ-Heteroatom 1,3-Dicarbonyl 
Amides 
 
  The cyclopropanes were prepared using a modified version of Soumeillant’s 
protocol:153 A round bottom flask was charged with Rh2esp2 (0.1 mol%) and a magnetic 
stir bar. DCM (2.0 mL) was added to the flask. The reaction vessel was cooled to 0 °C, and 
the corresponding alkene (1.0 equiv) was added. After 10 minutes, the diazo reagent (1.3 
equiv.) was dissolved in DCM (5 mL) and syringed into the reaction mixture. After 10 
minutes, the ice bath was removed, and the reaction proceeded at room temperature. Upon 
completion (monitored by TLC) or 12 hours of reactivity, the solution was quenched with 
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saturated thiourea and stirred for 30 minutes. The organic layer was separated, and the 
aqueous layer was extracted three times with DCM. The combined organic layers were 
washed with brine, dried with anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by silica gel flash chromatography. 
 
 
Methyl 1-(3-methyl-1H-indole-1-carbonyl)-2-phenylcyclopropanecarboxylate (3-51): 
The general procedure was followed using styrene (0.100 g, 0.960 mmol), methyl 2-diazo-
3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (0.329 g, 1.28 mmol), Rh2esp2 (1.0 mg, 1.32 
μmol), and DCM (13 mL). After 15 hours, the reaction was quenched, and column 
chromatography (20% EtOAc/Hex, Rf= 0.60) gave 3-51 as a white solid (0.273 g, 85%). 
1H NMR (300 MHz, CDCl3) δ ppm 8.46 (d, J = 8.0 Hz, 1H), 7.55 – 7.48 (m, 1H), 7.45 – 
7.26 (m, 8H), 3.48 (t, J = 8.8 Hz, 1H), 3.40 (s, 3H), 2.46 (dd, J = 8.3, 5.2 Hz, 1H), 2.29 (s, 
3H), 1.84 (dd, J = 9.3, 5.2 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ ppm 167.9, 165.6, 136.0, 
134.2, 131.5, 129.1, 128.2, 127.4, 125.4, 123.8, 121.4, 119.2, 118.9, 116.5, 52.8, 39.5, 31.5, 
18.5, 9.8. IR: 3037.6 (w), 2951.9 (w), 2918.5 (w), 1732.7 (s), 1692.0 (s), 1446.9 (s), 1390.8 
(s), 1348.3 (s), 1208.8 (m), 1051.6 (m), 742.1 (m), 684.9 (m) cm-1.  HRMS (ESI) M/Z+ 
Calc. 333.1365, Obs. 333.1367. 
 
Methyl 2-(4-fluorophenyl)-1-(3-methyl-1H-indole-1-carbonyl)cyclopropane 
carboxylate (3-53): The general procedure was followed using 4-fluorostyrene (0.311 g, 
2.55 mmol), methyl 2-diazo-3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (0.655 g, 2.55 
mmol), Rh2esp2 (1.00 mg, 1.32 μmol), and DCM (8 mL). After 12 hours, the reaction was 
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quenched, and column chromatography (20% EtOAc/Hex, Rf= 0.64) afforded 3-53 as a 
pale green solid (0.757 g, 85%). 1H NMR (300 MHz, CDCl3) δ ppm 8.45 (d, J = 8.0 Hz, 
1H), 7.52 (d, J = 8.3 Hz, 1H), 7.44 – 7.29 (m, 4H), 7.25 (s, 1H), 7.07 – 6.98 (m, 2H), 3.46 
(t, J = 8.5 Hz, 1H), 3.42 (s, 3H), 2.42 (dd, J = 8.2, 5.3 Hz, 1H), 2.29 (s, 3H), 1.84 (dd, J = 
9.3, 5.3 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ ppm 167.8, 165.4, 163.8, 160.5, 136.0, 
131.5, 130.7, 130.0, 125.4, 123.9, 121.3, 119.4, 118.9, 116.5, 115.3, 115.0, 52.9, 39.5, 30.8, 
18.7, 9.8. IR: 3010.0 (w), 2947.1 (w), 2904.3 (w), 1727.9 (m), 1685.1 (s), 1518.4 (s), 
1456.5 (s), 1399.3 (s), 1337.4 (s), 1215.2 (s), 1146.9 (s), 1051.7 (m), 846.9 (m), 723.1 (s), 
608.7 (m) cm-1. HRMS (ESI) M/Z+ Calc. 351.1271, Obs. 351.1268. 
 
Methyl 2-(4-chlorophenyl)-1-(3-methyl-1H-indole-1-carbonyl)cyclopropane 
carboxylate (3-55): The general procedure was followed using 4-chlorostyrene (0.138 g, 
0.994 mmol), methyl 2-diazo-3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (0.268 g, 1.04 
mmol), Rh2esp2 (1.4 mg, 1.85 μmol), and DCM (8 mL). After 12 hours, the reaction was 
quenched, and column chromatography (20% EtOAc/Hex, Rf= 0.64) furnished 3-55 as a 
white solid (0.338 g, 92%). 1H NMR (300 MHz, CDCl3) δ ppm 8.46 (d, J = 8.0 Hz, 1H), 
7.55 – 7.50 (m, 1H), 7.45 – 7.29 (m, 6H), 7.26 (d, J = 1.3 Hz, 1H), 3.44 (t, J = 6.8 Hz, 1H), 
3.44 (s, 3H), 2.43 (dd, J = 8.3, 5.3 Hz, 1H), 2.30 (s, 3H), 1.86 (dd, J = 9.3, 5.3 Hz, 1H). 13C 
NMR (75 MHz, CDCl3) δ ppm 167.7, 165.3, 136.0, 133.3, 132.8, 131.5, 130.4, 128.3, 
125.4, 123.9, 121.2, 119.4, 118.9, 116.5, 52.9, 39.5, 30.8, 18.6, 9.7. IR: 3010.0 (w), 2951.9 
(w), 2913.8 (w), 1727.9 (s), 1691.9 (s), 1485.0 (m), 1451.0 (s), 1389.9 (s), 1347.9 (s), 
1218.3 (m), 1156.4 (m), 1080.2 (m), 842.1 (m), 742.1 (m) 708.7 (w) cm-1. HRMS (ESI) 




(3-73): The general procedure was followed using phenyl(vinyl)sulfane (0.311 g, 2.29 
mmol), methyl 2-diazo-3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (0.723 g, 2.81 
mmol), Rh2esp2 (1.8 mg, 2.4 μmol), and DCM (13 mL). After 15 hours, the reaction was 
quenched, and column chromatography (20% EtOAc/Hex, Rf= 0.40) afforded 3-73 as a 
colorless oil (0.125 g, 15%). 1H NMR (300 MHz, CDCl3) δ ppm 8.44 (d, J = 7.9 Hz, 1H), 
7.55 – 7.47 (m, 3H), 7.43 – 7.28 (m, 4H), 7.23 – 7.16 (m, 2H), 3.56 (dd, J = 7.5, 5.6 Hz, 
1H), 3.52 (s, 3H), 2.25 (d, J = 1.3 Hz, 3H), 2.15 (dd, J = 7.3, 5.7 Hz, 1H), 1.92 (dd, J = 9.2, 
5.7 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ ppm 167.3, 164.6, 135.9, 135.4, 131.6, 129.0, 
127.7, 126.0, 125.7, 124.0, 121.1, 119.7, 119.0, 116.6, 53.1, 39.8, 28.2, 20.0, 9.7. IR: 
3080.6 (w), 2939.6 (w), 2896.9 (w), 1724.3 (s), 1657.6 (s), 1421.8 (s), 1382.7 (s), 1267.7 
(s), 789.5 (s), 664.3 (s) cm-1. HRMS (ESI) M/Z+ Calc. 365.1079, Obs. 365.1083. 
 
Methyl 7-(3-methyl-1H-indole-1-carbonyl)-2-oxabicyclo[4.1.0]heptane-7-carboxylate 
(3-75): The general procedure was followed using 2,3-dihydropyran (95 μL, 1.04 mmol), 
methyl 2-diazo-3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (0.350 g, 1.36 mmol), 
Rh2esp2 (1.0 mg, 1.31 μmol), and DCM (8 mL). After 12 hours, the reaction was quenched, 
and column chromatography (20% EtOAc/Hex, Rf = 0.40) generated 3-75 as a white solid 
(0.189 g, 58%). 1H NMR (300 MHz, CDCl3) δ ppm 8.45 (d, J = 8.1 Hz, 1H), 7.51 – 7.43 
(m, 1H), 7.42 – 7.22 (m, 2H), 7.17 (s, 1H), 6.54 (s, 1H), 4.60 (s, 1H), 4.00 – 3.87 (m, 2H), 
3.77 (s, 3H), 2.39 – 2.27 (m, 1H), 2.26 (s, 3H), 2.14 – 2.02 (m, 1H), 1.97 – 1.77 (m, 2H). 
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13C NMR (75 MHz, CDCl3) δ ppm 168.8, 165.6, 144.5, 136.0, 131.2, 125.3, 123.8, 121.1, 
119.2, 118.7, 116.7, 106.4, 80.77, 65.6, 56.0, 52.6, 21.8, 21.5, 9.6. IR: 2942.4 (w), 2866.2 
(w), 1756.5 (s), 1694.6 (s), 1651.7 (s), 1608.9 (w), 1451.7 (s), 1385.0 (s), 1349.3 (s), 1140.7 




phenyl)cyclopropanecarboxylate (3-81): The general procedure was followed using 4-
methoxystyrene (0.168 g, 1.25 mmol), methyl 3-(3-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-
1H-indol-1-yl)-3-oxopropanoate (0.610 g, 1.46 mmol), Rh2esp2 (1.6 mg, 2.11 μmol), and 
DCM (13 mL). After 12 hours, the reaction was quenched, and column chromatography 
(40% EtOAc/Hex, Rf = 0.38) afforded 3-81 as a pale brown solid (0.108 g, 17%). 
1H NMR 
(300 MHz, CDCl3) δ ppm 8.44 (d, J = 7.9 Hz, 1H), 7.88 – 7.81 (m, 2H), 7.78 – 7.65 (m, 
3H), 7.44 – 7.24 (m, 5H), 6.92 – 6.83 (m, 2H), 4.02 (t, J = 7.2 Hz, 2H), 3.81 (s, 3H), 3.39 
(t, J = 9.0, 1H), 3.38 (s, 3H), 3.11 (t, J = 7.7 Hz, 2H), 2.41 (dd, J = 8.3, 5.3 Hz, 1H), 1.79 
(dd, J = 9.4, 5.3 Hz, 1H). 13C NMR (75 MHz, CDCl3) (Rotamers) δ ppm 168.2, 167.7, 
166.0, 158.9, 136.1, 134.0, 133.8, 132.0, 130.4, 130.2, 126.0, 125.6, 124.0, 123.3, 123.2, 
122.1, 122.0, 119.6, 119.5, 119.0, 118.9, 116.6, 113.6, 55.2, 53.4, 52.7, 39.6, 38.5, 37.4, 
31.3, 24.3, 18.9. IR: 3051.9 (w), 2942.4 (w), 1760.0 (w), 1708.8 (s), 1685.1 (s), 1594.6 
(m), 1513.6 (m), 1442.2 (m), 1375.5 (m), 1242.2 (m), 1104.0 (w), 832.6 (m), 732.8 (s), cm-
1. HRMS (ESI) M/Z+ Calc. 522.1791, Obs. 522.1777. 
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3.7.5 In(OTf)3-Catalyzed Ring-opening/Friedel-Crafts Alkylation Sequence 
3.7.5.1 General Method A 
 The cyclopropyl β-amide ester (1.0 equiv) was added to a solution of In(OTf)3 (0.30 
equiv.) in anhydrous dichloromethane (2 mL) at room temperature. Upon completion, the 
reaction mixture was quenched with water, and the product was extracted from the aqueous 
phase with dichloromethane. The combined organic layers were washed with brine and 




a]indole-7-carboxylate (3-80):  Methyl 1-(3-(2-bromoethyl)-1H-indole-1-carbonyl)-2-(4-
methoxyphenyl)cyclopropane carboxylate (0.050 g, 0.109 mmol), In(OTf)3 (0.018 g, 0.032 
mmol) and DCM (3 mL) were mixed according to general method A to afford 3-80 as a 
colorless oil (0.049 g, 98%) after 1 hour. Rf= 0.35 (20% EtOAc/Hex). Diastereomeric 
ratio: (3.4:1). 1H NMR (300 MHz, CDCl3) δ ppm 8.54 (ddd, J = 10.3, 6.9, 1.4 Hz, 1.29), 
7.53 – 7.42 (m, 1.52), 7.41 – 7.29 (m, 2.75), 7.16 – 7.11 (m, 0.72), 6.95 (dd, J = 6.9, 4.7 
Hz, 2.19), 6.89 – 6.80 (m, 2.82), 4.68 (t, J = 4.2 Hz, 1), 4.43 (dd, J = 8.8, 5.3 Hz, 0.29), 
3.86 – 3.77 (m, 7.56), 3.69 (dd, J = 12.2, 4.6 Hz, 1.48), 3.57 (d, J = 3.5 Hz, 1.04), 3.53 – 
3.05 (m, 4.53), 3.03 – 2.73 (m, 3.48), 2.66 – 2.37 (m, 2.06). 13C NMR (75 MHz, CDCl3) δ 
ppm 169.47, 165.25, 158.87, 135.52, 134.75, 132.33, 129.66, 129.12, 128.35, 125.22, 
124.46, 118.03, 116.94, 116.04, 114.37, 114.18, 55.29, 52.72, 47.11, 35.45, 33.09, 30.91, 
27.71. IR: 3023.9 (w), 2918.9 (w), 1725.1 (s), 1658.6 (s), 1591.0 (m), 1493.2 (s), 1349.0 




tetrahydro-pyrido[1,2-a]indole-7-carboxylate (3-82): Methyl 1-(3-(2-(1,3-
dioxoisoindolin-2-yl)ethyl)-1H-indole-1-carbonyl)-2-(4-
methoxyphenyl)cyclopropanecarboxylate (0.050 g, 0.096 mmol), In(OTf)3 (0.016 g, 0.028 
mmol) and DCM (6 mL) were mixed according to general method A to yield 3-82 as a 
brown oil (0.038 g, 76.0%) after 2 hours. Rf= 0.38 (40% EtOAc/Hex). Diastereomeric 
ratio: (3.4:1). 1H NMR (300 MHz, CDCl3) δ ppm 8.52 – 8.46 (m, 1.26), 7.79 – 7.58 (m, 
7.02), 7.41 – 7.26 (m, 2.66), 7.18 – 7.13 (m, 0.75), 7.00 – 6.93 (m, 2.16), 6.86 - 6.72 (m, 
2.79), 4.70 (t, J = 4.1 Hz, 1), 4.48 (dd, J = 8.3, 5.1 Hz, 0.27), 3.85 – 3.80 (m, 0.50), 3.79 - 
3.77 (m, 4.32), 3.76 – 3.74 (m, 0.89), 3.74-3.72 (m, 3.51), 3.70 – 3.63 (m, 2.36), 3.54 (s, 
0.89), 3.02 – 2.90 (m, 1.09), 2.88 – 2.71 (m, 2.78), 2.61 – 2.50 (m, 0.36), 2.44 – 2.33 (m, 
1.38). 13C NMR (75 MHz, CDCl3) δ ppm 169.6, 169.2, 168.0, 165.3, 165.1, 158.8, 158.7, 
135.6, 135.3, 134.7, 134.6, 133.9, 132.6, 131.9, 131.9, 130.5, 130.1, 129.1, 128.3, 125.2, 
125.1, 124.5, 124.4, 123.1, 123.1, 118.4, 118.2, 116.8, 116.8, 115.7, 115.2, 114.3, 114.1, 
55.2, 55.2, 52.7, 52.6, 49.7, 47.1, 37.8, 37.0, 36.9, 35.3, 33.7, 33.2, 23.2, 22.9. IR: 3047.1 
(w), 2947.1 (w), 2847.1 (w), 1766.03 (w), 1751.74 (m), 1708.8 (s), 1618.4 (m), 1504.1 
(m), 1451.7 (m), 1376.6 (s), 1245.9 (s), 1032.6 (s), 837.3 (m), 715.9 (s) cm-1. HRMS (ESI) 




tetrahydropyrido[1,2-a]indole-7-carboxylate (3-84): Methyl 1-(3-(2-methoxy-2-
oxoethyl)-1H-indole-1-carbonyl)-2-(4-methoxyphenyl) cyclopropanecarboxylate (0.070 
g, 0.167 mmol), In(OTf)3 (0.028 g, 0.049 mmol) and DCM (6 mL) were combined 
according to general method A to afford 3-84 as a brown oil (0.062 g, 88.0%) after 3 hours. 
Rf= 0.45 (40% EtOAc/hex). Diastereomeric ratio: (2.0:1).
 1H NMR (300 MHz, CDCl3) δ 
ppm 8.56 – 8.47 (m, 1.45), 7.56 – 7.48 (m, 1.05), 7.44 – 7.28 (m, 3.67), 7.18 – 7.11 (m, 
1.06), 7.01 – 6.90 (m, 2.29), 6.88 – 6.78 (m, 3.02), 4.66 (t, J = 4.5 Hz, 1), 4.40 (dd, J = 9.7, 
5.1 Hz, 0.48), 3.90 – 3.81 (m, 1.32), 3.81 – 3.78 (m, 7.54), 3.73 – 3.67 (m, 1.32), 3.64 (s, 
1.44), 3.55 (s, 1.42), 3.53 (s, 2.98), 3.52 (s, 0.31), 3.43 (d, J = 17.3 Hz, 1.59), 3.32 (d, J = 
17.7 Hz, 0.85), 3.02 – 2.69 (m, 2.34), 2.58 – 2.38 (m, 1.62). 13C NMR (75 MHz, CDCl3) δ 
ppm 170.8, 170.7, 169.5, 169.2, 165.2, 158.9, 158.8, 136.3, 135.8, 134.6, 134.5, 132.3, 
131.9, 130.3, 130.0, 129.2, 128.5, 125.3, 125.2, 124.5, 124.4, 118.5, 118.0, 116.8, 114.3, 
114.2, 112.4, 112.0, 55.3, 52.8, 52.6, 52.0, 51.9, 50.1, 47.3, 38.5, 35.4, 34.1, 33.2, 29.7, 
29.5. IR: 3013.8 (w), 2918.6 (w), 2832.8 (w), 1747.0 (s), 1737.7 (s), 1699.3 (s), 1613.6 
(m), 1518.4 (m), 1456.5 (s), 1366.0 (s), 1245.6 (s), 1152.1 (s), 1032.6 (s), 837.3 (m), 731.8 
(s) cm-1. HRMS (ESI) M/Z+ Calc. 421.1525, Obs. 421.1522. 
 
3.7.5.2 General Method B  
 Into a mixture of In(OTf)3 (0.30 equiv.) in anhydrous 1,2-dichloroethane heated to 
a reflux, the dissolved cyclopropyl β-amide ester (1.0 equiv) was syringed into the reaction 
vessel. The reaction was monitored by TLC and quenched with water. The phases were 
separated, and the product was extracted from the aqueous phase with dichloromethane. 
The combined organic layers were washed with brine, dried over Na2SO4, filtered, and 




carboxylate (3-54): Methyl 2-(4-fluorophenyl)-1-(3-methyl-1H-indole-1-carbonyl) 
cyclopropane carboxylate (0.100 g, 0.285 mmol), In(OTf)3 (0.047 g, 0.085 mmol, 30 
mol%) and 1,2-dichloroethane (3 mL) were combined according to general method B to 
give 3-54 as a brown oil (0.048 g, 48%) after 8 hours. Rf= 0.28 (20% EtOAc/Hex). 
Diastereomeric ratio: (2.6:1). 1H NMR (300 MHz, CDCl3) δ 8.57 – 8.46 (m, 1.37), 7.76 
(d, J = 8.1 Hz, 0.68), 7.53 – 7.29 (m, 5.16), 7.26 – 6.77 (m, 12.82), 5.75 (s, 0.62), 4.62 (t, 
J = 4.4 Hz, 1.00), 4.39 (dd, J = 8.2, 5.3 Hz, 0.35), 3.80 (s, 3.03), 3.65 (dd, J = 11.8, 4.5 Hz, 
1.24), 3.55 (s, 1.24), 2.93 – 2.79 (m, 2.17), 2.61 – 2.38 (m, 1.87), 2.00 (s, 3.18), 1.76 (s, 
1.43). 13C NMR (75 MHz, CDCl3) δ 169.5, 169.2, 164.8, 160.2, 136.2, 134.6,132.9, 131.0, 
129.6, 129.5, 129.0, 128.8, 125.1, 124.3, 124.2, 118.3, 118.1, 116.7, 116.0, 115.7, 115.4, 
115.2, 52.8, 52.5, 49.7, 47.8, 47.1, 35.9, 35.5, 33.8, 33.0, 33.0, 8.5. IR: 3051.9 (w), 2932.8 
(w), 2861.4 (w), 1738.3 (m), 1664.6 (m), 1604.1 (m), 1535.1 (m), 1508.3 (m), 1314.8 (m), 
1250.8 (s), 1209.5 (s), 1097.4 (m), 989.0 (w), 832.4 (m), 736.0 (s) cm-1.  HRMS (ESI) 
M/Z+ Calc. 351.1271, Obs. 351.1272. 
 
Methyl 10-methyl-6-oxo-9-(phenylthio)-6,7,8,9-tetrahydropyrido[1,2-a]indole-7-
carboxylate (3-74): Methyl 1-(3-methyl-1H-indole-1-carbonyl)-2-
(phenylthio)cyclopropane carboxylate (0.018 g, 0.049 mmol), In(OTf)3 (0.008 g, 0.014 
mmol) and 1,2-dichloroethane (3 mL) were mixed according to general method B to yield 
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3-74 as a colorless oil (0.014 g, 81%) after 7 hours.  Rf= 0.30 (20% EtOAc/Hex). 
Diastereomeric ratio: (10:1). 1H NMR (300 MHz, CDCl3) δ ppm 8.54 (d, J = 8.6 Hz, 0.10), 
8.47 – 8.40 (m, 1), 7.54 – 7.29 (m, 9.0), 4.91 – 4.84 (m, 1.06), 4.48 (dd, J = 13.1, 4.8 Hz, 
1.04), 3.94 – 3.76 (m, 3.80), 2.72 (td, J = 13.6, 3.9 Hz, 1.19), 2.42 – 2.32 (m, 1.42), 2.20 
(s, 0.31), 2.04 (s, 3.10). 13C NMR (75 MHz, CDCl3) δ ppm 169.6, 164.5, 134.7, 134.5, 
132.6, 130.6, 130.5, 129.4, 129.2, 128.8, 128.6, 125.6, 124.3, 118.6, 116.6, 52.8, 46.9, 40.0, 
29.7, 8.3. IR: 2997.7 (w), 2890.9 (w), 1766.6 (m), 1711.7 (m), 1468.2 (m), 1269.7 (s), 
760.1 (s), 663.0 (s) cm-1. HRMS (ESI) M/Z+ Calc. 365.1119, Obs. 365.1089. 
  
 79 
CHAPTER 4  ALUMINUM(III)-CATALYZED TANDEM RING-
OPENING/FRIEDEL-CRAFTS CYCLIZATION METHOD FOR 
5,6,7,8-TETRAHYDROINDOLIZINE SYNTHESIS 
 Indolizines and tetrahydroindolizines are key structural motifs in compounds 
considered to be potential candidates for medicinal purposes.211–222 Indolizine (4-1) and 
tetrahydroindolizine (THI) (4-2) along with quinolizidine cores are reported to exist in 25-
30% of identified alkaloids.223–225 Specifically, the 5,6,7,8-tetrahydroindolize core is found 
in antimicrobials polygonatine A (4-3), polygonatine B (4-4), kinganone (4-5), and the 
anticancer natural products rhazinicine (4-6) and rhazinilam (4-7).217,220,221,226 For human 
cytomegalovirus (HCMV) therapeutics, antiviral CMV423 (4-8) is effective and serves as 
a basis for other structure activity relationship inquiries (Figure 4.1).222,227 
 
Figure 4.1: Biologically-active tetrahydroindolizines 
 
4.1 5,6,7,8-Tetrahydroindolizine Synthesis Representative Examples 
To date, there have been many approaches reported for the preparation of 5,6,7,8-
tetrahydroindolizines with varying substitution arrangements involving transition-metal 
catalysis to nucleophilic ring-opening reactions.223,226–242 This chapter reviews several 
approaches used to synthesize 5,6,7,8-tetrahydroindolizines.  
 80 
In 1977, Pizzorno and Albonico reported a cycloaddition route using ethyl 
propiolate to N-acyl-2-pieridinecarboxylic acids 4-9 in acetic anhydride with heat to give 
substituted tetrahydroindolizines 4-10 in 45-95% yield.243 After synthesizing different 
products, they determined that the reaction was regiospecific since only one isomer was 
observed. Although the scope was limited, the transformation worked well (Figure 4.2). 
 
Figure 4.2: Pizzorno and Albonico's cycloaddition method  
 
 Tanis and Raggon used N-(epoxyalkyl)pyrroles (4-11) to form 5,6,7,8-
tetrahydroindolizidines (4-12) with stoichiometric amounts of Lewis acids (e.g., BF3•OEt2, 
EtAlCl2, Et2AlCl, Ti(O-i-Pr)3Cl and ZnI2). The group was guided by their success in using 
furans for terminating cation cyclizations.234,244–247 Logically, it followed that a pyrrole unit 
could participate in the same manner if the epoxide was used as both a metal binding site 
and as an initiator for ring-opening and ring-closure to form bioactive alkaloids.234 The 
predictable cyclization substrates 4-11 were access points for 5-,6-, or 7-membered rings, 
and tetrahydroindolizines 4-12 depicted in Figure 4.3 were afforded in 23-81% yield. 
 
Figure 4.3: Tanis and Raggon's cationic cyclization  
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 In 1995, Wang and Alper synthesized 5,6,7,8-tetrahydroindolizines from 2-methyl 
(or 2,6-dimethyl)piperidinyl ketones 4-13 by using Co2(CO)8 or Ru3(CO)12.
233 With their 
metal-catalyzed cyclization, Wang and Alper were interested in including molecular 
oxygen to oxidize organic compounds. By using Co2(CO)8 and oxygen, they found that 2-
aryl-5,6,7,8-tetrahydroindolizines gave 8a-hydroxy-6,7,8,8a-tetrahydro-
3(5H)indolizinones 4-15 in fair to good yields (63-76%) Figure 4.4.  
 
Figure 4.4: Ruthenium and cobalt-catalyzed cyclization  
 
 In 2001, Marchalín et al. sought to make azabicyclics that could be screened for 
biological activity.230 They synthesized tetrahydroindolizines 4-17 by using a one-pot 
procedure with 2-formyl-1,4-dihydropyridine derivatives 4-16 and malonitrile as reagents 
to afford the desired products 4-17 in 57-69% yield. This protocol was short and involved 
a cascade pathway for product formation via a tandem Knoevenagel reaction/amino-nitrile 
cyclization (Figure 4.5). 
 
Figure 4.5: One-pot Knoevenagel reaction/amino-nitrile cyclization 
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 In 2009, Bowie and Trauner reported on the total synthesis of (±)-rhazinal 4-20. In 
order to assemble the tetrahydroindolizine framework, they performed an oxidative Heck 
cyclization with 10 mol% Pd(OAc)2 and t-BuOOH.
226 The desired stereochemistry was 
installed within this intramolecular step. Incorporating the palladium-catalyzed 
intramolecular ring closure made the route more concise, providing chemists with a direct 
approach to tetrahydroindolizine 4-19. Other subsequent steps afforded (±)-rhazinal 4-20. 
 
Figure 4.6: Oxidative Heck cyclization for the rhazinal framework 
 
 In 2015, Teodoro et al. published a procedure for tetrahydroindolizines from 
Morita-Baylis-Hillman adducts.223 The group strategically used Morita-Baylis-Hillman 
adducts because of the simplicity of using acrylates or α,β-unsaturated ketones and 2-
pyridinecarboxaldehydes. From indolizines 4-21, tetrahydroindolizines 4-22 were formed 
through a PtO2 partial hydrogenation under neutral conditions. This method employed 
commercially available catalysts, low temperatures, and low pressure conditions, resulting 
in yields ranging from 40-95%.  
 
Figure 4.7: Partial hydrogenation of indolizines 
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4.2  Hypothesis and Synthetic Rationale for 5,6,7,8-Tetrahydroindolizine 
Assembly 
 While various procedures have been developed for the designing of 5,6,7,8-
tetrahydroindolizine, some representative protocols require long reaction times, high 
pressure flammable gases,223 high temperatures,238,248 and large excess of base149. 
Moreover, some protocols require multistep operations249–251 and give low overall 
yields238,252,253. Our recent work utilizing Lewis acid-catalyzed intramolecular Friedel-
Crafts (F-C) annulations137,254 has led us to envision another simple protocol for the 
formation of 5,6,7,8-tetrahydroindolizines 4-28 from methyl 1-(1H-pyrrole-1-
carbonyl)cyclopropanecarboxylates 4-26. Analogous to the tandem ring-opening/Friedel-
Crafts alkylation for hydropyrido[1,2-a]indoles formation (Figure 4.8, scheme 1), the 
pyrrole substitution would afford 5,6,7,8-tetrahydroindolizines (Figure 4.8, scheme 2). 
 When D-A-A cyclopropane 4-26 is subjected to catalytic Lewis acid, the 
carbocycle opens promoting an intramolecular Friedel-Crafts alkylation. We propose the 
formation of aza-cationic intermediate 4-27 which can generate a new lactam ring for the 
bicyclic scaffold to afford 5,6,7,8-tetrahydroindolizines 4-28 (Figure 4.8, scheme 2). 
Pyrroles are reactive π-nucleophiles capable of participating in this Friedel-Crafts-type 
chemistry. Some pyrroles are not stable to oxygen, silica, or alumina.227 Hence, possible 
degradation of the products and starting materials is of concern. Regardless of the potential 
drawbacks, this goal is synthetically important to pursue because our method is the first 
example of employing donor-acceptor-acceptor or donor-donor-acceptor-acceptor 
cyclopropanes to form diverse methyl oxo-5,6,7,8,tetrahydroindolizine-6-carboxylates. 
Furthermore, the method allows for facile functionalization around the 
tetrahydroindolizine ring. To investigate this, we synthesized pyrrole cyclopropanes.  
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Figure 4.8: Rationale for 5,6,7,8-tetrahydroindolizine formation 
 
4.3  Precursor Assembly and Reaction Optimization for 5,6,7,8-
Tetrahydroindolizine Formation 
 Methyl 1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylates 4-33 were prepared 
according to Figure 4.9. First, commercially-available starting materials were used to form 
β-amidoester 4-31 over two linear steps.255 Diazo transfer152 gave precursor 4-32256 for 
cyclopropanation with Rh2esp2 [bis(rhodium(α,α,α’,α’-tetramethyl-1,3-
benzenedipropionic acid)]153,257–260 and the requisite alkene to form cyclopropanes 4-33 in 
moderate to good yields (up to 81 %).  
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Figure 4.9: Cyclopropane synthesis for 5,6,7,8-tetrahydroindolizine assembly 
 
Exploring the reaction scope for this annulation methodology required the use of methyl 
2-phenyl-1-(1H-pyrrole-1-carbonyl)cyclopropane-1-carboxylate 4-34, which served as the 
model substrate for the reaction optimization. In accordance with our previous In(III)-
mediated ring-opening annulations,136,137,254 we utilized In(OTf)3 as an initial Lewis acid 
to investigate the relative reactivity for the transformation at different temperatures, 
concentrations, and catalyst loadings. 
 The optimization study commenced by subjecting pyrrole cyclopropane 4-34 to 17 
mol% In(OTf)3 in acetonitrile (ACN) 0.1 M at 52 ˚C for 15 hours (Table 4.1, entry 1). No 
cyclized product was formed. To push the reaction forward, we increased the catalyst 
loading to 22 mol% In(OTf)3 in toluene 0.2 M at reflux for 30 minutes to give 36% yield 
of the desired diastereomers (Table 4.1, entry 2). The loading was changed to 31 mol% 
In(OTf)3 in toluene 0.2 M at reflux for 30 minutes, which furnished 42% of the cyclized 
material (Table 4.1, entry 3).  With the same concentration of 0.2 M, trials using 21 mol% 
and 30 mol% indium gave yields of 4-35 in 46% (Table 4.1, entry 4) and 47% (Table 4.1, 
entry 5) respectively, the highest yields so far. We sought to lower the temperature by using 
dichloromethane as a solvent either at room temperature (Table 4.1, entry 6) or reflux 
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(Table 4.1, entry 7); however, the outcomes were not better even when the Lewis acid 
loading was increased to 28 mol% at reflux (Table 4.1, entry 10). Although acetonitrile has 
the advantage of being a cheap, “greener” solvent, 1,2-dichloroethane was employed to 
strike a good balance in temperature such that the reaction would not proceed at high 
temperatures, which could cause degradation of the starting materials and products. 
Furthermore, because we understood that 1,2-dichloroethane was effective for 
hydropyrido[1,2-a]indole synthesis, we altered the loading for the catalyst and reaction 
concentration to identify an optimal condition (Table 4.1, entry 8, 9, and 11). Since 
increasing the concentration from 0.1 M to 0.2 M had a deleterious outcome, 0.1 M was 
chosen as the reaction concentration. In the end, 21 mol% In(OTf)3 at 0.1 M in 1,2-
dichloroethane at reflux formed 51% of tetrahydroindolizine 4-35, the best outcome to this 
point. Given these results, we then screened typical Lewis acid catalysts used for 
cyclopropane ring-openings to examine the Lewis acid effects on the Friedel-Crafts 
alkylation and to improve the yield. 
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Table 4.1: Indium(III) Triflate Screening for Reaction Optimization 
 
 
 Zinc(II) triflate [Zn(OTf)2], nickel(II) triflate [Ni(OTf)2], magnesium(II) triflate 
[Mg(OTf)2], and lanthanum(III) triflate [La(OTf)3] did not afford a significant amount of 
desired product with 20 mol% catalyst loading at reaction times 21 hours or above at 0.1 
M (Table 4.2, entries 1, 3, 4, and 9). Initially, indium(III) salts remained the best catalysts 
for the transformation (Table 4.2, entries 11 and 12). When 20 mol% aluminum(III) triflate 
at 0.1 M in 1,2-dichloroethane at reflux was employed as the reaction conditions, the 
product was formed in 56% yield (Table 4.2, entry 14), a 5% improvement over the yield 
achieved by using In(OTf)3. As already reported in various Friedel-Crafts reactions, 
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aluminum(III) salts are prime Lewis acceptors which can be used for this 
transformation.261–269 From the data, we speculated that the aluminum would be sufficient 
for apt ring activation through metal chelation and that it could accommodate a six 
membered-coordinating transition state where the pyrrole is poised to quench the charge 
build up.  We further hypothesize that a balance could be attained in which the reaction 
conditions are not too acidic or harsh and in which the starting material and product 
stabilities are not compromised. Next, catalyst loading and solvent effects were examined 
under the higher yielding conditions.  
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Table 4.2: Lewis Acid Screen for 5,6,7,8-Tetrahydroindolizines 
 
  
 As a result of the higher yield obtained using 1,2-dichloromethane at reflux, the 
catalyst loading was lowered to 10 mol% for Al(OTf)3 and In(OTf)3. In(OTf)3 gave 49% 
(Table 4.3, entry 2) versus 46% with Al(OTf)3 (Table 4.3, entry 1) with similar reaction 
times. In order to take into account the findings published by Davies and Leonori in their 
paper on using calcium for the Nazarov cyclization, we included 10 mol% Ca(NTf2)2 with 
(Bu)4N(PF)6 as an additive to test the success of this reaction trial.
270  We obtained a 42% 
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yield of 4-35 after 15 hours (Table 4.3, entry 3). Since 20 mol% Al(OTf)3 was superior to 
10 mol% loading, a concentration effect was explored again. The concentration was 
changed to 0.2 M, and once again, a lower product yield was obtained. We then examined 
the reaction’s sensitivity to solvent effects at reflux by using 19-20 mol% Al(OTf)3.  Ethyl 
acetate (EtOAc) afforded 40% of the product after 17.5 hours (Table 4.3, entry 5), and 
toluene gave 48% yield after 2 hours (Table 4.3, entry 6); acetonitrile afforded 64% after 
2 hours with 1.5:1 dr (Table 4.3, entry 7). In our previous studies, the trans diastereomer 
was the more thermodynamically stable diastereomer than the cis. NMR experiments are 
underway for further verification of this stereochemical relationship. Benzene furnished a 
29% yield after 18.0 hours (Table 4.3, entry 8). The reaction may proceed better in 
acetonitrile because of the solubility of the catalyst, the lower reaction temperature, and the 
solvent stability of the charged intermediates that may form; moreover, acetonitrile was 
shown to be a good solvent for rendering hydropyrido[1,2-a]indoles in batch and 
continuous flow operations.271 The appropriate controls revealed that heat is required for 
ring-opening (Table 4.3, entry 9) and that an appropriate Lewis acid is necessary for 
product formation in a reasonable time (Table 4.3, entry 10). Hence, the final optimized 





Table 4.3: Further Lewis Acid Screening for Optimization 
 
4.4 Results and Discussion 
 Within the model precursor, a phenyl group serves as the aryl donor substituent. In 
order to explore the electronic effects of aryl substituents, we investigated differing para-
substituted electron-donating and electron-withdrawing groups. 4-Bromo phenyl 
cyclopropane 4-36 gave cyclized tetrahydroindolizine 4-37 in 51% yield with 1.8:1 dr 
(Table 4.4, entry 2).  In the same manner, 4-chloro phenyl substrate 4-38 generated 4-39 in 
54% yield with 1.8:1 dr in the same reaction time of 3 hours as bromo aryl 4-35 (Table 4.4, 
entry 3). In contrast to the cyclization that results from the use of the phenyl precursor, the 
halogenated precursors have longer reaction times and lower yields for the cyclization. F-
phenyl precursor 4-40 afforded bicycle 4-41 after 1 hour in 71% yield with 1.5:1 dr (Table 
4.4, entry 4). When a donating group, such as the OMe moiety in 4-42 was added, the yield 
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increased to 97% for 4-43 with 1.3:1 dr in 20 minutes (Table 4.4, entry 5). Since the ring 
becomes more donating by adding an OMe, the positive charge build up is more stabilized. 
In comparison to the bromo, chloro, and fluoro cases, reaction times increase and lower 
yields are obtained. The bromo and chloro aryls have similar product outcomes owing to 
less stabilization of the benzylic position.  Interestingly, the fluoro product was obtained in 
a higher yield. If our mechanistic thinking is plausible, increasing stability at the benzylic 
position should promote reactivity; this notion was tested by synthesizing α -methyl styrene 
derivative 4-44. 
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Table 4.4: Al(OTf)3-Catalyzed Friedel-Crafts Alkylation of Pyrrole Cyclopropyl        
       Amides 
 
 We sought to test the stabilizing effect of adding another donor group. α-Methyl 
styrene derivative 4-44 was placed under the reaction conditions to yield bicycle 4-45 in 
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95% yield with 4.0:1.0 dr in 30 minutes (Table 4.5, entry 1). Adding another donor group 
improved the product outcome in comparison to the outcome achieved by using only one 
phenyl group for stabilization, as in precursor 4-34 (Table 4.4, entry 1). Of note, this 
protocol affords a quaternary center directly, increasing product complexity.  In accordance 
with Yadav’s previous disclosure106 where he used methylsilyl groups for β-cation 
stability, precursor 4-46 was synthesized, and it reacted to form 4-47 in 72% yield with 
1.5:1 dr (Table 4.5, entry 2).  Pleased so far with our product outcomes, we examined the 
effects of other aryl groups and heteroatoms as donor groups. 
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Table 4.5: Donor Effects on the Cyclization 
 
 Naphthalene derivative 4-48 afforded tetrahydroindolizine 4-49 in 69% with 1.3:1 
dr in 30 minutes (Table 4.5, entry 3). 2-Furyl 4-50 gave 4-51 in 78% yield with 1.2:1 dr in 
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30 minutes as well. The furan did not degrade under the reaction conditions. Hence, the 
aromatic groups acted as a good donor for this methodology. However, when vinyl phenyl 
sulfide derivative 4-52 was subjected to the reaction conditions, the reaction proceeded 
very rapidly rendering 100% conversion of the starting material to other compounds. 
According to TLC, multiple side-products appeared to form. Although the desired products 
were evident by NMR, more purification was necessary. For this thioether substrate, 
heating may not have been necessary because of the donating ability and polarizability of 
the sulfur, but this assertion has yet to be affirmed. Vinyl phenyl ether derivative 4-53 did 
not give any appreciable product. Despite the setbacks with heteroatom donors, the other 
donor-acceptor-acceptor cyclopropanes formed their desired tetrahydroindolizines. 
Moreover, the yields obtained are comparable if not better than the reported protocols to 
date. To apply this methodology in natural product synthesis, rhazinicine 4-6 was chosen 
as an initial target compound. 
4.5 rac-Rhazinicine Synthesis 
Rhazinicine, a member of the rhazinilam family, has garnered considerable 
attention from synthetic and medicinal chemists as a potential lead antitumor compound as 
a result of its in vitro cytotoxic activity against human promyelocytic leukemia cells (CD50 
>60 μg/mL), human cervical cancer cells (CD50 2.9 μg/mL), and vincristine-resistant 
human oral epidermoid carcinoma cells (IC50 4.06 μM).
272,273 Originally reported in a 
hemisynthesis by Guénard, this Malaysian Apocynaceae alkaloid was isolated from Kopsia 
dasyrachis and Kopsia singapurensis stem extract.215,272 Although the natural product’s 
anticancer activity afforded promising medicinal results, rhazinicine exhibited harmful 
cytotoxic effects on normal mouse fibroblast cells (CD50 20.8 μg/mL), warranting further 
SAR studies and derivatives to improve its efficacy and selectivity for cancer cells over 
adherent cells.273 The devised modular ring-opening/Friedel-Crafts cyclization sequence 
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could be used to complete the total synthesis of rhazinicine and synthesized derivatives for 
medicinal testing. 
 Structurally, rhazinicine contains a nine-membered lactam flanked by a 
heterobiaryl unit with a 5,6,7,8-tetrahydroindolizine skeleton encompassing a stereogenic 
quaternary center.  As a result of these architectural features, Gaunt, using IrI- and PdII-
catalyzed C-H functionalizations, and Tokuyama, employing a gold-catalyzed cascade 
cyclization, published elegant syntheses of the target molecule.217,274  Tokuyama 
synthesized rhazinicine in 14 steps whereas Gaunt trimmed the total synthesis to 10 linear 
steps. In contrast to Gaunt’s approach, we envisioned an early construction of the 5,6,7,8-
tetrahydroindolizinone moiety through a unique Lewis acid-catalyzed ring-
opening/Friedel-Crafts alkylation sequence of a donor-donor-acceptor-acceptor 
cyclopropane synthetic equivalent without an extensive 10 step precursor preparation as in 
Tokuyama’s report.  Our retrosynthetic analysis is displayed in Figure 4.10.  
 In the final stages of the synthesis, we intended to form the heterobiaryl unit and 
nine-membered lactam using a late-stage C-H functionalization. Before amide formation 
with a N-protected-2-iodoaniline, we planned to install the 5,6,7,8-tetrahydroindolizine 
framework from a polarized donor-donor-acceptor-acceptor (D-D-A-A) cyclopropane. 
 




Figure 4.11: Synthetic route for rhazinicine 
 
 In the forward synthesis, Rh(II)-catalyzed cyclopropanation with diazo 4-32 and 
alkene 4-56 gave cyclopropane 4-57 in 30% yield in an unoptimized step. Tandem ring-
opening/Friedel-Crafts alkylation sequence with In(OTf)3 produced tetrahydroindolizine 
4-58 in 63% yield with 1.1:1 dr. Krapcho275 decarbalkoxylation  with lithium chloride gave 
a 66% yield of 4-59. To finish the natural product, future steps would include 
saponification to afford 4-60 or a direct amide coupling with the ester 4-59. After 
saponification, amide formation via acyl chloride would furnish 4-61. Direct C-C coupling 
with the pyrrole through a C(sp2)-H functionalization step would give 4-62. Deprotection 
would afford rac-rhazinicine 4-6 (Figure 4.11). With our method, this total synthesis would 
showcase the use a donor-acceptor cyclopropane to access the 5,6,7,8-tetrahydroindolizine 
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core for rhazinicine. Thus, our synthetic route would form the target in 10 steps with a 
more direct approach.   
4.6 Conclusion 
 In summary, an Al(III)-catalyzed tandem ring-opening/Friedel-Crafts cyclization 
method was designed to afford functionalized 5,6,7,8-tetrahydroindolizines in yields up to 
95%. The protocol is amenable, atom economical, and useful for assembling diverse 
tetrahydroindolizines. Products obtained for this protocol were obtained quickly and were 
stable on silica gel. Further utility of this method was applied toward the total synthesis of 
rac-rhazinicine such that the tetrahydroindolizine core was obtained in good yield, 
affirming the importance of donor-acceptor cyclopropanes as synthetic equivalents for C-
C bond formation.  
4.7 Research Participants 
This work was conducted by Marchello Cavitt.  
4.8 Experimental Information 
4.8.1 Synthetic Methods for Tetrahydroindolizine Preparation 
 All reactions were carried out in pre-dried glassware from the oven and any 
additional moisture was removed by flame-drying the reaction vessel.  Each reaction 
proceeded under a nitrogen atmosphere with anhydrous solvents, unless stated otherwise. 
Tetrahydrofuran and diethyl ether were distilled from a sodium/benzophenone ketyl under 
nitrogen and stored in a Schlenk flask. Benzene, toluene, 1,2-dichloroethane and 
dichloromethane were purified by distillation from calcium hydride. All other reagents 
were purchased from Acros, Sigma-Aldrich, Fluka, VWR, Merck, Alfa Aesar, TCI and 
Strem (for metal catalysts) and used without further purification. 
 Chromatographic purification was performed as flash chromatography with 
Silicycle silica gel (40-65µm). For quantitative flash chromatography, technical grades 
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solvents were utilized. Analytical thin-layer chromatography (TLC) was performed on 
Dynamic Absorbents, Inc. silica gel F254 TLC glass plates. Visualization was 
accomplished with UV light, aqueous basic potassium permanganate (KMnO4) solution, 
iodine, aqueous acidic dinitrophenylhydrazine (DNP) solution, aqueous acidic p-
anisaldehyde (PAA) solution, and an ethanol solution of phosphomolybdic acid (PMA) 
followed by heating.  Each yield refers to an isolated, analytically-pure material.  
 Infrared (IR) spectra were obtained using a Nicolet 4700 FTIR with an ATR 
attachment from SmartOrbit Thermoelectronic Corp. The IR bands are characterized as 
weak (w), medium (m), and strong (s). Proton and carbon nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) were recorded on a Varian Mercury Vx 300 MHz 
spectrometer, Varian Mercury Vx 400 MHz spectrometer or Bruker 400 MHz spectrometer 
with solvent resonances as the internal standard (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: 
CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift (ppm), 
multiplicity (s = singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, ddd 
= doublet of doublet of doublets, t = triplet, m = multiplet, br = broad), coupling constants 
(Hz), and integration. Diastereomeric ratios for the cyclized products were determined by 
1H NMR based on a comparison of the signal ratios of the benzylic protons (~4.0-5.0 ppm) 
for the two diastereomeric protons or other signals displaying clear separation. These 
assignments are based on the coupling constants.  A single observable diastereomer 
corresponds to >99:1 dr. Mass spectra were obtained using a MicroMass Autospec M.  The 
accurate mass analyses were run in EI mode at a mass resolution of 10,000 using PFK 
(perfluorokerosene) as an internal calibrant. Compound 4-31255 and 4-32276 were 
synthesized according to previous reports. Compounds synthesized and not reported in the 
literature are listed below. 
4.8.2 Cyclopropane Synthesis for Tetrahydroindolizine Formation 
 
  The cyclopropanes were prepared using a modified version of Soumeillant’s 
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protocol:153 A round bottom flask was charged with Rh2esp2 and a magnetic stir bar. DCM 
(2.0 mL) was added to the flask. The reaction vessel was cooled to 0°C, and the 
corresponding alkene (1.0-3.0 equiv) was added. After 10 minutes, the diazo reagent256 4-
32 (1.0-2.0 equiv.) was dissolved in DCM (5 mL) and syringed into the reaction mixture. 
After 10 minutes, the ice bath was removed and the reaction proceeded at room 
temperature. Upon completion (monitored by TLC) or 12 hours of reactivity, the solution 
was quenched with saturated thiourea and stirred for 30 minutes. The organic layer was 
separated, and the aqueous layer was extracted three times with DCM. The combined 
organic layers were washed with brine, dried with anhydrous sodium sulfate, filtered, and 




Methyl 2-phenyl-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (4-34): The 
general procedure was followed using styrene (650 µL, 5.67 mmol), methyl 2-diazo-3-oxo-
3-(1H-pyrrol-1-yl)propanoate (538.8 mg, 2.79 mmol), Rh2esp2 (4 mg, 5.06 µmol), and 
DCM (12.5 mL). After 7 hours, the reaction was quenched, and column chromatography 
(30% EtOAc/Hex, Rf= 0.66) afforded 4-34 as a white solid (605.7 mg, 81%). 
1H NMR 
(500 MHz, CDCl3) δ ppm 7.35 – 7.30 (m, 6H), 7.29 – 7.26 (m, 1H), 6.33 – 6.29 (m, 2H), 
3.44 (dd, J1=J2= 9.5 Hz, 1H), 3.39 (s, 3H), 2.41 (dd, J = 8.3, 5.3 Hz, 1H), 1.80 (dd, J = 9.3, 
5.3 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ ppm 167.6, 165.6, 133.9, 129.1, 128.2, 127.5, 




36): The general procedure was followed using 1-bromo-4-vinylbenzene (105 mg, 0.574 
mmol), methyl 2-diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (159.8 mg, 0.827 mmol), 
Rh2esp2 (1.0 mg, 1.266 µmol), and DCM (5.5 mL). After 7 hours, the reaction was 
quenched, and column chromatography (30% EtOAc/Hex, Rf= 0.66) gave 4-36 as a white 
solid (87.8 mg, 44%). 1H NMR (300 MHz, CDCl3) δ ppm 7.50 – 7.39 (m, 2H), 7.31 (t, J = 
2.4 Hz, 2H), 7.24 – 7.16 (m, 2H), 6.35 – 6.28 (m, 2H), 3.43 (s, 3H), 3.36 (dd, J1=J2=  8.8 
Hz, 1H), 2.37 (dd, J = 8.3, 5.4 Hz, 1H), 1.81 (dd, J = 9.3, 5.4 Hz, 1H). 13C NMR (75 MHz, 
CDCl3) δ ppm 167.4, 165.3, 133.0, 131.3, 130.8, 121.6, 119.5, 113.6, 52.9, 38.4, 30.5, 18.6. 
HRMS (ESI) M/Z+ Calc. 347.0157, Obs. 347.0169. 
 
Methyl 2-(4-chlorophenyl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (4-
38): The general procedure was followed using 1-chloro-4-vinylbenzene (88 µL, 0.726 
mmol), methyl 2-diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (187.6 mg, 0.971 mmol), 
Rh2esp2 (1.2 mg, 1.519 µmol), and DCM (7 mL). After 8 hours, the reaction was quenched, 
and column chromatography furnished 4-38 as a white solid (105.3 mg, 48%). 1H NMR 
(300 MHz, CDCl3) δ ppm 7.32 – 7.27 (m, 2H), 7.28 – 7.20 (m, 4H), 6.29 (dd, J = 2.7, 2.0 
Hz, 2H), 3.41 – 3.33 (m, 4H), 2.35 (dd, J = 8.3, 5.4 Hz, 1H), 1.79 (dd, J = 9.3, 5.4 Hz, 1H). 
13C NMR (75 MHz, CDCl3) δ ppm 167.3, 165.3, 133.4, 132.4, 130.4, 128.4, 119.4, 113.5, 




40): The general procedure was followed using 1-fluoro-4-vinylbenzene (100 µL, 0.822 
mmol), methyl 2-diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (216.4 mg, 1.120 mmol), 
Rh2esp2 (1.2 mg, 1.519 µmol), and DCM (8.2 mL). After 7 hours, the reaction was 
quenched, and column chromatography rendered 4-40 as a white solid (131.8 mg, 56%). 
1H NMR (300 MHz, CDCl3) δ ppm 7.37 – 7.26 (m, 4H), 7.09 – 6.88 (m, 2H), 6.32 (dd, J 
= 2.7, 2.0 Hz, 2H), 3.45 – 3.36 (m, 4H), 2.38 (dd, J = 8.3, 5.4 Hz, 1H), 1.80 (dd, J = 9.3, 
5.4 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ ppm 167.4, 165.4, 163.7, 160.5, 130.7and 130.6 
(13C-19F coupling, J = 8.1 Hz), 129.7 and 129.6 (13C-19F coupling, J = 3.4 Hz), 119.4, 115.2, 
114.9, 113.4, 52.8, 38.3, 30.3, 18.7. HRMS (ESI) M/Z+ Calc. 287.0958, Obs. 287.0967. 
 
Methyl 2-(4-methoxyphenyl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (4-
42): The general procedure was followed using 1-methoxy-4-vinylbenzene (104 µL, 0.742 
mmol), methyl 2-diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (192.7 mg, 0.998 mmol), 
Rh2esp2 (1.1 mg, 1.392 μmol), and DCM (7.5 mL). After 12 hours, the reaction was 
quenched, and column chromatography afforded 4-42 as a white solid (0.134 mg, 61%). 
1H NMR (300 MHz, CDCl3) δ ppm 7.37 – 7.30 (m, 2H), 7.30 – 7.20 (m, 2H), 6.91 – 6.80 
(m, 2H), 6.35 – 6.27 (m, 2H), 3.79 (s, 3H), 3.46 – 3.32 (m, 4H), 2.36 (dd, J = 8.3, 5.3 Hz, 
1H), 1.78 (dd, J = 9.4, 5.2 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ ppm 167.6, 165.7, 158.9, 
130.1, 125.7, 119.4, 113.5, 113.3, 104.9, 55.1, 52.7, 38.3, 30.7, 18.7. HRMS (ESI) M/Z+ 




44): The general procedure was followed using prop-1-en-2-ylbenzene (110 µL, 0.838 
mmol), methyl 2-diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (247.5 mg, 1.281 mmol), 
Rh2esp2 (1.2 mg, 1.519 µmol), and DCM (6 mL). After 12 hours, the reaction was 
quenched, and column chromatography (30% EtOAc/Hex, Rf= 0.68) gave 4-44 as a white 
solid (176 mg, 74%). Diastereomeric ratio: (14.7:1) ( 1H NMR (300 MHz, CDCl3) δ ppm 
7.46 – 7.27 (m, 7.25), 7.21 – 7.11 (m, 0.56), 7.09 – 7.03 (m, 0.16), 6.34 (dd, J = 2.7, 2.1 
Hz, 1.91), 6.15 – 6.12 (m, 0.14), 3.71 (s, 0.18), 3.41 (s, 2.94), 2.60 (d, J = 5.5 Hz, 0.07), 
2.42 (d, J = 5.1 Hz, 1.03), 1.91 – 1.86 (m, 0.30), 1.81 (d, J = 5.2 Hz, 1.00), 1.49 (s, 3.11). 
13C NMR (125 MHz, CDCl3) δ ppm 168.0, 164.8, 140.4, 128.4, 128.1, 127.3, 119.9, 113.3, 
52.6, 40.8, 38.1, 25.9, 25.5.  HRMS (ESI) M/Z+ Calc. 283.1208, Obs. 283.1208. 
 
Methyl 2-((tert-butyldiphenylsilyl)methyl)-1-(1H-pyrrole-1-
carbonyl)cyclopropanecarboxylate 4-46): The general procedure was followed using 
allyl(tert-butyl)diphenylsilane (1.17 g, 4.17 mmol), methyl 2-diazo-3-oxo-3-(1H-pyrrol-1-
yl)propanoate (399.2 mg, 2.067 mmol), Rh2esp2 (3.4 mg, 4.30 µmol), and DCM (10 mL). 
After 12 hours, the reaction was quenched, and column chromatography furnished 4-46 as 
a white solid (129 mg, 14%). 1H NMR (500 MHz, CDCl3) δ ppm 7.66 – 7.63 (m, 4.02), 
7.63 – 7.59 (m, 0.85), 7.60 – 7.56 (m, 4.52), 7.45 – 7.31 (m, 14.58), 7.21 – 7.17 (m, 2.30), 
6.32 (t, J = 2.3 Hz, 2.21), 6.24 (t, J = 2.4 Hz, 2.13), 3.67 (s, 2.74), 3.59 (s, 3.00), 2.21 – 
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2.16 (m, 0.40), 2.13 – 1.96 (m, 2.42), 1.63 – 1.57 (m, 2.28), 1.45 – 1.32 (m, 2.41), 1.30 – 
1.16 (m, 4.20), 1.11 – 1.05 (m, 11.53), 1.00 (s, 11.29), 0.50 (dd, J = 14.7, 12.5 Hz, 1.41). 
13C NMR (125 MHz, CDCl3) δ ppm 170.9, 169.3, 166.2, 165.2, 136.1, 136.0, 135.9 (2C), 
134.1, 133.7 (2C), 133.6, 129.4, 129.3 (2C), 129.0, 127.8, 127.7 (2C), 127.6, 127.5, 119.6, 
119.4, 113.3, 113.0, 52.8, 52.8, 36.2, 35.9, 27.8 (2C), 27.7, 26.2, 25.4, 23.8, 22.98, 18.7, 
18.1, 18.0, 10.61, 7.87.  HRMS (ESI) M/Z+ Calc. 445.2064, Obs. 445.2063.
 
Methyl 2-(naphthalen-2-yl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate 4-
48: The general procedure was followed using 2-vinylnaphthalene (0.5824 g, 3.66 mmol), 
methyl 2-diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (402.0 mg, 2.081 mmol), Rh2esp2 (3.8 
mg, 4.81 µmol), and DCM (11 mL). After 15 hours, the reaction was quenched, and column 
chromatography rendered 4-48 as a yellow solid (412 mg, 62%). Diastereomeric ratio: 
(4.7:1) 1H NMR (500 MHz, CDCl3) δ ppm 7.86 – 7.77 (m, 4.12), 7.74 – 7.69 (m, 0.48), 
7.65 – 7.61 (m, 0.34), 7.57 – 7.55 (m, 0.29), 7.52 – 7.43 (m, 3.14), 7.44 – 7.39 (m, 0.51), 
7.38 (s, 1.85), 7.20 (dd, J = 8.5, 1.9 Hz, 0.25), 7.05 (s, 0.39), 6.35 – 6.28 (m, 1.98), 6.04 – 
5.98 (m, 0.42), 3.73 (s, 0.61), 3.60 (dd, J1=J2= 8.8 Hz, 0.97), 3.54 (dd, J1=J2= 8.7 Hz, 
0.25), 3.35 (s, 2.91), 2.56 (dd, J = 8.3, 5.3 Hz, 1.00), 2.50 (dd, J = 8.0, 5.4 Hz, 0.26), 2.00 
(dd, J = 9.3, 5.4 Hz, 0.22), 1.89 (dd, J = 9.3, 5.3 Hz, 1.01). 13C NMR (125 MHz, CDCl3) δ 
ppm 167.5, 165.6, 133.1, 133.0, 132.7, 131.4, 128.1, 128.0, 127.8 (2C), 127.7, 127.6, 
127.5, 126.9, 126.5, 126.2, 126.0, 125.9, 119.5, 119.4, 113.5, 112.9, 53.1, 52.8, 38.9, 38.6, 
33.5, 31.4, 19.9, 18.8.  HRMS (ESI) M/Z+ Calc. 319.1208, Obs. 319.1215. 
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Methyl 2-(furan-2-yl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (4-50): 
The general procedure was followed using 2-vinylfuran (1.79 g, 9.51 mmol), methyl 2-
diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (600 mg, 3.11 mmol), Rh2esp2 (11.2 mg, 0.014 
mmol), and DCM (10 mL). After 15 hours, the reaction was quenched, and column 
chromatography  afforded 4-50 as a yellow solid (382 mg, 48%). 1H NMR (500 MHz, 
CDCl3) δ ppm 7.42 – 7.35 (m, 3H), 6.36 – 6.30 (m, 3H), 6.27 – 6.25 (m, 1H), 3.53 (s, 3H), 
3.21 (d, J1=J2=  8.8 Hz, 1H), 2.28 (dd, J = 8.0, 5.3 Hz, 1H), 1.90 (dd, J = 9.5, 5.3 Hz, 1H). 
13C NMR (125 MHz, CDCl3) δ ppm 167.3, 165.0, 148.8, 142.4, 119.7, 113.5, 110.5, 108.8, 
52.9, 37.2, 24.4, 18.6.  HRMS (ESI) M/Z+ Calc. 259.0845, Obs. 259.0844. 
 
Methyl 2-(phenylthio)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (4-52): 
The general procedure was followed using phenyl(vinyl)sulfane (97 µL, 0.720 mmol), 
methyl 2-diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (214.1 mg, 1.108 mmol), Rh2esp2 (1.1 
mg, 1.392 µmol), and DCM (7.3 mL). After 12 hours, the reaction was quenched, and 
column chromatography (30% EtOAc/Hex, Rf= 0.69) afforded 4-52 as a brown solid (14 
mg, 6.5%). 1H NMR (400 MHz, CDCl3) δ ppm 7.48 – 7.43 (m, 2H), 7.34 – 7.27 (m, 4H), 
7.21 – 7.16 (m, 1H), 6.31 – 6.29 (m, 2H), 3.55 – 3.50 (m, 4H), 2.13 (dd, J = 7.4, 5.8 Hz, 
1H), 1.88 (dd, J = 9.3, 5.8 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ ppm 166.9, 164.7, 
135.3, 128.9, 127.6, 126.0, 119.4, 113.8, 53.1, 38.8, 27.8, 20.0. HRMS (ESI) M/Z+ Calc. 
301.0773, Obs. 301.0768. 
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Methyl 2-(furan-2-yl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (4-53): 
The general procedure was followed using 2-vinylfuran (1.79 g, 9.51 mmol), methyl 2-
diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (600 mg, 3.11 mmol), Rh2esp2 (11.2 mg, 0.014 
mmol), and DCM (10 mL). After 15 hours, the reaction was quenched, and column 
chromatography formed 4-53 as a yellow solid (382 mg, 48%). 1H NMR (500 MHz, 
CDCl3) δ ppm 7.34 – 7.27 (m, 4H), 7.20 – 7.16 (m, 2H), 7.03 – 6.99 (m, 1H), 6.32 – 6.30 
(m, 2H), 4.67 (dd, J = 7.1, 5.4 Hz, 1H), 3.45 (s, 3H), 2.53 (dd, J = 6.7, 5.3 Hz, 1H), 1.80 
(t, J = 6.9 Hz, 1H). 13C NMR (125MHz, CDCl3) δ ppm 167.3, 165.0, 148.8, 142.4, 119.7, 
113.5, 110.5, 108.8, 52.9, 37.2, 24.4, 18.6.  HRMS (ESI) M/Z+ Calc. 259.0845, Obs. 
259.0844. 
4.8.3 Al(OTf)3-Catalyzed Ring-opening/Friedel-Crafts Alkylation Sequence 
 The Al(OTf)3, cyclopropyl β-amide ester (1.0 equiv) and dichloromethane needed 
for 0.1 M at room temperature were combined in a round bottom flask. Upon completion, 
the reaction mixture was purified directly by silica gel flash column chromatography. 
Products were shown by 2-D thin layer chromatography to be stable on silica gel. 
 
Methyl 5-oxo-8-phenyl-5,6,7,8-tetrahydroindolizine-6-carboxylate (4-35): Methyl 2-
phenyl-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (50.1 mg, 0.186 mmol), 
Al(OTf)3 (17.6 mg, 0.037 mmol) and ACN (2.0 mL) were combined according to the 
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general method  to give 4-35 as a green oil (32 mg, 64%)  after 3 hours. Diastereomeric 
ratio: (1.54:1.0) 1H NMR (500 MHz, CDCl3) δ ppm 7.47 – 7.43 (m, 0.89), 7.41 (dt, J = 
3.5, 1.3 Hz, 1.13), 7.39 – 7.27 (m, 8.68), 7.20 – 7.15 (m, 1.98), 6.27 (t, J = 3.3 Hz, 0.88), 
6.23 (t, J = 3.3 Hz, 1.07), 5.79 (m, 0.90), 5.64 (m, 1.04), 4.28 (dd, J = 9.4, 4.5 Hz, 1.00), 
4.08 (dd, J = 12.5, 4.5 Hz, 1.16), 3.89 – 3.68 (m, 8.30), 2.76 – 2.60 (m, 2.05), 2.49 – 2.36 
(m, 2.12). 13C NMR (125 MHz, CDCl3) δ ppm 169.2, 169.1, 164.4, 164.0, 141.3, 140.9, 
136.0, 135.0, 128.7, 128.7, 128.2, 127.8, 127.6, 127.4, 117.0, 116.9, 113.4, 113.3, 111.3, 
52.9, 52.7, 50.7, 48.1, 40.5, 37.6, 34.4, 34.0. HRMS (ESI) M/Z+ Calc. 269.1052, Obs. 
269.1058. 
 
Methyl 8-(4-bromophenyl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-carboxylate (4-37): 
Methyl 2-(4-bromophenyl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (50.0 mg, 
0.144 mmol), Al(OTf)3 (13.8 mg, 0.029 mmol) and ACN (1.5 mL) were combined 
according to the general method to furnish 4-37 as a green oil (25.6 mg, 51%)  after 3 
hours. Diastereomeric ratio: (1.79:1.0) 1H NMR (500 MHz, CDCl3) δ ppm 7.52 – 7.45 (m, 
4.22), 7.44 (ddd, J = 3.4, 1.6, 0.7 Hz, 0.91), 7.41 (dt, J = 3.4, 1.3 Hz, 1.02), 7.21 – 7.16 (m, 
2.25), 7.10 – 7.05 (m, 1.83), 6.26 (t, J = 3.3 Hz, 0.89), 6.23 (t, J = 3.3 Hz, 1.01), 5.77 – 
5.74 (m, 0.83), 5.65 – 5.61 (m, 1.00), 4.24 (dd, J = 9.5, 4.3 Hz, 0.88), 4.05 (dd, J = 12.5, 
4.4 Hz, 1.04), 3.84 – 3.78 (m, 7.30), 3.76 (t, J = 5.5 Hz, 1.12), 2.70 – 2.56 (m, 2.00), 2.44 
– 2.34 (m, 1.97). 13C NMR (125 MHz, CDCl3) δ ppm 169.0, 168.9, 164.2, 163.6, 140.4, 
139.9, 135.4, 134.5, 131.9, 131.7, 129.9, 129.6, 121.5, 121.3, 117.2, 117.1, 113.4, 1113.3, 
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111.5, 111.4, 53.0, 52.8, 50.6, 48.1, 39.9, 37.2, 34.3, 33.9. HRMS (ESI) M/Z+ Calc. 
347.0157, Obs. 347.0165. 
 
Methyl 8-(4-methoxyphenyl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-carboxylate (4-
39): Methyl 2-(4-chlorophenyl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (50.5 
mg, 0.166 mmol), Al(OTf)3 (17.3 mg, 0.036 mmol) and ACN (1.8 mL) were combined 
according to the general method  to furnish 4-39 as a green oil (27.3 mg, 54%)  after 20 
minutes. Diastereomeric ratio: (1.75:1) 1H NMR (500 MHz, CDCl3) δ ppm 7.46 – 7.43 
(m, 0.87), 7.42 – 7.39 (m, 1.09), 7.36 – 7.29 (m, 4.34), 7.27 – 7.22 (m, 2.93), 7.15 – 7.11 
(m, 2.13), 6.26 (t, J = 3.3 Hz, 0.96), 6.23 (t, J = 3.3 Hz, 1.05), 5.77 – 5.74 (m, 0.83), 5.65 
– 5.61 (m, 1.00), 4.25 (dd, J = 9.3, 4.4 Hz, 0.94), 4.06 (dd, J = 12.5, 4.4 Hz, 1.10), 3.85 – 
3.74 (m, 9.01), 2.72 – 2.52 (m, 2.13), 2.47 – 2.34 (m, 2.14). 13C NMR (125 MHz, CDCl3) 
δ ppm 169.0, 168.9, 164.1, 163.7, 139.9, 139.4, 135.5, 134.6, 133.4, 133.2, 129.5, 129.3, 
128.9, 117.2, 117.1, 113.4, 113.3, 111.5, 111.4, 53.0, 52.8, 50.6, 48.1, 39.9, 37.1, 34.3, 
33.9. HRMS (ESI) M/Z+ Calc. 303.0667, Obs. 303.0671. 
 
Methyl 8-(4-fluorophenyl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-carboxylate (4-41): 
Methyl 2-(4-fluorophenyl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (50.2 mg, 
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0.175 mmol), Al(OTf)3 (16.8 mg, 0.035 mmol) and ACN (1.9 mL) were combined 
according to the general method to render 4-41 as a green oil (35.6 mg, 71%)  after 20 
minutes. Diastereomeric ratio: (1.47:1.0) 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.42 (m, 
1.00), 7.42 – 7.39 (m, 0.96), 7.29 – 7.26 (m, 1.56), 7.18 – 7.14 (m, 2.06), 7.08 – 6.99 (m, 
4.21), 6.26 (t, J = 3.3 Hz, 0.92), 6.23 (t, J = 3.3 Hz, 0.94), 5.80 – 5.72 (m, 0.88), 5.66 – 
5.58 (m, 0.90), 4.25 (dd, J = 10.2, 4.5 Hz, 1.09), 4.07 (dd, J = 12.5, 4.4 Hz, 1.04), 3.85 – 
3.74 (m, 9.14), 2.72 – 2.56 (m, 2.13), 2.46 – 2.32 (m, 2.07). 13C NMR (125 MHz, CDCl3) 
δ ppm 169.1, 169.0, 164.3, 163.8, 162.8, 161.1, 161.0, 137.0, 136.7, 136.6, 135.9, 134.9, 
129.7, 129.6, 129.5, 129.4, 128.2, 117.2, 117.0, 116.6, 115.7, 115.6, 115.4, 113.4, 113.3, 
113.2, 111.4, 111.3, 53.0, 52.8, 50.6, 48.2, 39.8, 37.0, 34.6, 34.1, which includes 13C-19F 
coupled peaks. HRMS (ESI) M/Z+ Calc. 287.0946, Obs. 287.0949. 
 
Methyl 8-(4-methoxyphenyl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-carboxylate (4-
43): Methyl 2-(4-methoxyphenyl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate 
(50.1 mg, 0.167 mmol), Al(OTf)3 (16.0 mg, 0.033 mmol) and ACN (1.8 mL) were 
combined according to the general method to afford 4-43 as a green oil (48.6 mg, 97%)  
after 20 minutes. Diastereomeric ratio: (1.25:1.0) 1H NMR (500 MHz, CDCl3) δ ppm 7.44 
– 7.41 (m, 0.99), 7.40 – 7.38 (m, 1.05), 7.24 – 7.19 (m, 2.21), 7.12 – 7.07 (m, 1.93), 6.92 
– 6.83 (m, 4.51), 6.25 (t, J = 3.3 Hz, 1.00), 6.22 (t, J = 3.3 Hz, 1.08), 5.78 – 5.75 (m, 0.87), 
5.64 – 5.62 (m, 1.00), 4.22 (dd, J = 9.4, 4.4 Hz, 0.97), 4.02 (dd, J = 12.6, 3.7 Hz, 1.14), 
3.85 – 3.74 (m, 16.87), 2.71 – 2.52 (m, 2.17), 2.45 – 2.30 (m, 2.23). 13C NMR (125 MHz, 
CDCl3) δ ppm 169.2, 169.1, 164.4, 163.9, 158.9, 158.8, 136.5, 135.5, 133.3, 132.9, 129.1, 
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128.8, 116.9, 116.8, 114.1, 114.0, 113.4,113.3, 111.2, 55.2, 52.9, 52.7, 50.8, 48.2, 39.7, 
36.8, 34.6, 34.1. HRMS (ESI) M/Z+ Calc. 299.1158, Obs. 299.1165. 
 
Methyl 8-methyl-5-oxo-8-phenyl-5,6,7,8-tetrahydroindolizine-6-carboxylate (4-45): 
Methyl 2-methyl-2-phenyl-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (49.8 mg, 
0.176 mmol), Al(OTf)3 (16.7 mg, 0.035 mmol) and ACN (1.9 mL) were combined 
according to the general method to give 4-45 as an off-white solid (47 mg, 95%) after  30 
minutes. Diastereomeric ratio: (4.0:1). 1H NMR (500 MHz, CDCl3) δ ppm 7.50 (dd, J = 
3.4, 1.6 Hz, 0.15), 7.44 (dd, J = 3.4, 1.6 Hz, 0.97), 7.31 – 7.26 (m, 2.26), 7.24 – 7.19 (m, 
1.27), 7.16 – 7.12 (m, 0.36), 6.99 – 6.95 (m, 2.11), 6.38 (t, J = 3.3 Hz, 0.97), 6.35 (t, J = 
3.3 Hz, 0.18), 6.21 (dd, J = 3.2, 1.5 Hz, 0.99), 6.04 (dd, J = 3.2, 1.6 Hz, 0.17), 3.76 (s, 
2.67), 3.32 (dd, J = 13.2, 4.6 Hz, 1.04), 3.22 (s, 0.49), 2.97 (dd, J = 13.9, 5.3 Hz, 0.20), 
2.64 (t, J = 13.2 Hz, 1.10), 2.56 (dd, J = 13.2, 4.7 Hz, 1.11), 2.41 (dd, J = 13.9, 6.2 Hz, 
0.22), 1.74 (s, 3.00), 1.71 (s, 0.53).13C NMR (125 MHz, CDCl3) δ ppm 169.4, 164.5, 144.9, 
138.3, 128.7, 128.0, 127.0, 126.9, 125.9, 117.2,  117.1, 113.3, 113.2, 110.9, 110.7, 52.6, 
52.3, 47.9, 40.1, 39.9, 39.7, 29.3, 29.1.  HRMS (ESI) M/Z+ Calc. 283.1208, Obs. 283.1206.
 
Methyl 8-((tert-butyldiphenylsilyl)methyl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-
carboxylate (4-47): Methyl 2-((tert-butyldiphenylsilyl)methyl)-1-(1H-pyrrole-1-
carbonyl)cyclopropanecarboxylate (49.8 mg, 0.112 mmol), Al(OTf)3 (10.8 mg, 0.023 
mmol) and ACN (1.2 mL) were combined according to the general method to furnish 4-47 
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as an off-white solid (35.7 mg, 72%) after  30 minutes. Diastereomeric ratio: (1.45:1) 1H 
NMR (500 MHz, CDCl3) δ ppm 7.74 – 7.70 (m, 0.84), 7.69 – 7.64 (m, 7.77), 7.46 – 7.35 
(m, 13.33), 7.33 – 7.27 (m, 1.99), 6.24 (t, J = 3.3 Hz, 0.86), 6.21 (t, J = 3.3 Hz, 1.01), 6.13 
– 6.09 (m, 0.84), 6.00 – 5.97 (m, 1.00), 3.68 (s, 2.54), 3.58 (t, J = 5.0 Hz, 1.02), 3.47 (s, 
3.09), 3.23 (dd, J = 13.0, 4.6 Hz, 0.85), 3.02 – 2.92 (m, 1.06), 2.85 – 2.75 (m, 1.03), 2.10 
– 2.01 (m, 1.14), 1.93 (dd, J = 15.4, 3.1 Hz, 0.91), 1.89 – 1.81 (m, 1.86), 1.81 – 1.71 (m, 
1.36), 1.69 – 1.62 (m, 1.04), 1.47 – 1.31 (m, 2.25), 1.10 – 1.06 (m, 10.01), 1.05 (s, 9.59). 
13C NMR (75 MHz, CDCl3) δ ppm 169.1, 169.0, 164.6, 164.0, 139.0, 138.9, 136.0 (2C), 
135.9. 135.8, 134.8, 134.2, 133.5, 133.3, 129.6, 129.5 (2C), 129.4, 129.3, 127.9 (2C), 
127.8, 127.7 (2C), 116.8 (2C), 113.0, 108.9, 108.8, 52.6, 52.5, 50.8, 48.8, 34.0, 33.4, 29.9, 
27.8, 27.7, 27.4, 26.5, 18.2 (2C), 14.4, 13.8.  HRMS (ESI) M/Z+ Calc. 445.2073, Obs. 
445.2075. 
 
Methyl 8-(naphthalen-2-yl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-carboxylate (4-49): 
Methyl 2-(naphthalen-2-yl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (49.9 mg, 
0.156 mmol), Al(OTf)3 (14.8 mg, 0.031 mmol) and ACN (1.7 mL) were mixed according 
to the general method to render 4-49 as an off-white solid (34.6 mg, 69%) after  30 minutes. 
Diastereomeric ratio: (1.31:1). 1H NMR (500 MHz, CDCl3) δ ppm 7.90 – 7.73 (m, 7.19), 
7.61 (s, 0.82), 7.54 – 7.46 (m, 5.96), 7.46 – 7.38 (m, 1.09), 7.34 (dd, J = 8.5, 1.8 Hz, 0.80), 
6.29 (t, J = 3.3 Hz, 0.74), 6.24 (t, J = 3.3 Hz, 0.97), 5.83 – 5.80 (m, 0.78), 5.67 – 5.64 (m, 
1.00), 4.46 (dd, J = 9.2, 4.0 Hz, 0.81), 4.25 (dd, J = 12.3, 4.3 Hz, 1.04), 3.88 (dd, J = 12.7, 
4.6 Hz, 1.19), 3.85 – 3.73 (m, 6.69), 2.83 – 2.72 (m, 1.89), 2.60 – 2.51 (m, 0.85), 2.52 – 
2.43 (m, 1.11). 13C NMR (125 MHz, CDCl3) δ ppm  169.2, 169.1, 164.4, 163.9, 138.7, 
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138.2, 135.9, 135.0, 133.4, 133.3, 132.8, 132.6, 128.6, 128.5, 127.7 (2C), 127.6, 127.1, 
126.8, 126.3 (2C), 126.0 (2C), 125.9, 125.7, 117.1, 116.9, 113.4, 111.5, 111.5, 52.9, 52.7, 
50.7, 48.1, 40.6, 37.8, 34.3, 33.9. HRMS (ESI) M/Z+ Calc. 319.1208, Obs. 319.1201. 
 
Methyl 8-(furan-2-yl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-carboxylate (4-51): 
Methyl 2-(furan-2-yl)-1-(1H-pyrrole-1-carbonyl)cyclopropanecarboxylate (50.0 mg, 
0.193 mmol), Al(OTf)3 (18.5 mg, 0.039 mmol) and ACN (2.0 mL) were combined 
according to the general method to give 4-51 as an off-white solid (34.6 mg, 69%) after  30 
minutes. Diastereomeric ratio: (1.15:1) 1H NMR (500 MHz, CDCl3) δ ppm 7.43 – 7.39 
(m, 2.72), 7.37 (dd, J = 1.9, 0.9 Hz, 0.90), 6.35 (dd, J = 3.2, 1.8 Hz, 0.97), 6.31 (dd, J = 
3.2, 1.9 Hz, 0.94), 6.27 (dt, J = 6.4, 3.3 Hz, 1.86), 6.18 – 6.16 (m, 0.92), 6.04 – 6.01 (m, 
1.81), 5.98 – 5.95 (m, 0.90), 4.45 – 4.41 (m, 0.95), 4.29 (dd, J = 10.3, 4.4 Hz, 1.00), 3.83 
– 3.73 (m, 7.54), 2.80 – 2.66 (m, 2.04), 2.60 (ddd, J = 13.5, 7.4, 5.0 Hz, 0.99), 2.54 – 2.46 
(m, 1.00). 13C NMR (75 MHz, CDCl3) δ ppm 169.1, 168.8, 164.0, 163.8, 153.6, 153.4, 
142.2, 142.1, 132.5, 131.9, 117.2, 117.1, 113.4, 113.3, 111.2, 111.1, 110.3, 107.0, 106.8, 
52.9, 52.8, 49.8, 47.8, 33.4, 31.5, 31.1, 30.4.  HRMS (ESI) M/Z+ Calc. 259.0845, Obs. 
259.0844. 





carbonyl)cyclopropanecarboxylate (4-57): Rh2esp2 (1.9 mg, 2.405 µmol) was added to 
a dry flask equipped with a stir bar under nitrogen. 2 mL of DCM was added. Methyl 2-
diazo-3-oxo-3-(1H-pyrrol-1-yl)propanoate (124.7 mg, 0.646 mmol) was dissolved in 4.0 
mL of DCM. Methyl 4-methylenehexanoate (298.5 mg, 2.099 mmol) was added to the 
reaction pot followed by slow addition of the diazo at 0.5 mL/h (2 mL/4h). The reaction 
proceeded for 12 hours. The reaction was quenched with saturated thiourea. The organic 
phase was collected. The aqueous phase was extracted three times with DCM. The 
combined layers were dried over sodium sulfate, filtered, concentrated and purified using 
silica gel column chromatography (10%EtOAc/Hex). 4-57 was obtained as a yellow oil 
(59.8 mg, 30%). Diastereomeric ratio: (1.15:1) 1H NMR (500 MHz, CDCl3) δ ppm 7.35 – 
7.26 (m, 1.63), 6.28 – 6.25 (m, 1.85), 3.69 (s, 1.01), 3.68 – 3.65 (m, 2.68), 3.63 (s, 1.60), 
2.58 – 2.45 (m, 1.00), 2.41 – 2.23 (m, 1.41), 2.17 – 2.03 (m, 1.01), 1.87 – 1.76 (m, 1.26), 
1.76 – 1.65 (m, 1.46), 1.57 – 1.49 (m, 1.00), 1.35 – 1.21 (m, 0.93), 1.00 (t, J = 7.5 Hz, 
1.92), 0.95 (t, J = 7.0 Hz, 1.11), 0.92 – 0.86 (m, 0.48).13C NMR (125 MHz, CDCl3) δ ppm 
173.2, 173.1, 169.2, 169.1, 165.0, 164.9, 119.8, 119.7, 113.2, 113.1, 53.0, 52.9, 51.7 (2C), 
40.3, 40.0, 37.7 (2C), 31.2, 31.1, 28.4, 27.1, 27.0, 26.7, 24.0, 21.9, 10.6, 10.5.  HRMS (ESI) 
M/Z+ Calc. 307.1420, Obs. 307.1419. 
 
Methyl 8-ethyl-8-(3-methoxy-3-oxopropyl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-
carboxylate (4-58): Indium(III) trifluoromethanesulfonate (84.1 mg, 0.150 mmol) was 
charged to a flame-dried flask. Methyl 2-ethyl-2-(3-methoxy-3-oxopropyl)-1-(1H-pyrrole-
1-carbonyl)cyclopropanecarboxylate (153.3 mg, 0.499 mmol) was dissolved in 3 mL of 
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DCM and added to the flask. The reaction mixture turned a brown color. 2 mL of DCM 
was used to rinse the flask containing the starting material and syringed into the reaction 
pot. The flask was placed in an oil bath, and the temperature was 50 °C. The reaction heated 
at reflux for 50 min. and cooled to room temperature. The crude was purified directly to 
obtain 4-58 as a brown oil (95.8 mg, 65%). Diastereomeric ratio: (1.1:1) 1H NMR (500 
MHz, CDCl3) δ ppm 7.33 – 7.30 (m, 1.90), 6.22 (t, J = 3.3 Hz, 0.91), 6.20 (t, J = 3.3 Hz, 
0.99), 5.97 (dd, J = 3.3, 1.5 Hz, 0.93), 5.94 (dd, J = 3.3, 1.5 Hz, 1.00), 3.93 (dd, J = 13.0, 
5.1 Hz, 1.07), 3.85 (dd, J = 12.8, 5.1 Hz, 1.13), 3.81 – 3.77 (m, 6.10), 3.64 (s, 2.94), 3.57 
(s, 3.05), 2.44 – 2.26 (m, 5.23), 2.25 – 2.17 (m, 1.25), 2.11 – 1.88 (m, 5.58), 1.83 – 1.74 
(m, 1.47), 1.71 (q, J = 7.5 Hz, 2.17), 1.65 – 1.46 (m, 2.20), 0.91 – 0.82 (m, 6.50). 13C NMR 
(125 MHz, CDCl3) δ ppm 173.7, 173.4, 169.8, 169.7, 164.0, 163.9, 137.0, 136.9, 117.1, 
117.0, 113.1, 112.9, 109.9, 109.7, 52.7 (2C), 51.6 (2C), 46.9, 46.8, 36.8, 36.5, 34.8, 34.2, 
31.7, 31.3, 31.1, 29.7, 28.9, 28.7, 8.12, 7.7.  HRMS (ESI) M/Z+ Calc. 307.1420, Obs. 
307.1427. 
 
Methyl 3-(8-ethyl-5-oxo-5,6,7,8-tetrahydroindolizin-8-yl)propanoate (4-59): Methyl 
8-ethyl-8-(3-methoxy-3-oxopropyl)-5-oxo-5,6,7,8-tetrahydroindolizine-6-carboxylate 
(95.8 mg, 0.312 mmol), LiCl (30.9 mg, 0.729 mmol), water 1 (drop), and DMSO (Anh) 
was charged to a round bottom flask equipped with a stir bar. The air was removed and 
replaced with nitrogen, and the flask was heated at 150 °C for 2 hours. The pot was cooled 
at room temperature and poured onto water. Ethyl Ether was added and the aqueous phase 
was extracted three times with Ethyl ether. The combined organic layers were dried with 
sodium sulfate, filtered, concentrated and purified with silica gel column chromatography 
to afford 4-59 as a brown oil (51 mg, 66%). 1H NMR (500 MHz, CDCl3) δ ppm 7.32 (dd, 
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J = 3.4, 1.5 Hz, 1H), 6.18 (t, J = 3.3 Hz, 1H), 5.93 (dd, J = 3.2, 1.5 Hz, 1H), 3.61 (s, 3H), 
2.82 – 2.67 (m, 2H), 2.36 – 2.26 (m, 1H), 2.26 – 2.17 (m, 1H), 2.03 – 1.93 (m, 1H), 1.94 – 
1.82 (m, 3H), 1.73 – 1.63 (m, 1H), 1.63 – 1.55 (m, 1H), 0.85 (t, J = 7.5 Hz, 3H). 13C NMR 
(125 MHz, CDCl3) δ ppm173.8, 167.7, 137.6, 116.6, 112.2, 109.3, 51.6, 36.7, 31.1, 30.5, 





CHAPTER 5  FRIEDEL-CRAFTS CYCLIZATIONS OF 
REACTIVE MICHAEL-ACCEPTORS: AN INTRAMOLECULAR, 
DIASTEREOSELECTIVE SYNTHESIS OF FUNCTIONALIZED 
1H-PYRROLO[1,2-A]INDOLES 
Pyrroloindoles are of great interest to synthetic chemists for their medical value and 
structural diversity.277–280 If described, these [a]-annelated heterocycles are comprised of 
an indole ring and pyrrole ring fused along a C-N bond “a” connector. The pyrrolo[1,2-
a]indole is classified by its subclasses which differ in degrees of unsaturation or isomeric 
locales of π-bonds about the tricyclic core. Below are common scaffolds, 9H-pyrrolo[1,2-
a]indole 5-1, 3H-pyrrolo[1,2-a]indole 5-2, 1H-pyrrolo[1,2-a]indole 5-3, 2,3-dihydro-1H-
pyrrolo[1,2-a]indole 5-4, and 2,3,9,9a-tetrahydro-1H-pyrrolo[1,2-a]indole 5-5, displayed 
in Figure 5.1.  
 
Figure 5.1: Pyrrolo[1,2-a]indole numbering and representative scaffolds 
 
Unique to the pyrroloindole framework, compounds consisting of this specific 
molecular stature are biologically active and useful for combating human diseases.174,281 In 
particular, flinderole C282 5-6 and isoborreverine283 5-7 have selective antimalarial activity; 
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isatisine A284 5-8 is an antiviral; and mitomycin C285 5-9 acts as an anticancer agent (Figure 
5.2).  
 
Figure 5.2: Bioactive pyrrolo[1,2-a]indole-based natural products 
5.1 Pyrrolo[1,2-a]indole Synthesis 
To date, a plethora of reports for the synthesis of pyrrolo[1,2-a]indoles is in the 
chemical literature,286–294 signifying the general interest and importance of this alkaloid 
group.295,296  Given the large number of routes, complete coverage of all syntheses will not 
be reviewed in this dissertation, but representative examples are presented (vide infra). 
Typically, as described by Makarov in a recent review, pyrrolo[1,2-a]indoles are 
synthesized by annulation of a pyrrole onto an indole, annealation of a pyrrole ring to 
benzene and pyrrole rings, concomitant addition of two pyrroles or pyrrole-type units to a 
benzene unit, and chemical manipulation of related heterocycles.296 
 
5.1.1 Annealation of Pyrrole to Benzene and Pyrrole Rings 
In 1995, Moody and Norton297 reported a radical cyclization of 1-(ω-
iodoalkyl)indole-3-carboxaldehydes 5-10 with excess tributyltin hydride and 1.0 
equivalent azobisisobutyronitrile (AIBN) in toluene. In contrast to an oxidative protocol298 
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using H2O2, Fe(II), and DMSO, the yields (64% and 47%) for Norton’s transformation 
were higher for 2,3-dihydro-1H-pyrrolo[1,2-a]indoles 5-11 (Figure 5.3).  
 
 
Figure 5.3: Radical cyclization for 2,3-dihydro-1H-pyrrolo[1,2-a]indoles  
 
5.1.2 Annealation of a Pyrrole to Benzene and Pyrrole Rings 
Knochel and Ren299 published a chemoselective palladium-catalyzed cyclization of 
N-(2-haloaryl)pyrroles 5-12 to form 9H-pyrrolo[1,2-a]indoles 5-13. For the mechanism, 
the substrate undergoes an oxidative addition to generate palladium(II) in situ. Subsequent 
C-H activation and HX elimination forms a palladacycle where reductive elimination 
generates pyrroloindoles 5-13 (Figure 5.4).  
 
 
Figure 5.4: Palladium-catalyzed cyclization for 9H-pyrrolo[1,2-a]indoles 
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5.1.3 Concomitant Addition of Two Pyrrole Units to a Benzene Unit 
Synthetically, the simultaneous addition of two pyrrole rings to a benzene unit to 
form pyrrolo[1,2-a]indoles is advantageous if the number of steps to form the framework 
is considered. Iwasawa et al. published a Pt(II)/Au(III)-catalyzed [3+2] cycloaddition 
protocol for 2,3-dihydro-1H-pyrrolo[1,2-a]indoles 5-15 from N-(o-alkynylphenyl)imines 
5-14 containing an internal alkyne (Figure 5.5).300 These tricyclic indoles are postulated to 
form from a platinum or gold azomethine ylide which undergoes a [3+2] cycloaddition 
with a vinyl ether followed by a 1,2-migration to afford 2,3-dihydro-1H-pyrrolo[1,2-
a]indoles 5-15 in good yields (60-95%).  
 
 
Figure 5.5: Pt(II)- or Au(III)-catalyzed [3+2] cycloaddition for 2,3-dihydro-1H- 
         pyrrolo[1,2-a]indoles 
 
5.1.4 Rearrangement of Heterocycles 
In order to transform heterocycles into pyrrolo[1,2-a]indoles, rearrangement occurs 
with precursors containing an annelated benzene ring. With this in mind, in an effort to 
assemble an aziridinomitosene skeleton, Miller et al. designed a precursor, specifically 5-
16, capable of undergoing a tandem deprotection/transannular cyclization/dehydration 
sequence with trifluoroacetic acid in dichloromethane at room temperature, and within five 
minutes, 5-17 was generated in 92% yield (Figure 5.6).301 If the retrosynthetic analysis 
were assessed, it is evident that the reaction sequence was key to form the desired 




Figure 5.6: Deprotection/transannular cyclization/dehydration sequence for 
                   pyrrolo[1,2-a]indole 
 
5.2 Hypothesis and Synthetic Rationale for Pyrrolo[1,2-a]indole Synthesis 
Until our work, a broad, efficient intramolecular approach to install disparate 
functionality around the 1H-pyrrolo[1,2-a]indole skeleton had not been attained. In 2011, 
we disclosed a modular synthesis of hydropyrido[1,2-a]indole-6(7H)-ones 5-20 using an 
In(OTf)3-catalyzed tandem cyclopropane ring-opening/intramolecular Friedel-Crafts 
alkylation sequence from D-A-A cyclopropanes 5-18.302 In this report, six-membered 
constructs were synthesized; for a new methodology, we sought to construct similar five-
membered indolic systems.  Our rationale emanated from the reactivity exhibited by D-A-
A cyclopropanes. According to Walsh, electronically, cyclopropanes have inherent π-
character which is influenced by ring substitution—meaning donating and withdrawing 
moieties alter bond polarization and bond strength.51,53,303 Therefore, polarized alkylidene 
malonate monoamide or acrylate 5-21 containing an indoyl moeity would be prone to an 
intramolecular annulation to form a new five-membered lactam via a different mechanistic 
pathway with  an identical π-nucleophile and akin aza-cationionic intermediate 
(comparatively, 5-19 and 5-22, Figure 5.7). Hence, precursors with this Michael-type 




Figure 5.7: Cyclopropane and alkylidene malonate monoamide reactivity 
 
By utilizing this Michael-type setup, Friedel-Crafts alkylation chemistry becomes 
a viable alternative for pyrroloindole formation. If recognized, employing this approach 
with an α,β-unsaturated carbonyl can be a powerful strategy for natural product 
synthesis.304 Although intermolecular reactions are prevalent,305,306 intramolecular variants 
would be more beneficial for the assembly of complex indole polycycles.120,307–310 In 
affirmation of our proposed aim, a literature search was conducted; in 2010, Hadjipavolou-
Litina reported the unexpected formation of a 1H-pyrrolo[1,2-a]indole-3(2H)-one 5-25 
from N-cinnamoyl indole derivative 5-24 with stoichiometric trifluoracetic acid in 
dichloromethane.311 Without donating groups located in both ortho- and para-positions, 5-
24 does not form 5-25. However, if an additional acceptor group, such as an ester, were 
positioned α to the indolic amide to form a more polarized conjugated arrangement, 
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alkylidene malonate monoamides 5-21 would become more reactive units than their simple 
α,β-unsaturated counterparts,312 leading to the prospect that our proposed hypothesis was 
more plausible.  
 
 
Figure 5.8: Hadjipavolou-Litina and Papaioannour’s TFA-promoted annulation 
 
5.3 Precursor Assembly and Reaction Optimization for Pyrrolo[1,2-a]indole 
Synthesis 
To begin our study, model precursor 4-OMe-phenyl derivative 5-29, shown in 
Table 5.1, was prepared in the following manner (Figure 5.9). N-acylated indoles 5-27 were 
synthesized according to our previous preparation from indoles 5-26 with methyl malonyl 
chloride (MMC).  Base-promoted acylation gave β-amidoesters 5-27. Knoevenagel 
condensation with the appropriate aldehyde or ketone afforded the desired acrylates 5-28 
in 40-95% yields. Overall, a majority of our precursors were prepared according to the 
Figure 5.9; alkylidene malonate monoamides derived from ketones were prepared using 
TiCl4 (General Procedure 5.7.2.2). After synthesis of model precursor 5-29 in Table 5.1, 
several Lewis acids were selected for screening.  
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Figure 5.9: Alkylidene malonate monoamide synthesis for pyrrolo[1,2-a]indole 
synthesis 
 
 Given our past successes with indium, we chose In(OTf)3 as the starting Lewis acid 
for our initial cyclization study with model substrate 5-29. After 48 hours, 30 mol% 
In(OTf)3 at room temperature and 50 °C in dichloromethane (Table 5.1, entry 1 and 2) did 
not yield any of the desired product as indicated by 1H NMR,  but toluene at 111 °C with 
30 mol% In(OTf)3  gave 100% conversion to product 5-30 after 30 minutes (Table 5.1, 
entry 3) with a high trans:cis diastereomeric ratio (dr) determined by 1H NMR (5.7.3.2 
Rationale for cis/trans assignment). Of note, the large diastereoselectivities may be 
associated from a post-cyclization thermodynamic equilibration of the product.  
 Then, the solvent was changed from toluene to 1,2-dichloroethane to increase 
polarity and decrease temperature. 30 mol% In(OTf)3  at 84 ˚C afforded full conversion 
after 45 minutes (Table 5.1, entry 4). Next, the catalyst loading was reduced to 10 mol% 
In(OTf)3 and complete conversion was observed after 1 hour in 1,2-dichloroethane at reflux 
(Table 5.1, entry 5). Other Lewis acids with varying Z-effectives at 10 mol% were 
examined in 1,2-dichloroethane at reflux. Sc(OTf)3 and Al(OTf)3 gave quantitative 
conversion to product  after 1.5 hours (Table 5.1, entries 6 and 7). Cu(OTf)2 (100% 
conversion, Table 5.1, entry 8), Yb(OTf)2 (100% conversion, Table 5.1, entry 9), and 
Zn(OTf)2 (45% conversion, Table 5.1, entry 10) usage resulted in longer reaction times, 9, 
10, and 48 hours respectively. Due to short reaction times for indium, catalyst loading was 
lowered to 5 mol% in 1,2-dichloroethane at 84 ˚C to give full conversion after 2 hours 
(Table 5.1, entry 11). When 5 mol% In(OTf)3  was used for other precursors, reaction 
completion was not attained. Consequently, 10 mol% In(OTf)3 in 1,2-dichloroethane at 
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reflux formed most of the products in a timely and efficient manner. With these optimized 
conditions on hand, reaction extent and scope were examined for the Friedel-Crafts 
alkylation.  
 
Table 5.1: Reaction Optimization for Pyrrolo[1,2-a]indoles 
 
5.4 Results and Discussion 
 Aryl groups on the acrylates were altered using electron-donating and electron-
withdrawing groups (Table 5.2). 4-Methoxy aryl derivative 5-29 gave 1H-pyrrolo[1,2-
a]indole 5-30 in 95% yield with 15:1 dr in 1 hour (Table 5.2, entry 1).  Substitution was 
made from a more activated 4-OMe precursor 5-29 to a less activated one 5-31. Indole 5-
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32 was obtained in 97% with 16:1 dr (Table 5.2, entry 2) with the same reaction time.  4-
Br-C6H5 derivative 5-33 was subjected to the reaction conditions and afforded 5-34 in 93% 
yield with 16:1 dr (Table 5.2, entry 3) albeit with a longer reaction time. More electron 
deficient aryls such as 4-CF3-C6H5 5-35 and 4-NO2-C6H5 5-37 were reacted to form 
pyrrolo[1,2-a]indoles 5-36 and 5-38 in 92% yield with 20:1 dr (Table 5.2, entry 4) and 
84% with 19:1 dr (Table 5.2, entry 5) respectively. These findings suggest the electronics 
of the aryl substituents does not affect product outcomes significantly, but the reaction 
times change depending on substitution. Moreover, the more stable trans isomer is 
thermodynamically more favorable over its cis version because of the repeated high 
diastereoselectivities. This reaction success of aryl precursors then led us to investigate 
electron-rich heteroaromatics.  
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Table 5.2: Friedel-Crafts Alkylation with Aromatic Alkylidiene Malonate 
Monoamides 
 
 With this intention, 2-furyl acrylate 5-39, 2-thienyl acrylate 5-41, and 2-pyridyl 
acrylate 5-43 were synthesized. The furyl derivative cyclized to 5-40 in 97% yield with 
18:1 dr (Table 5.3, entry 1), and the 2-thienyl derivative formed 5-42 in 98% with 24:1 dr 
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(Table 5.3, entry 2). 2-Pyridyl precursor 5-43 did not form the desired 1H-pyrrolo[1,2-
a]indole (Table 5.3, entry 3). Presumably, the lack of reactivity is attributed to the 
coordinating nitrogen forms a complex with the indium catalyst, preventing product 
formation. Once establishing differing aryls work, substituent changes were made at the 3-
position of the indole.  
Table 5.3: Heteroaromatic Donor Group Reaction Scope 
 
 Phthalimido precursor 5-44 was subjected to the optimized conditions to give 5-45 
in 96% yield with 14:1 dr (Table 5.4, entry 1). Deprotection of 5-45 furnishes the primary 
amine which is synthetically appealing for the construction of natural products, such as 
flinderole C 5-6. Bromo substrate 5-46 provided 5-47 in 69% yield with 25:1 dr (Table 5.4, 
entry 2). Likewise, methyl acetate derivative 5-48 generates 5-49 in 93% yield with 13:1 
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dr (Table 5.4, entry 3). Then, indole acrylate 5-50, having no substituent in the 3-position, 
was assembled and generated 5-51 in 98% yield with 10:1 dr (Table 5.4, entry 4), 
demonstrating substitution at the 3-position is not crucial for product formation, and the 
reaction time is not extended substantially. As a part of the scope investigation, the 
alkylidene malonate monoamides were changed to nonaromatic groups that represent 
moieties derived from alkyl aldehydes and cinnamaldehyde.  
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Table 5.4: Alterations at the 3-Position on the Indole 
 
 The ethyl substituted alkylidene malonate monoamide 5-52 under the optimized 
reaction conditions did not yield product after >24 hours. After some further optimization, 
the catalyst loading was increased to 15 mol% In(OTf)3 with a higher boiling solvent 
(toluene) and heated to reflux. 5-52 was subjected to the new conditions and formed 5-53 
in 89% yield as the trans isomer exclusively (Table 5.5, entry 1). Propyl precursor 5-54 
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gave 5-55 in 84% yield (Table 5.5, entry 2) with one observable diastereomer. When 
formaldehyde derived substrate 5-56 was subjected to the reaction conditions, 5-57 formed 
in 47% yield (Table 5.5, entry 3); degradation was observed due to the stability of the 
starting material and product under the higher temperature and catalyst loading. 
Conjugated cinnamate 5-58 afforded 5-59 in 71% yield with 8:1 dr (Table 5.5, entry 4). 
2,2-Disubstituted acrylate 5-60 cyclized to form 5-61 in 98% yield (Table 5.5, entry 5) with 
a quaternary center. As a direct consequence of this new finding, our methodology is useful 
for installing quaternary centers, chiral or achiral, derived from ketones. With all the data 
so far, we predicted indole could be exchanged for pyrrole on the alkylidene malonate 
monoamide to an entirely new scaffold.  
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Table 5.5: Reaction Scope of Nonaromatic Alkylidene Malonate Monoamides 
 
 Consequently, if pyrrole is used, our methodology would furnish 1H-pyrrolizin-
3(2H)-ones. Pyrrolizines, naturally occurring compounds, have unique synthetic and 
medicinal potential due to their therapeutic and biological activities.313–320 Excitingly, 
when acrylate 5-62 was treated with 10 mol% In(OTf)3 in 1,2-dichloroethane at reflux, 
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desired pyrrolizine 5-63  was recovered in 54% yield with 13:1 dr (Figure 5.10). 
Unfortunately, product degradation under the reaction conditions attenuated the isolated 
yield. 
 
Figure 5.10: Reaction assessment for 1H-pyrrolizin-3(2H)-one formation 
 
5.5 Conclusion 
 In brief, the reactivity of donor-acceptor-acceptor cyclopropane systems explored 
previously evolved into the development of a new intramolecular route for pyrrolo[1,2-
a]indoles. This amenable, efficient protocol was devised using a diastereoselective, Lewis 
acid-catalyzed intramolecular Friedel-Crafts reaction. The protocol gives high yields (up 
to 98%) of five-membered lactams with high diastereoselectivities (up to 25:1 dr), and 
precursors were built from cheap, commercially-available reagents in two steps. The scope 
was broadened using heteroaromatics, halogens, and a N-phthalimide, providing access to 
functional groups typically incapable of direct installation due to Lewis basicity (e.g. 
amine). Moreover, quaternary center incorporation is simple to install with high yields; 
notably, removal of the indole and installment of a pyrrole resulted in 1H-pyrrolizin-3(2H)-
one formation, opening a new avenue for the synthesis of functionalized pyrrolizines and 
verifying the fundamental rationale for the methodological development.   
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This research was conducted with Dr. Dadasaheb V. Patil. He made the precursors and 
the final products. 
This work was published in Chemical Communications:  Patil, D. V.; Cavitt, M. A.; 
Grzybowski, P.; France, S. An Efficient Synthesis of hydropyrido[1,2-a]indole-6(7H)-
ones via an In(III)-Catalyzed Tandem Cyclopropane Ring-opening/Friedel-Crafts 
Alkylation Sequence. Chem. Commun. Camb. U. K. 2011, 47, 10278–10280. 
5.7 Experimental Information 
5.7.1 Synthetic Methods for Pyrrolo[1,2-a]indole Preparation 
 All reactions were carried out in pre-dried glassware from the oven and any 
additional moisture was removed by flame-drying the reaction vessel.  Each reaction 
proceeded under a nitrogen atmosphere with anhydrous solvents, unless stated otherwise. 
Tetrahydrofuran and diethyl ether were distilled from a sodium/benzophenone ketyl under 
nitrogen and stored in a Schlenk flask. Benzene, toluene, 1,2-dichloroethane, and 
dichloromethane were purified by distillation from calcium hydride. Acetonitrile was dried 
by fractional distillation over CaH2. All other reagents were purchased from Acros, Sigma-
Aldrich, Fluka, VWR, Merck, Alfa Aesar, TCI, and Strem (for metal catalysts). These 
reagents were used without further purification.  All methyl 3-(1H-indol-1-yl)-3-
oxopropanoates 5-27 were synthesized as previously reported.302  
 Chromatographic purification was performed as flash chromatography with 
Dynamic Adsorbents silica gel (32-65µm) and solvents indicated as eluent with 0.1-0.5 bar 
pressure. For quantitative flash chromatography, technical grades solvents were utilized. 
Analytical thin-layer chromatography (TLC) was performed on EMD silica gel 60 F254 
TLC glass plates. Visualization was accomplished with UV light, aqueous basic potassium 
permanganate (KMnO4) solution, iodine, aqueous acidic dinitrophenylhydrazine (DNP) 
solution, aqueous acidic p-anisaldehyde (PAA) solution, and an ethanol solution of 
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phosphomolybdic acid (PMA) followed by heating.  Each yield refers to an isolated, 
analytically-pure material.  
 Infrared (IR) spectra were obtained using a Nicolet 4700 FTIR with an ATR 
attachment from SmartOrbit Thermoelectronic Corp. The IR bands are characterized as 
weak (w), medium (m), and strong (s). Proton and carbon nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) were recorded on a Varian Mercury Vx 300 MHz 
spectrometer, Varian Mercury Vx 400 MHz spectrometer or Bruker 400 MHz spectrometer 
with solvent resonances as the internal standard (1H NMR: CDCl3 at 7.26 ppm; 
13C NMR: 
CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift (ppm), 
multiplicity (s = singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, ddd 
= doublet of doublet of doublets, t = triplet, m = multiplet), coupling constants (Hz), and 
integration values. Mass spectra were obtained by the Georgia Institute of Technology 
Bioanalytical Mass Spectrometry Facility using a VG-70SE instrument. Compounds 
synthesized and not reported in the literature until our publication are listed below. Dr. 
Dadasaheb V. Patil synthesized the precursors and the final products as well. 
5.7.2 Alkylidene Malonate Monoamide Preparation for Pyrrolo[1,2-a]indole 
Synthesis 
5.7.2.1 General Procedure A321 
 The β-esteramide (1.0 equiv.), aldehyde (1.3 equiv.), glacial acetic acid (0.5 equiv.), 
and piperidine (0.1 equiv.) were heated to a reflux in benzene using a Dean-Stark trap for 
12 hours. After cooling the reaction mixture to room temperature, water was added to the 
reaction vessel, and the organic layer was collected. Subsequently, the aqueous phase was 
extracted with EtOAc three times. The combined organic layers were washed with 1 M 
HCl and saturated sodium bicarbonate. The combined organic layers were dried with 
Na2SO4, filtered, concentrated, and purified by silica gel column chromatography (gradient 
EtOAc/Hex). 
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5.7.2.2 General Procedure B322 
 A round bottom flask was charged with the β-esteramide (1.0 equiv.) and THF (25 
mL). After cooling the solution to 0 ̊ C, titanium(IV) chloride tetrahydrofuran complex (2.0 
equiv.) and CCl4 (2.0 equiv.) were added to the reaction vessel. After 1 hour at 0 ˚C, the 
aldehyde (1.0 equiv.) was added slowly, and the reaction was stirred for an hour. Then, 
pyridine (4.0 equiv.) was added to the solution dropwise. The reaction mixture was warmed 
to room temperature and allowed to stir for 14 hours. The reaction was quenched with 
water and the organic layer was collected. The aqueous layer was extracted with ether, and 
the combined organic layers were washed with saturated NaHCO3 and brine. The organic 
layer was dried with MgSO4, filtered, concentrated, and purified by silica gel column 
chromatography (gradient EtOAc/Hex).   
 
Methyl 3-(4-methoxyphenyl)-2-(3-methyl-1H-indole-1-carbonyl)acrylate (5-29):  
Methyl 3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (1.04 g, 4.50 mmol), 4-
methoxybenzaldehyde (0.65 mL, 5.34 mmol), glacial acetic acid (0.126 g, 2.10 mmol), 
piperidine (0.0780 g, 0.911 mmol) and benzene (15 mL) were mixed according to general 
procedure A to afford 5-29 as a white solid (1.32 g, 84%) after 12 hours. Rf= 0.30 (20% 
EtOAc/Hex). [m.p. 138-140 ˚C]  1H NMR (300 MHz, CDCl3) δ ppm 8.69 (d, J = 8.1 Hz, 
1H), 7.94 (s, 1H), 7.53 – 7.32 (m, 5H), 7.01 (s, 1H), 6.79 – 6.72 (m, 2H), 3.80 (s, 3H), 3.70 
(s, 3H), 2.18 (d, J = 0.6 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ ppm 165.2, 164.9, 161.7, 
142.9, 135.3, 132.1, 131.9, 125.2, 124.6, 124.1, 123.3, 122.4, 119.1, 118.8, 116.7, 114.5, 
55.1, 52.6, 9.5. IR: 3070.1 (w), 3007.0 (w), 2930.6 (w), 2824.4 (w), 1715.1 (m), 1678.1 
(s), 1598.3 (s), 1511.9 (m), 1448.1 (m), 1395.8 (m), 1341.2 (m), 1254.3 (s), 1170.5 (s), 
1047.5 (s), 874.9 (m), 732.2 (s), 698.5 (m), 536.2 (m) cm-1. HRMS (ESI) M/Z+ Calc. 




methoxyphenyl)acrylate (5-44): Methyl 3-(3-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-1H-
indol-1-yl)-3-oxopropanoate (1.08 g, 2.77 mmol), 4-methoxybenzaldehyde (0.459 g, 3.37 
mmol), glacial acetic acid (0.0940 g, 1.57 mmol), piperidine (0.022 g, 0.253 mmol) and 
benzene (150 mL)  were mixed according to general procedure A to yield 5-44 as a light 
yellow solid (0.569 g, 40%) after 16 hours. Rf= 0.40 (40% EtOAc/Hex). [m.p. 147-149 ˚C]  
1H NMR (300 MHz, CDCl3) δ ppm 8.64 (d, J = 8.0 Hz, 1H), 7.92 (s, 1H), 7.78 – 7.72 (m, 
2H), 7.71 – 7.64 (m, 3H), 7.48 – 7.31 (m, 4H), 7.13 (s, 1H), 6.79 – 6.71 (m, 2H), 3.95 – 
3.88 (m, 2H), 3.77 (s, 3H), 3.74 (s, 3H), 3.05 – 2.96 (m, 2H). 13C NMR (75 MHz, CDCl3) 
δ ppm 168.1, 165.5, 164.9, 161.9, 143.3, 135.5, 133.9, 132.1, 131.9, 131.1, 125.6, 124.8, 
124.4, 123.2, 122.9, 119.7, 118.9, 117.0, 114.6, 55.3, 52.7, 37.1, 24.1. IR: 3120.0 (w), 
3060.2 (w), 2950.6 (w), 2844.3 (w), 1790.2 (s), 1691.8 (s), 1678.5 (s), 1652.9 (s), 1598.7 
(s), 1434.3 (m), 1390.0 (s), 1256.0 (s), 1203.9 (s), 1172.7 (s), 1121.3 (m), 1019.5 (m), 888.2 




46): Methyl 3-(3-(2-bromoethyl)-1H-indol-1-yl)-3-oxopropanoate (0.345 g, 1.06 mmol), 
4-methoxybenzaldehyde (0.244 g, 1.64 mmol), glacial acetic acid (0.0315 g, 0.524 mmol), 
piperidine (0.0172 g, 0.202 mmol) and benzene (30 mL)  were combined according to 
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general procedure A to afford 5-46 as a yellowish orange solid (0.384 g, 82%) after 14 
hours. Rf= 0.31 (20% EtOAc/Hex). [m.p. 90-92 ˚C]  
1H NMR (300 MHz, CDCl3) δ ppm 
8.67 (d, J = 8.0 Hz, 1H), 7.94 (s, 1H), 7.55 – 7.42 (m, 2H), 7.42 – 7.34 (m, 3H), 7.07 (s, 
1H), 6.79 – 6.73 (m, 2H), 3.80 (s, 3H), 3.75 (s, 3H), 3.66 (t, J = 7.2 Hz, 1H), 3.52 (t, J = 
7.3 Hz, 1H), 3.16 (t, J = 7.3 Hz, 1H), 3.06 (t, J = 7.1 Hz, 1H). 13C NMR (101 MHz, CDCl3) 
δ ppm 165.5, 165.0, 162.0, 143.6, 135.5, 132.1, 130.6, 125.7, 124.7, 124.3, 123.6, 123.4, 
123.2, 120.3, 118.5, 117.2, 114.7, 77.2 (Rotamers), 55.4, 52.8, 43.1 (Rotamers), 31.0, 28.7, 
28.5. IR: 3060.2 (w), 3007.0 (w), 2957.2 (w), 2834.3 (w), 1708.5 (m), 1691.0 (m), 1598.9 
(s), 1512.2 (m), 1450.9 (m), 1392.8 (m), 1256.3 (s), 1203.1 (s), 1172.6 (s), 1026.8 (m), 
878.2 (w), 830.6 (m), 730.4 (s), 700.6 (s), 539.5 (m) cm-1.  HRMS (ESI) M/Z+ Calc. 
441.0576, Obs. 441.0580. 
 
Methyl 2-(3-(2-methoxy-2-oxoethyl)-1H-indole-1-carbonyl)-3-(4-
methoxyphenyl)acrylate (5-48): Methyl 3-(3-(2-methoxy-2-oxoethyl)-1H-indol-1-yl)-3-
oxopropanoate (1.01 g, 3.50 mmol), 4-methoxybenzaldehyde (0.615 g, 4.52 mmol), glacial 
acetic acid (0.105 g, 1.75 mmol), piperidine (0.043 g, 0.506 mmol) and benzene (150 mL)  
were combined according to general procedure A to generate 5-48 as a light yellow solid 
(0.568 g, 40%) after 16 hours. Rf= 0.26 (40% EtOAc/Hex). [m.p. 147-149 ˚C] 
1H NMR 
(300 MHz, CDCl3) δ ppm 8.66 (d, J = 8.1 Hz, 1H), 7.93 (s, 1H), 7.57 – 7.42 (m, 3H), 7.42 
– 7.33 (m, 2H), 7.20 (s, 1H), 6.80 – 6.74 (m, 2H), 3.80 (s, 3H), 3.74 (s, 3H), 3.65 (s, 3H), 
3.63 (s, 2H). 13C NMR (75 MHz, CDCl3) δ ppm 170.8, 165.6, 164.9, 161.9, 143.5, 135.4, 
132.1, 130.8, 125.6, 124.7, 124.4, 124.2, 123.1, 119.0, 117.0, 115.8, 114.6, 55.3, 52.8, 52.1, 
30.7. IR: 3050.2 (w), 3003.7 (w), 2953.9 (w), 2841.0 (w), 1737.6 (m), 1722.3 (m), 1710.6 
(m), 1691.1 (m), 1598.9 (s), 1512.4 (m), 1450.7 (m), 1392.8 (m), 1256.2 (s), 1202.3 (m), 
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1172.0 (s), 1045.5 (m), 1026.7 (m), 888.2 (w), 730.4 (s), 700.4 (s) cm-1. HRMS (ESI) M/Z+ 
Calc. 407.1369, Obs. 407.1389. 
 
Methyl 2-(3-methyl-1H-indole-1-carbonyl)acrylate (5-56): Using conditions 
established by Yiotakis323, a round bottom flask was charged with acetic acid (12 mL), 
methyl 3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (0.602 g, 2.60 mmol), formaldehyde 
(0.0708 g, 2.359 mmol), and Cu(OAc)2 (0.0416 g, 0.229 mmol) and the mixture was heated 
at reflux for 3 hours. The solvent was removed in vacuo and diethyl ether was added. The 
mixture was filtered and the filtrate was washed successively with 1 M HCl, dilute 
NaHCO3, 1 M HCl, and brine. The organics were dried with Na2SO4 and concentrated 
under reduced pressure. The residue was purified using silica gel flash chromatography to 
yield 5-56 as a brown oil (0.470 g, 74%). Rf = 0.37 (20% EtOAc/Hex). 
1H NMR (300 MHz, 
CDCl3) δ ppm 8.44 (d, J = 7.3 Hz, 1H), 7.56 – 7.49 (m, 1H), 7.44 – 7.30 (m, 2H), 6.99 (s, 
1H), 6.79 (d, J = 0.4 Hz, 1H), 6.15 (s, 1H), 3.81 (d, J = 0.8 Hz, 3H), 2.27 – 2.25 (m, 3H).  
13C NMR (75 MHz, CDCl3) δ ppm 163.8, 163.6, 137.3, 135.7, 132.0, 131.7, 125.4, 124.1, 
122.7, 119.2, 119.0, 116.6, 52.8, 9.7. IR: 3119.9 (w), 3060.2 (w), 2960.5 (w), 2914.0 (w), 
1736.9 (s), 1728.1 (s), 1690.8 (s), 1678.3 (s), 1449.6 (s), 1387.6 (m), 1343.5 (m), 1235.7 
(m), 1170.7 (m), 1151.2 (m), 1061.6 (m), 931.4 (w), 881.6 (m), 735.1 (s), 701.4 (m) cm-1.  
HRMS (ESI) M/Z+ Calc. 243.0895, Obs. 243.0891. 
 
Methyl 2-(3-methyl-1H-indole-1-carbonyl)-5-phenylpenta-2,4-dienoate (5-58): 
Methyl 3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (0.201 g, 0.868 mmol), 
cinnamaldehyde (0.158 g, 1.19 mmol), glacial acetic acid (0.0525 g, 0.873 mmol), 
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piperidine (0.0259 g, 0.304 mmol) and benzene (15 mL)  were combined according to 
general method A to yield 5-58 as a red solid (0.280 g, 93%) after 12 hours. Rf = 0.40 (20% 
EtOAc/Hex). [m.p. 108-110 ˚C] 1H NMR (300 MHz, CDCl3) δ ppm 8.65 (s, 1H), 7.76 (d, 
J = 11.8 Hz, 1H), 7.58 – 7.52 (m, 1H), 7.49 – 7.27 (m, 7H), 7.12 (d, J = 15.3 Hz, 1H), 6.97 
(s, 1H), 6.89 – 6.76 (m, 1H), 3.79 (s, 3H), 2.25 (s, 3H). 13C NMR (75 MHz, CDCl3) 
(Isomers) δ ppm 164.6, 145.0, 144.2, 135.6, 135.1, 132.1, 130.0, 128.8, 127.8, 126.7, 
125.3, 124.1, 122.8, 122.2, 119.2, 119.0,116.8, 52.6, 34.5, 31.5, 25.1, 22.5, 14.1, 9.7. IR: 
3123.3 (w), 3036.9 (w), 2953.9 (w), 2841.0 (w), 1710.8 (s), 1720.8 (s), 1678.1 (s), 1611.5 
(s), 1589.9 (s), 1434.0 (s), 1392.4 (m), 1340.6 (m), 1236.3 (s), 1210.4 (s), 1154.0 (m), 
1080.2 (m), 1047.9 (m), 974.9 (w), 888.2 (w), 746.8 (s), 689.0 (s) cm-1. HRMS (ESI) M/Z+ 
Calc. 345.1365, Obs. 345.1367. 
 
Preparation of Methyl 3-(4-methoxyphenyl)-2-(1H-pyrrole-1-carbonyl)acrylate (5-
62): 
 
Methyl 3-oxo-3-(1H-pyrrol-1-yl)propanoate: Following a modification of Evans' 
reported procedure324: n-BuLi (10M in hexanes, 36 mmol) was added to a solution of 
diisopropylamine (3.13 mL, 22.16 mmol) in THF (40 mL) at -78 °C. After 30 minutes, 
methyl acetate (2.9 mL, 36.5 mmol) was added slowly and the mixture was stirred for 
another 30 minutes. A solution of di(1H-pyrrol-1-yl)methanone325 (3.55 g, 22.16 mmol) in 
THF (10 mL) was added to the reaction vessel. After 1 hour, the reaction was quenched 
with AcOH and washed with saturated NaHCO3. The organic layer was separated, and the 
aqueous layer was washed with Et2O. The combined organic layers were dried over 
Na2SO4, filtered, and concentrated. The crude product was dissolved in THF, and 1,8-
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diazabicyclo[5.4.0]undec-7-ene (500 µL, 3.34 mmol) was added. After 1 hour, ethyl 
acetate was added to the reaction flask. The mixture was washed with 0.5 M CuSO4, 
washed with brine, dried over Na2SO4, filtered, concentrated, and purified to afford the 
desired product as a brown oil (2.92g, 79%). Rf = 0.28 (20% EtOAc/Hex). 
1H NMR (300 
MHz, CDCl3) δ ppm 7.23 (s, 2H), 6.31 – 6.22 (m, 2H), 3.83 (s, 2H), 3.70 (s, 3H).  
13C 
NMR (75 MHz, CDCl3) δ ppm 166.2, 163.1, 119.1, 113.7, 52.6, 41.8. IR: 3143.2 (w), 
3000.4 (w), 2950.6 (w), 1742.1 (s), 1709.9 (s), 1469.4 (m), 1343.4 (s), 1249.2 (s), 1208.0 
(m), 1160.0 (m), 1115.1 (s), 1076.0 (m), 994.5 (m), 917.8 (s), 738.5 (s), 675.7 (m), 610.0 
(m), 597.7 (m), 519.6 (m) cm-1. HRMS (ESI) M/Z+ Calc. 167.0582, Obs. 167.0596. 
 
Methyl 3-(4-methoxyphenyl)-2-(1H-pyrrole-1-carbonyl)acrylate (5-62): 
Methyl 3-oxo-3-(1H-pyrrol-1-yl)propanoate (0.500 g, 2.99 mmol), 4-
methoxybenzaldehyde (0.560 g,  4.11 mmol), glacial acetic acid (0.105 g, 1.75 mmol), 
piperidine (0.0431 g, 0.506 mmol) and benzene (25 mL)  were combined according to 
general method A to afford 5-62 as a brown solid (0.780 g, 91%) after 12 hours. Rf = 0.25 
(20% EtOAc/Hex). [m.p. 79-81 ˚C]  1H NMR (300 MHz, CDCl3) δ ppm 7.91 (s, 1H), 7.37 
– 7.29 (m, 3H), 6.85 – 6.78 (m, 3H), 6.27 (s, 2H), 3.80 (s, 3H), 3.78 (s, 3H). 13C NMR (75 
MHz, CDCl3) δ ppm 165.2, 164.7, 162.0, 144.0, 132.0, 124.6, 122.3, 114.6, 114.1, 55.3, 
52.8. IR: 3143.2 (w), 3073.4 (w), 2960.5 (w), 2837.6 (w), 1709.6 (s), 1678.6 (s), 1598.3 
(s), 1512.6 (s), 1451.8 (m), 1288.9 (m), 1253.2 (m), 1202.3 (m), 1173.4 (s), 1126.4 (m), 
1069.3 (m), 1017.7 (m), 884.9 (m), 825.1 (m), 730.3 (s), 700.5 (s) cm-1. HRMS (ESI) M/Z+ 
Calc. 285.1001, Obs. 285.0997. 
5.7.3 In(III)-catalyzed Cyclizations 
5.7.3.1 General Procedure for Friedel-Crafts Cyclizations 
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 To a mixture of In(OTf)3 (0.10 equiv) in 1,2-dichloroethane or toluene heated to a 
reflux, dissolved acrylates 5-28 (1.0 equiv) were syringed into the reaction vessel. The 
reaction was monitored by TLC and quenched with water. The phases were separated, and 
the product was extracted from the aqueous phase with dichloromethane. The combined 
organic layers were washed with brine, dried over MgSO4, filtered, and concentrated for 
column chromatography using silica gel. 
5.7.3.2 Rationale for cis/trans assignment 
 The major diastereomer is trans in spatial orientation based on a correlation 
between the calculated dihedral angle between Ha and Hb for both the cis- and trans-
isomers and the expected Karplus326,327 coupling constant. This value was compared to the 
experimental value using 1H NMR (Table 5.6).  Diastereomeric ratios are reported where 
applicable, and the integral value for each signal is noted.    
 
 
Table 5.6 Cis/Trans Assessment for Spatial Orientation 




cis 8.5˚ ~7-8 9-10 
trans 125.8˚ ~5-6 5-6 
 
aDetermined from energy minimizations using Trident software from Schrodinger, Inc. 
bDetermined from Karplus coupling constant chart 





a]indole-2-carboxylate (5-47): Methyl 2-(3-(2-bromoethyl)-1H-indole-1-carbonyl)-3-(4-
methoxyphenyl)acrylate (0.061 g, 0.138 mmol), In(OTf)3 (0.0081 g, 0.014 mmol) and 1,2-
DCE (7 mL) were combined according to the general procedure to afford 5-47 as a brown 
oil (0.0418 g, 69%) after 12 hours. Rf= 0.24 (30% EtOAc/Hex). Diastereomeric ratio: 
(25:1). 1H NMR (300 MHz, CDCl3) δ ppm 8.20 – 8.14 (m, 0.17), 8.12 – 8.06 (m, 0.95), 
7.71 (s, 0.07), 7.52 – 7.44 (m, 1.30), 7.42 – 7.29 (m, 2.54), 7.21 – 7.14 (m, 2.08), 7.10 – 
7.14  (m, 0.31), 6.93 – 6.80 (m, 2.44), 5.06 (d, J = 4.9 Hz, 1.00), 4.52 – 4.45 (m, 0.04), 4.06 
– 4.01 (m, 0.98), 3.90 – 3.77 (m, 6.82), 3.56 – 3.21 (m, 3.42H), 3.12 – 2.64 (m, 3.54). 13C 
NMR (75 MHz, CDCl3) δ ppm 167.8, 164.7, 159.4, 141.1, 140.9, 135.2, 135.0, 131.5, 
131.1, 131.0, 130.2, 130.0, 128.3, 124.6, 124.3, 118.8, 114.7, 114.4, 114.2, 113.9, 112.2, 
111.3, 62.6, 55.3, 53.3, 43.2, 42.3, 31.1, 27.3, 27.2. IR: 3017.0 (w), 2953.9 (w), 2927.3 
(w), 2831.0 (w), 1737.2 (s), 1726.3 (s), 1712.0 (s), 1610.9 (m), 1452.8 (s), 1392.3 (m), 
1365.0 (m), 1317.0 (m), 1245.5 (s), 1173.6 (s), 1028.3 (m), 931.4 (w), 831.0 (m), 747.6 (s) 
cm-1. HRMS (ESI) M/Z+ Calc. 441.0576, Obs. 441.0575. 
 
Methyl 9-methyl-3-oxo-2,3-dihydro-1H-pyrrolo[1,2-a]indole-2-carboxylate(5-57): 
Methyl 2-(3-methyl-1H-indole-1-carbonyl)acrylate (0.100 g, 0.411 mmol), In(OTf)3 
(0.0355 g, 0.0632 mmol) and toluene (5 mL) were combined according to the general 
procedure to afford 5-57 as a pale yellow solid (0.0471 g, 47%)  after 1 hour. Rf= 0.34 
(20% EtOAc/Hex). [m.p. 95-97 ˚C] 1H NMR (300 MHz, CDCl3) δ ppm 8.04 – 7.97 (m, 
1H), 7.49 – 7.41 (m, 1H), 7.35 – 7.27 (m, 2H), 4.15 (dd, J = 9.3, 4.9 Hz, 1H), 3.84 (s, 3H), 
3.54 – 3.44 (m, 1H), 3.33 (ddd, J = 17.2, 9.3, 1.3 Hz, 1H), 2.20 (t, J = 1.3 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ 168.8, 165.5, 136.4, 136.3, 130.4, 124.3, 123.6, 118.7, 113.8, 
109.7, 53.2, 52.5, 23.0, 8.3. HRMS (ESI) M/Z+ Calc. 243.0895, Obs. 243.0897. 
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Methyl 1-(4-methoxyphenyl)-3-oxo-2,3-dihydro-1H-pyrrolizine-2-carboxylate (5-63): 
Methyl 3-(4-methoxyphenyl)-2-(1H-pyrrole-1-carbonyl)acrylate (0.152 g, 0.531 mmol), 
In(OTf)3 (0.0308 g, 0.055 mmol) and 1,2-DCE (13 mL) were combined according to the 
general procedure to afford 5-63 as a red oil (0.0817 g, 54%)  after 12 hours. Rf= 0.35 (20% 
EtOAc/Hex). Diastereomeric ratio: (13:1). 1H NMR (400 MHz, CDCl3) δ 7.20 – 7.06 (m, 
3.27), 6.91 – 6.78 (m, 2.20), 6.53 (t, J = 3.1 Hz, 0.10), 6.36 – 6.29 (m, 0.96), 6.02 – 6.00 
(m, 0.08), 5.99 – 5.94 (m, 0.95), 4.87 (d, J = 3.9 Hz, 1.01), 4.40 (d, J = 9.1 Hz, 0.07), 3.92 
(d, J = 5.1 Hz, 0.91), 3.85 (s, 2.96), 3.80 (s, 3.00), 3.79 (s, 0.67), 3.24 (s, 0.26). 13C NMR 
(75 MHz, CDCl3) δ 167.8, 165.5, 159.2, 140.5, 131.9, 128.4, 120.0, 114.4, 113.6, 111.7, 
106.2, 105.0, 62.5, 55.3, 53.2, 42.4. IR: 3143.2 (w), 3106.6 (w), 3000.4 (w), 2957.2 (w), 
2910.7 (w), 2837.6 (w), 1754.8 (s), 1737.3 (s), 1727.2 (s), 1608.9 (w), 1512.0 (m), 1401.6 
(m), 1291.3 (m), 1242.7 (m), 1161.7 (m), 1080.8 (m), 974.5 (w), 901.5 (w), 833.4 (w), 
719.4 (s) cm-1. HRMS (ESI) M/Z+ Calc. 285.1001, Obs. 285.1004. 
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CHAPTER 6  PYRROLO[3,2,1-IJ]QUINOLINE SYNTHESIS VIA 
IN(III)-CATALYZED FRIEDEL-CRAFTS CYCLIZATIONS 
  Along with the theme of heterocycle synthesis, another class of compounds, the 
pyrroloquinolines, was targeted. This class contains in its molecular skeleton the 
1,2,3,4-tetrahydroquinoline skeleton (THQ) (6-1). Prevalent in nature, the 1,2,3,4-
tetrahydroquinoline framework is one of the most valued nitrogen-containing 
architectures because it is used in medicinal, biological, and agrochemical research.328 
As a subgroup within the THQ class, pyrrolo[3,2,1-ij]quinolines (PQ, 2) and their 
reduced and oxidized derivatives have become of great interest in the area of drug 
discovery, agrochemistry, and materials science.329–338 For example, PHA-529311 (6-
3) demonstrates inhibitory activity against herpesvirus DNA polymerases,332,339 and  6-
4 strongly activates sirtuin 1 (SIRT1).340  KC 11404 (6-5), a promising molecule for 
asthma, has potent histamine and platelet activating factor (PAF) antagonism along 
with strong inhibition of 5-lipoxygenase activities.335  Pyrrolo[3,2,1-ij]quinoline 6-6 
was reported as a good agonist for the 5-hydroxytryptamine receptor (5-HT2c) with 
greater selectivity for the 5-HT2a isoform, becoming a possible therapeutic candidate 
for epilepsy and obesity.334  In several cases, PQ derivatives exhibited high diuretic,341 
melatoninergic,337 and anti-acetylcholinesterase activity.338  Moreover, PQs were 
reported as key intermediates towards the synthesis of other bioactive compounds and 
natural products.225,342,342,343 Lastly, the 1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-
ij]quinoline system comprises the central core of lilolidine (6-7) alkaloids,344 which 
have been explored as therapeutics, fungicides (i.e., lilolidone 6-8),345 and as red-light-








Figure 6.1: Molecules containing the pyrroloquinoline framework 
 
6.1 Syntheses of Pyrroloquinolines 
  Many methods have been reported for the synthesis of pyrrolo[3,2,1-ij]quinoline 
derivatives. Most methodologies involve the annellation of a six-membered construct 
onto an indolic-type structural analog or that of five-membered ring construction onto 
a quinoline molecule. Other transformations include free radical cyclizations, 185,346–351 
sigmatropic reactions,352–355 Wittig-type,356 Michael-type annulations,330,357 Fischer 
indolization,358 Friedel-Crafts reactions,359–361 multicomponent reactions,356 transition 
metal-catalyzed annulations,293,362–366 and C-H functionalization.364,366–368 In light of 
the numerous approaches, interesting, recent advances are discussed below.  
  In 2014, Xiao-Ming et al. published a cyclodehydration of α-amino carbonyl 
molecules 6-10 to form pyrrolo[3,2,1-ij]quinolines 6-11.369 The authors implemented 
the Bischler370,371 reaction as their guide to design a green synthesis for quinolines and 
indoles. To become more eco-friendly, the group used inorganic salts—not corrosive 
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acids or heavy metals. Settling on NH4PF6 in 1,1,1,3,3,3-hexafluoropropan-2-ol (HFIP) 
at 110 ˚C, they obtained pyrrolo[3,2,1-ij]quinolines 6-11 in 61-92% yield. The 
ammonium group was hypothesized to activate the carbonyl for a nucleophilic ring 
attack followed by dehydration to afford the desired products. Alkyls, methy esters, and 
aryl containing methoxy, chloro, bromo, and trifluormethyl moieties were compatabile, 
and the reactions proceeded smoothly (Figure 6.2). 
 
Figure 6.2: Xiao-Ming's cyclodehydration for pyrroloquinolines 
 
 Within the same year as Xiao-Ming’s protocol, Mphahlele and Oyeyiola disclosed 
a method for the synthesis of 2‑substituted 4‑aryl-8-bromo-4H-pyrrolo[3,2,1-ij]quinolin-
6-ones 6-13 from 2‑aryl-6,8-dibromoquinolin-4(1H)-ones 6-12 via a site-selective 
Sonogashira372 cross-coupling with Pd/C-PPh3, copper(I) iodide, and potassium carbonate 
in DMF:H2O at 110 ˚C.
365 Using a bromine at the C6 position for the Sonogashira coupling 
with phenylacetylene, the Pd/C-PPh3-CuI pre-catalyst mixture performed the oxidative 
addition to install an alkyne. Deprotonation of the nitrogen caused a base-promoted 
cyclization to afford compounds 6-13 in 62-68% yield (Figure 6.3). Four substrates were 
shown to display reactivity. Final Suzuki-Miyaura373 cross coupling with 4-
flurophenylboronic acid afforded derivatives of compounds 6-13. 
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Figure 6.3: Mphahlele's one-pot site-selective Sonogashira cross-coupling           
         heteroannulation 
 
 Recently, transition metal-catalyzed protocols to form pyrroloquinolines were 
reported by Wang, Manoharan, and Yang in 2015 (Figure 6.4). Wang et. al. divulged a 
Rh(III)-catalyzed redox-neutral C-H functionalization of indolines 6-14 with alkynes.374 
Noticing that indoles can be functionalized at the C2-H and C3-H, they designed a method 
such that C-H functionalization would provide access to the pyrrolo[3,2,1-ij]quinolin-4-
one framework. Using electron-releasing and electron-accepting indolines, [RhCl2(Cp*)]2, 
sodium acetate (NaOAc), and methanol heated to 80 ˚C for 24 hours, they generated 
1,2,5,6-tetrahydropyrrolo[3,2,1-ij]-quinoline-4-ones 6-16 in 40-55% yield. The conditions 
were compatible with methoxy groups, esters, and halogens, but propargyl acetates and 
propargyl alcohols did not form any of the desired products, and the reaction was not 
affected by substitution on the indoline. For the mechanism, the group suggested a 
rhodium(III) reversible C-H cleavage at C7 to form a six-membered rhodacycle after 
proton removal. Alkyne insertion formed an expanded rhodacycle (8-membered). 
















 Yang et al. developed a Rh(III)-catalyzed approach to the indoline skeleton for a 
C-H functionalization/annulation sequence to assemble pyrroloquinolinone derivatives 6-
19 in 2015 as well (Figure 6.4).364 As a part of the strategy, the group incorporated a 
morpholine moiety to act as a directing group such that the C-H and C-N bond cleavages 
would occur. [RhCl2(Cp*)]2, AgSbF6, alkynes, and Zn(OTf)2 in 1,2-dichloroethane at 100-
120 ̊ C gave pyrroloquinolines 6-19 in moderate to good yields (50-76%) after 18-24 hours. 
Similar to the previous protocol mentioned above, halogens, aryls, and alkyl groups were 
tolerated. Accordingly, if the electronics were tuned appropriately such that the directing 
ability and carbamoyl moiety were balanced, the annulation reactions worked well. 
Furthermore, since the redox was neutral, the asymmetric alkynes afforded good 
regioselectivity. 
  Manoharan and Jeganmohan reported another route to pyrroloquinolinones 
using 6-20, alkynes, {RuCl2(p-cymene)}2, AgSbF6, and Ad-1-COOH in tert-amyl 
alcohol at 130 ˚C for 24 hours (Figure 6.4).366 Aryl, alky, and ether-based alkynes were 
reported to form pyrroloquinolinones 6-22 in 47-79% yield. Mechanistically, they 
hypothesized that the products would form along a similar pathway as the route outlined 
by Wang except that a ligand exchange would occur between the catalyst and AgSbF6. 
Chelation and deprotonation at C7-H formed a six-membered ruthenacycle. Insertion 
of the alkyne into the Ru-C connectivity was postulated to occur. Then, protonation and 
elimination of dimethyl amine furnished the desired pyrroloquinolines. The method was 
regioselective and tolerable of various functional groups.   
  Despite the broad applicability and rising interest among synthetic chemists, 
reported methods for the preparation of pyrrolo[3,2,1-ij]quinolines exhibit major 
drawbacks.  Harsh reaction conditions, high catalyst loadings, lengthy synthetic 
protocols, poor atom economy, and/or functional group intolerance were complications 
for previous approaches. For example, methods that involved the formation of the PQ 
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framework via Fischer indolization were limited by the preparation of the 1-amino-
THQs.334,335,337  Likewise, transition metal-catalyzed annulations that were used to form 
PQs tended to use high catalyst loadings with expensive catalysts.293,362,363  In one 
report, 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-1-ones were obtained by appending a 
pyrrole ring onto 2,3-dihydroquinolin-4(1H)-ones by using a Sonogashira coupling 
with 10% Pd/C followed by  an intramolecular C-N bond formation reaction using 5 
mol% PdCl2.
340 Another representative example involved Friedel-Crafts annulations on 
indoles to form a PQ tricycle,359–361,375 but unfortunately,  stoichiometric amounts of 
protic or Lewis acids were required for cyclization.  Finally, other examples involving 
either multicomponent reactions,356 free radical cyclizations,346,347 sigmatropic 
rearrangements352,353 and Michael-type annulations357 had a narrow substrate scope.  In 
general, efficient syntheses for the assembly of functionalized pyrrolo[3,2,1-
ij]quinolines for greater selectivity, economic viability, and operational simplicity are 
needed. 
6.2 Hypothesis and Synthetic Rationale for the Synthesis of                  
Pyrrolo[3,2,1-ij]quinolin-4-ones 
  In conjuction with our previous efforts to develop routes that readily tap into 
broad skeletal diversity for N-annelated polycycles,254,255 we sought to prepare 
pyrrolo[3,2,1-ij]quinolines.  We devised an In(OTf)3-catalyzed intramolecular Friedel-
Crafts alkylation of methyl 2-(1H-indole-1-carbonyl)acrylates 6-23 (Figure 6.5, scheme 
1) as a highly efficient and diastereoselective approach to functionalized 1H-
pyrrolo[1,2-a]-indole-3(2H)-ones 6-24 under mild conditions.255 Using similar 
chemistry, we predicted that Freidel-Crafts alkylation chemistry would afford 
pyrrolo[3,2,1-ij]quinolines by employing a substrate with the indole 2-position 
blocked, as in the methyl 2-(2-methyl-1H-indole-carbonyl)acrylate 6-25 (Figure 6.5, 
scheme 2). With the 2-position unavailable, electrophilic attack would be feasible at 
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the indole 7-position, yielding pyrrolo[3,2,1-ij] quinolin-4-ones 6-26.  
 
Figure 6.5: Rationale for pyrroloquinoline formation 
 
6.3 Precursor Assembly for Pyrroloquinoline Synthesis 
  Testing this rationale required synthesizing the desired alkylidene malonate 
monoamides as previously reported in the literature.255 Treatment of an indole with 
methyl malonyl chloride afforded β-amide esters 6-28. Knoevenagel condensation376 
with the appropriate aldehydes formed the appropriate alkylidene malonate 
monoamides 6-29.  
 
Figure 6.6: Alkylidene malonate monoamide synthesis for pyrroloquinoline       
         assembly 
 
6.4 Results and Discussion 
  For our first trial run, 6-30 (derived from 2-methyl indole and p-anisaldehyde) 
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was subjected to 15 mol% In(OTf)3 in refluxing 1,2-dichloroethane.  As anticipated, 6-
30 cyclized to form the desired pyrrolo[3,2,1-ij]quinolin-4-one product 6-31 in 63% 
yield with 50:1 trans:cis dr (Table 6.1, entry 1). With the same donating group as 6-30, 
2-methoxyphenyl derivative 6-32 generated its PQ product 6-33 in 87% yield with a 
3.7:1 dr (Table 6.1, entry 2).   
  We then sought to probe the electronic effects of the transformation and 
discovered a strong electronic influence on the reaction when the aryl substituent was 
changed to a strong electron-withdrawing group (Table 6.1, entries 3-5). Although the 
4-nitro-, 3-nitro-, and 4-cyano-aryl substituted alkylidene malonate monoamides 
formed products 6-35, 6-37, and 6-39 in good yields (78%, 86%, and 78%, 
respectively), low diastereoselectivities were observed (~2:1 dr).  When halogens were 
used (F or Br, Table 6.2, entries 1 and 2), both produced their respective products 6-41 
and 6-43 in 94% and 61% yield.  Although m-bromo gave an 8.3:1 dr, the p-fluoro gave 
a 2.6:1 dr.  Given fluorine’s high electronegativity, an akin electronic effect may have 
influences like those in the nitro and cyano groups. We then substituted a 
heteroaromatic group on the alkylidiene malonate monoamide. 2-Thienyl derivative 6-
44 cyclized to afford 6-45 as a single observable diastereomer in 51% yield with dr 
>99:1 (Table 6.2, entry 3). 
 154 
Table 6.1: Alkene Substituent Effect on Reactivity 
 
  As a result of the data obtained from aromatic substituents, the precursor scope 
was expanded to include nonaromatic substrates.  In particular, alkylidiene malonate 
monoamides derived from alkyl aldehydes and cinnamaldehyde were investigated.  
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When the ethyl-substituted alkylidiene malonate monoamide 6-46 was subjected to the 
reaction conditions, no conversion was observed after 24 hours.  Further optimization 
with a higher catalyst loading (30 mol%) in toluene at reflux gave pyrroloquinoline 6-
47 in 84% yield with 25:1 dr (Table 6.2, entry 4). After treatment of cinnamaldehyde-
derived alkylidiene malonate monoamide 6-48 under the same conditions, 6-49 was 
formed in 65% yield with 20:1 dr (Table 6.2, entry 5). 
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Table 6.2: Alkene Substituent Effect on Reactivity 
 
  Next, differing substitutions were made around the indole ring (Table 6.3).  
When 2-phenyl indolyl alkylidiene malonate monoamide 6-50 was subjected to the 
reaction conditions, pyrrolo[3,2,1-ij]quinolin-4-one 6-51 was obtained in 97% yield 
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with 17:1 dr (Table 6.3, entry 1).  2,3-Disubstituted indoles also  cyclized.  2,3-
Dimethyl indolyl alkylidiene malonate monoamide 6-52 formed 6-53 in 86% yield with 
>99:1 dr (Table 6.3, entry 2).  Similarly, the tetrahydrocyclopenta[b]indole based 
alkylidiene malonate monoamide 6-54 furnished tetracyclic product 6-55 in 82% yield 
as a single observable diastereomer (Table 6.3, entry 3). 
  Installing substituents on the benzenoid portion of indole was tolerated and did 
not inhibit the transformation from ocurring (Table 6.3, entries 4 and 5). Specifically, 
the 5-fluoro- and 5-chloro-2-methyl indole derivatives 6-56 and 6-58 produced 
pyrrolo[3,2,1-ij]-quinolin-4-ones 6-57 and 6-59 in high yields (88% and 90%), 
respectively, with high diastereoselectivities (>99:1 dr).  
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Table 6.3: Indole Substituent Effect on Reactivity 
 
  As previously mentioned, the tricyclic skeletons of the 1,2,5,6-tetrahydro-4H-
pyrrolo[3,2,1-ij]quinolines (lilolidines, 6-7 and 6-8) have been shown to have various 
applications.333,344,345 We investigated the reactivity of the indoline-derived substrate 6-
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60 to ascertain its compatibility in the intramolecular Friedel-Crafts annulation (Figure 
6.7).  Subjecting 6-60 to the reaction conditions provided the lilolidine derivative 6-62 
in 81% yield as one observable diastereomer in a mixture with its decarboxylated 
product.  
 
Figure 6.7: Lilolidine and julolidine alkaloid skeleton synthesis 
 
  Because of the success of indoline, we also employed the substrate 6-61 (derived 
from tetrahydroquinoline) in the cyclization (Figure 6.7).  The resulting product 
encompassed the 1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline core, which is central 
in the julolidine class of alkaloids. Julolidine derivatives have attracted considerable 
attention due to their wide-ranging biological activities, including their role as 
bifunctional intercalators for DNA.377 As expected, 6-61 readily cyclized, and it formed 
the expected tricyclic product 6-63 in 83% yield as the trans-diastereomer. 
6.5 Conclusion 
  In conclusion, we have devised a general route for the efficient construction of 
a variety of 5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-ones.  This transformation 
involves an In(OTf)3-catalyzed diastereoselective Friedel-Crafts alkylation of methyl 
2-(2-methyl-1H-indole-carbonyl)acrylates.  One simple hydrogen replacement with a 
poor leaving group at the 2-position of the indole resulted in pyrroloquinolines. The 
products were formed in good to high yields with diastereoselectivities up to >99:1 dr.  
This protocol also provided a convenient route to the lilolidine and julolidine family of 
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alkaloids.   
6.6 Research Participants 
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made the precursors and the final products. 
This work was published in Chemical Communications: Patil, D. V.; Cavitt, M. A.; 
Grzybowski, P.; France, S. A General Intramolecular Friedel-Crafts Approach to 




6.7 Experimental Information 
6.7.1 Synthetic Methods for Pyrrolo[3,2,1-ij]quinolines Preparation 
 All reactions were carried out in pre-dried glassware from the oven and any 
additional moisture was removed by flame-drying the reaction vessel.  Each reaction 
proceeded under a nitrogen atmosphere with anhydrous solvents, unless stated otherwise. 
Tetrahydrofuran and diethyl ether were distilled from a sodium/benzophenone ketyl under 
nitrogen and stored in a Schlenk flask. Benzene, toluene, 1,2-dichloroethane and 
dichloromethane were purified by distillation from calcium hydride. All other reagents 
were purchased from Acros, Sigma-Aldrich, Fluka, VWR, Merck, Alfa Aesar, TCI and 
Strem (for metal catalysts) and used without further purification.  Compounds 6-28 and 6-
29 were synthesized according to our reported protocol.302   
 Chromatographic purification was performed as flash chromatography with 
Silicycle silica gel (40-65µm). For quantitative flash chromatography, technical grades 
solvents were utilized. Analytical thin-layer chromatography (TLC) was performed on 
Dynamic Absorbents, Inc. silica gel F254 TLC glass plates. Visualization was 
accomplished with UV light, aqueous basic potassium permanganate (KMnO4) solution, 
iodine, aqueous acidic dinitrophenylhydrazine (DNP) solution, aqueous acidic p-
anisaldehyde (PAA) solution, and an ethanol solution of phosphomolybdic acid (PMA) 
followed by heating.  Each yield refers to an isolated, analytically-pure material.  
 Infrared (IR) spectra were obtained using a Nicolet 4700 FTIR with an ATR 
attachment from SmartOrbit Thermoelectronic Corp. The IR bands are characterized as 
weak (w), medium (m), and strong (s). Proton and carbon nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) were recorded on a Varian Mercury Vx 300 MHz 
spectrometer, Varian Mercury Vx 400 MHz spectrometer or Bruker 400 MHz spectrometer 
with solvent resonances as the internal standard (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: 
CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift (ppm), 
 162 
multiplicity (s = singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, ddd 
= doublet of doublet of doublets, t = triplet, m = multiplet, br = broad), coupling constants 
(Hz), and integration. Diastereomeric ratios for the cyclized products were determined by 
1H NMR based on a comparison of the signal ratios of the benzylic protons (~4.0-5.0 ppm) 
for the two diastereomeric protons or other signals displaying clear separation. These 
assignments are based on the coupling constants.  A single observable diastereomer 
corresponds to >99:1 dr. Mass spectra were obtained using a MicroMass Autospec M.  The 
accurate mass analyses were run in EI mode at a mass resolution of 10,000 using PFK 
(perfluorokerosene) as an internal calibrant. Compounds synthesized and not reported in 
the literature until our publication are listed below. Dr. Dadasaheb V. Patil and Paul 
Grzybowski synthesized the precursors and the final products as well. 
6.7.2 Synthesis of β-Amide Esters 6-27 for Pyrrolo[3,2,1-ij]quinoline Assembly 
 Sodium hydride (1.2 equiv.) was suspended in tetrahydrofuran and cooled to 0 °C. 
In a separate flask, the desired N-heterocycle (1.0 equiv.) was dissolved in tetrahydrofuran 
and syringed into the reaction vessel. After 30 minutes, methyl-3-chloro-3-oxopropanoate 
(1.25 equiv.) was added quickly. The reaction was stirred for 14 hours at room temperature. 
The reaction mixture was quenched with water. The organic layer was separated, and the 
aqueous layer was extracted three times with ethyl acetate. The combined organic layers 
were washed with brine, dried with anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by silica gel flash chromatography for product 
isolation. 
 
Methyl 3-(2-methyl-1H-indol-1-yl)-3-oxopropanoate (6-28a): The general procedure 
was followed using sodium hydride (0.636 g, 26.5 mmol), 2-methyl-1H-indole (3.00 g, 
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22.9 mmol), methyl-3-chloro-3-oxopropanoate (3.0 mL, 28.0 mmol), and THF (120 mL). 
After 5 hours, the reaction was quenched, and column chromatography formed 6-28a as a 
red solid (1.80 g, 34%). (Rf = 0.40, 30% EtOAc/Hex) [m.p. 74-76°C]  
1H NMR (400 MHz, 
CDCl3) ppm 7.87 - 7.92 (m, 1H), 7.43 - 7.48 (m, 1H), 7.21 - 7.28 (m, 2H), 6.39 (s, 1H), 
4.07 (s, 2H), 3.81 (s, 3H), 2.61 (d, J = 1.12 Hz, 3H). 13C NMR (101 MHz, CDCl3) ppm 
166.9, 165.9, 137.0, 136.3, 129.8, 123.9, 123.6, 120.0, 114.9, 110.6, 52.7, 45.6, 17.3. IR: 
3022.4 (w), 2953.1 (w), 1733.8 (s), 1700.1 (s), 1684.4 (s), 1606.3 (m), 1588.1 (m), 1526.9 
(m), 1450.5 (m), 1374.4 (m), 1300.3 (m), 1235.7 (s), 1162.5 (m), 1085.2 (w), 758.3 (s), 
668.5 (w), 649.4 (w) cm-1. HRMS (ESI) M/Z+ Calc. 231.0895, Obs. 231.0894. 
 
Methyl 3-oxo-3-(2-phenyl-1H-indol-1-yl)propanoate (6-28b): The general procedure 
was followed using sodium hydride (0.414 g, 17.3 mmol), 2-phenyl-1H-indole (3.00 g, 
15.5 mmol), methyl-3-chloro-3-oxopropanoate (2.0 mL, 18.7 mmol), and THF (140 mL). 
After 5 hours, the reaction was quenched, and column chromatography afforded 6-28b as 
a orange oil (1.28 g, 28%). (Rf = 0.48, 30% EtOAc/Hex) 
1H NMR (400 MHz, CDCl3) 
ppm 8.40 (qd, J = 0.84, 8.28 Hz, 1H), 7.55 - 7.59 (m, 1H), 7.44 - 7.49 (m, 5H), 7.36 - 
7.41 (m, 1H), 7.29 - 7.34 (m, 1H), 6.64 (d, J = 0.69 Hz, 1H), 3.63 (s, 3H), 3.39 (s, 2H). 13C 
NMR (101 MHz, CDCl3)ppm 166.8, 166.7, 139.0, 137.9, 133.3, 129.1, 129.0, 129.0, 
125.5, 124.2, 120.5, 120.4, 116.3, 112.5, 52.4, 45.9. IR: 3029.5 (w), 2958.2 (s), 2925.4 (s), 
2852.3 (s), 1745.4 (s), 1715.4 (s), 1604.8 (w), 1470.7 (m), 1451.8 (w), 1406.9 (m), 1359.4 
(m), 1341.8 (w), 1301.7 (m), 1253.6 (w), 1205.1 (m), 1155.5 (m), 1117.3 (w), 1076.5 (m), 
1056.7 (w), 1020.7 (w), 970.1 (m), 919.4 (w), 821.1 (w), 747.8 (m), 700.7 (w) cm-1. HRMS 
(ESI) M/Z+ Calc. 293.1052, Obs. 293.1053. 
 164 
 
Methyl 3-(2,3-dimethyl-1H-indol-1-yl)-3-oxopropanoate (6-28c): The general 
procedure was followed using sodium hydride (2.41 g, 18.1 mmol), 2,3-dimethyl-1H-
indole (2.02 g, 13.9 mmol), methyl-3-chloro-3-oxopropanoate (1.94 mL, 18.1 mmol), and 
THF (15 mL). After 14 hours, the reaction was quenched, and column chromatography 
afforded 6-28c as a pale yellow solid (1.55 g, 56%). (Rf = 0.26, 20% EtOAc/Hex) [m.p. 75-
77°C] 1H NMR (300 MHz, CDCl3)  ppm 7.77-7.84 (m, 1H), 7.26-7.32 (m, 1H), 7.17 (m, 
2H), 3.88 (s, 2H), 3.72 (s, 3H), 2.34 (s, 3H), 2.03 (s, 3H). 13C NMR (75 MHz, CDCl3)  
ppm 8.2, 13.5, 45.2, 52.1, 114.5, 115.8, 117.7, 122.9, 123.6, 130.8, 131.6, 135.0, 165.3, 
166.7. IR: 2989.2 (w), 2959.3 (w), 2925.6 (w), 1741.6 (s), 1681.3 (s), 1615.5 (w), 1449.6 
(m), 1433.5 (m), 1361.6 (s), 1329.6 (m), 1259.5 (s), 1229.0 (w), 1162.2 (s), 1127.1 (m), 
1100.2 (w), 1069.9 (w), 1019.5 (s), 928.9 (m), 833.2 (w), 759.5 (s), 691.3 (m), 613.1 (m) 
cm-1. HRMS (ESI) M/Z+ Calc. 245.1052, Obs. 245.1053. 
 
Methyl 3-(5-fluoro-2-methyl-1H-indol-1-yl)-3-oxopropanoate (6-28d): The general 
procedure was followed using potassium hydride (0.711 g, 17.7 mmol), 5-fluoro-2-methyl-
1H-indole (2.03 g, 13.6 mmol), methyl-3-chloro-3-oxopropanoate (1.9 mL, 17.7 mmol), 
and THF (18 mL). After 14 hours, the reaction was quenched, and column chromatography 
afforded 6-28d as a red solid (0.805 g, 24%). (Rf = 0.20, 20% EtOAc/Hex)  [m.p. 80-82°C] 
1H NMR (300 MHz, CDCl3) ppm 7.96 (dd, J = 4.45, 9.11 Hz, 1H), 7.08 (dd, J = 2.60, 
8.54 Hz, 1H), 6.95 (dt, J = 2.64, 9.09 Hz, 1H), 6.35 (s, 1H), 4.03 (s, 2H), 3.80 (s, 3H), 2.59 
(s, 3H). 13C NMR (75 MHz, CDCl3) ppm 166.8, 165.6, 161.2, 158.0, 138.1, 133.0, 130.9, 
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130.8, 116.5 and 116.4 (doublet), 111.6, 111.3, 110.6 and 110.5 (doublet), 105.8, 105.4, 
52.8, 45.4, 17.3. IR: 3013.0 (w), 2956.9 (w), 1752.2 (s), 1682.4 (s), 1603.6 (m), 1476.2 
(m), 1438.8 (m), 1376.3 (m), 1301.9 (w), 1259.5 (w), 1187.8 (m), 1157.8 (s), 1129.8 (m), 
1000.5 (m), 958.5 (m), 870.7 (m), 797.1 (m), 780.4 (m), 668.4 (m) cm-1. HRMS (ESI) 
M/Z+ Calc. 249.0801, Obs. 249.0809. 
6.7.3  Preparation of Alkylidene Malonate Monoamides for Pyrrolo[3,2,1-
ij]quinolone Formation  
6.7.3.1 General Method A321  
 The β-amide ester (1.0 equiv.), aldehyde (1.3 equiv.), glacial acetic acid (0.5 
equiv.), and piperidine (0.1 equiv.) were heated to a reflux in benzene with the use of a 
Dean-Stark trap for 14 hours. After the reaction mixture was cooled to room temperature, 
water was added to the reaction vessel, and the organic layer was collected. Subsequently, 
the aqueous phase was extracted with ethyl acetate three times. The combined organic 
layers were washed with 1M HCl and saturated sodium bicarbonate. The combined organic 
layers were dried with Na2SO4, filtered, concentrated, and purified by silica gel column 
chromatography (gradient EtOAc/Hex).  
 
Methyl 3-(4-methoxyphenyl)-2-(2-methyl-1H-indole-1-carbonyl)acrylate (6-30): 
Methyl 3-(2-methyl-1H-indol-1-yl)-3-oxopropanoate (1.80 g, 7.78 mmol), 4-
methoxybenzaldehyde (1.2 mL, 10.1 mmol), glacial acetic acid (0.262 g, 4.37 mmol), 
piperidine (80 µL , 0.810 mmol) and benzene (120 mL) were mixed according to general 
method A to afford 6-30 as an orange oil (2.50 g, 92%) after 18 hours. (Rf = 0.24, 20% 
EtOAc/Hex) (Diastereomer) 1H NMR (300 MHz, CDCl3) ppm 8.43 (br. s., 0.81), 7.87 
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(s, 1.13), 7.72 (s, 0.15), 7.33 - 7.47 (m, 3.50), 7.21 - 7.30 (m, 2.08), 6.89 (d, J = 8.79 Hz, 
0.27), 6.75 (d, J = 8.76 Hz, 2.10), 6.35 (s, 1.00), 3.87 (d, J = 0.70 Hz, 0.25), 3.83 (s, 0.26), 
3.81 (s, 0.31), 3.77 (s, 2.63), 3.72 (s, 2.94), 2.48 (br. s., 2.87).  13C NMR (75 MHz, CDCl3) 
ppm 166.3, 165.1, 161.8, 142.9, 142.5, 131.9, 131.4, 129.8, 125.6, 124.7, 119.6, 114.5, 
114.3, 55.2, 52.7, 16.7. IR: 3065.3 (w), 2951.7 (w), 2939.1 (w), 1720.6 (s), 1682.4 (s), 
1600.9 (s), 1511.8 (s), 1452.5 (s), 1385.8 (m), 1321.3 (m), 1290.4 (m), 1258.9 (s), 1203.7 
(m), 1172.3 (s), 1123.0 (m), 1056.1 (w), 1027.6 (m), 917.2 (w), 831.4 (m), 763.9 (s), 751.0 
(s), 700.6 (m) cm-1.  HRMS (ESI) M/Z+ Calc. 349.1314, Obs. 349.1319. 
 
Methyl 3-(4-methoxyphenyl)-2-(2-phenyl-1H-indole-1-carbonyl)acrylate (6-50): 
Methyl 3-oxo-3-(2-phenyl-1H-indol-1-yl)propanoate (1.28 g, 4.36 mmol), 4-
methoxybenzaldehyde (0.70 mL, 5.75 mmol), glacial acetic acid (0.131 g, 2.18 mmol), 
piperidine (50 µL , 0.506 mmol) and benzene (120 mL) were mixed according to general 
method A to afford 6-50 as a dark brown solid (0.457 g, 25%) after 18 hours. (Rf = 0.37, 
20% EtOAc/Hex) [m.p. 105-107 °C] 1H NMR (300 MHz, CDCl3) ppm 8.63 (d, J = 8.17 
Hz, 1H), 7.40 - 7.51 (m, 2H), 7.29 - 7.38 (m, 2H), 7.19 - 7.27 (m, 2H), 7.16 (s, 1H), 7.00 - 
7.13 (m, 4H), 6.54 - 6.61 (m, 2H), 6.34 (s, 1H), 3.73 (s, 3H), 3.71 (s, 3H). 13C NMR (75 
MHz, CDCl3) ppm 166.8, 164.4, 161.5, 143.1, 139.8, 138.2, 133.4, 131.6, 129.6, 128.6, 
127.8, 125.4, 125.2, 125.0, 124.3, 120.2, 116.6, 114.0, 111.9, 55.3, 52.3. IR: 3065.3 (w), 
2951.7 (w), 2939.1 (w), 1720.6 (s), 1682.4 (s), 1600.9 (s), 1511.8 (s), 1452.5 (s), 1385.8 
(m), 1321.3 (m), 1290.4 (m), 1258.9 (s), 1203.7 (m), 1172.3 (s), 1123.0 (m), 1056.1 (w), 
1027.6 (m), 917.2 (w), 831.4 (m), 763.9 (s), 751.0 (s), 700.6 (m) cm-1. HRMS (ESI) M/Z+ 
Calc. 411.1471, Obs. 411.1480. 
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Methyl 2-(2,3-dimethyl-1H-indole-1-carbonyl)-3-(4-methoxyphenyl)acrylate (6-52): 
Methyl 3-(2,3-dimethyl-1H-indol-1-yl)-3-oxopropanoate (0.501 g, 2.04 mmol), 4-
methoxybenzaldehyde (0.300 mL, 2.47 mmol), glacial acetic acid (0.094 g, 1.57 mmol), 
piperidine (0.043 g, 0.506 mmol) and benzene (30 mL) were mixed according to general 
method A to form 6-52 as a yellow solid (0.661 g, 89%) after 18 hours. (Rf = 0.25, 20% 
EtOAc/Hex) [m.p. 94-96°C] 1H NMR (300 MHz, CDCl3) ppm8.63 (br. s, 1H), 7.87 (br. 
s., 1H), 7.33 - 7.48 (m, 3H), 7.28 (br. s., 2H), 6.73 (d, J = 8.50 Hz, 2H), 3.77 (s, 3H), 3.67 
(d, J = 1.21 Hz, 3H), 2.25 - 2.53 (s, 3H), 2.15 (s, 3H). 13C NMR (75 MHz, CDCl3) ppm 
165.9, 165.2, 161.9, 142.5, 136.1, 131.8, 131.5, 126.6, 125.3, 124.3, 123.6, 117.9, 116.5, 
114.6, 55.2, 52.4, 13.4, 8.6. IR: 3008.4 (w), 2933.3 (w), 2839.7 (w), 1721.5 (s), 1675.4 (s), 
1601.6 (s), 1513.5 (s), 1458.5 (s), 1396.3 (m), 1306.8 (s), 1258.4 (s), 1203.4 (m), 1174.8 
(s), 1133.5 (w), 1028.0 (w), 907.9 (w), 832.0 (w), 750.0 (s) cm-1. HRMS (ESI) M/Z+ Calc. 
363.1471, Obs. 363.1470. 
 
Methyl 2-(5-fluoro-2-methyl-1H-indole-1-carbonyl)-3-(4-methoxyphenyl)acrylate (6-
56): Methyl 3-(5-fluoro-2-methyl-1H-indol-1-yl)-3-oxopropanoate (0.301 g, 1.21 mmol), 
4-methoxybenzaldehyde (0.180 mL, 1.48 mmol), glacial acetic acid (0.0520 g, 0.873 
mmol), piperidine (25 µL , 0.253 mmol) and benzene (30 mL) were mixed according to 
general method A to afford 6-56 as a red solid (0.382 g, 86%) after 18 hours. (Rf = 0.43, 
30% EtOAc/Hex) [m.p. 95-97 °C] (Temperature for the 1H NMR and 13C NMR = 60 °C)  
1H NMR (300 MHz, CDCl3) ppm 8.25 (br s, 1H), 7.85 (s, 1H), 7.28 - 7.39 (m, 2H), 7.05 
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(dd, J = 2.57, 8.61 Hz, 1H), 6.95 (dt, J = 2.58, 9.12 Hz, 1H), 6.70 - 6.79 (m, 2H), 6.27 (s, 
1H), 3.78 (s, 3H), 3.71 (s, 3H), 2.46 (s, 3H). 13C NMR (75 MHz, CDCl3) ppm 166.0, 
165.0, 162.1, 161.5, 158.3, 143.0, 133.3, 131.8, 131.1 and 131.0 (doublet), 125.8, 124.9, 
116.9, 114.6, 111.5, 111.2, 110.3, 105.5, 105.2, 55.2, 52.5, 16.5. IR: 2948.8 (w), 2903.6 
(w), 1720.7 (m), 1685.4 (m), 1602.5 (s), 1513.7 (s), 1472.7 (m), 1448.5 (m), 1389.2 (m), 
1301.5 (m), 1274.6 (s), 1260.5 (s), 1176.5 (s), 995.0 (w), 957.3 (w), 832.8 (w), 764.3 (s), 
750.0 (s) cm-1. HRMS (ESI) M/Z+ Calc. 367.1220, Obs. 367.1226. 
6.7.3.2  General Method B322  
 A round bottom flask was charged with the β-amide ester (1.0 equiv.) and THF (25 
mL). After the solution was cooled to 0 °C, titanium(IV) chloride tetrahydrofuran complex 
(2.0 equiv.) and CCl4 (2.0 equiv.) were added to the reaction vessel. After 1 hour at 0 °C, 
the aldehyde (1.0 equiv.) was added slowly, and the reaction was stirred for an hour. Then, 
pyridine (4.0 equiv.) was added to the solution dropwise. The reaction mixture was warmed 
to room temperature and allowed to stir for 14 hours. The reaction was quenched with 
water and the organic layer was collected. The aqueous layer was extracted with ether, and 
the combined organic layers were washed with saturated NaHCO3 and brine. The organic 
layer was dried with Mg2SO4, filtered, concentrated, and purified by silica gel column 
chromatography (gradient EtOAc/Hex). 
6.7.4 In(OTf)3-Catalyzed Annulations for Pyrrolo[3,2,1- ij]quinoline Assembly 
 To a mixture of In(OTf)3 (0.10-0.15 equiv.) in 1,2-dichloroethane (or toluene) 
heated to a reflux, dissolved alkylidene malonate monoamides (1.0 equiv) were syringed 
into the reaction vessel. The reaction was monitored by TLC and quenched with water. The 
phases were separated, and the product was extracted from the aqueous phase with DCM. 
The combined organic layers were washed with brine, dried over Mg2SO4, filtered. After 





ij]quinoline-5-carboxylate (6-31): Methyl 3-(4-methoxyphenyl)-2-(2-methyl-1H-indole-
1-carbonyl)acrylate (0.258 g, 0.739 mmol), In(OTf)3 (0.0428 g, 0.0760 mmol) and 1,2-
dichloroethane (13 mL) were combined according to the  general procedure to render 6-31 
as a brown solid (0.161 g, 63%) after 3 hours. (Rf = 0.35, 20% EtOAc/Hex) [m.p. 122-124 
°C] Diastereomeric ratio: (50:1).  1H NMR (300 MHz, CDCl3) ppm 7.31 - 7.37 (m, 1H), 
7.14 - 7.20 (m, 2H), 7.08 - 7.13 (m, 1H), 6.84 - 6.92 (m, 2H), 6.71 (d, J = 7.48 Hz, 1H), 
6.41 (d, J = 1.25 Hz, 1H), 4.96 (d, J = 10.85 Hz, 1H), 4.19 (d, J = 10.88 Hz, 1H), 3.81 (s, 
3H), 3.68 (s, 3H), 2.71 (d, J = 1.03 Hz, 3H). 13C NMR (75 MHz, CDCl3) ppm 169.0, 
164.0, 159.0, 137.2, 134.9, 130.9, 129.6, 127.4, 124.0, 122.7, 121.0, 118.4, 114.3, 109.4, 
58.8, 55.2, 52.6, 45.3, 15.2. IR: 2954.7 (w), 2922.5 (w), 2850.5 (w), 1749.6 (s), 1709.3 (s), 
1611.6 (w), 1513.5 (s), 1443.5 (s), 1381.8 (s), 1340.9 (s), 1252.6 (s), 1178.9 (w), 1153.2 




ij]quinoline-5-carboxylate (6-41): Methyl 3-(4-fluorophenyl)-2-(2-methyl-1H-indole-1-
carbonyl)acrylate (0.0760 g, 0.225 mmol), In(OTf)3 (0.0188 g, 0.0330 mmol) and 1,2-
dichloroethane (8 mL) were combined according to the  general procedure to afford 6-41 
as a yellow solid (0.0716 g, 94% for combined cis and trans isomers) after 1 hour. (Rf = 
0.68, 30% EtOAc/Hex) [m.p. 153-155 °C] Diastereomeric ratio: (2.6:1) (trans-
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Diastereomer chemical shifts reported)  1H NMR (300 MHz, CDCl3) ppm 7.36 (d, J = 
7.77 Hz, 1H), 7.19 - 7.25 (m, 2H), 7.13 (t, J = 7.62 Hz, 1H), 7.00 - 7.09 (m, 2H), 6.68 (d, 
J = 7.44 Hz, 1H), 6.42 (d, J = 1.17 Hz, 1H), 5.01 (d, J = 10.85 Hz, 1H), 4.18 (d, J = 10.85 
Hz, 1H), 3.68 (s, 3H), 2.71 (s, 3H). 13C NMR (75 MHz, CDCl3) ppm 168.8, 163.7, 137.3, 
134.8, 130.2 and 130.1 (doublet), 127.5, 124.2, 122.1, 120.9, 118.7, 116.1, 115.8, 109.5, 
77.2, 58.7, 52.7, 45.4, 15.2. IR: 3058.4 (w), 2954.5 (w), 2923.0 (w), 1746.8 (s), 1708.7 (s), 
1605.3 (w), 1509.8 (s), 1443.8 (s), 1380.9 (s), 1340.0 (s), 1267.9 (m), 1224.3 (s), 1159.1 
(s), 1097.6 (w), 1051.5 (w), 1010.0 (w), 967.1 (w), 818.5 (m), 748.7 (s) cm-1. HRMS (ESI) 
M/Z+ Calc. 337.1114, Obs. 337.1115. 
 
Methyl 6-(4-methoxyphenyl)-4-oxo-2-phenyl-5,6-dihydro-4H-pyrrolo[3,2,1-
ij]quinoline-5-carboxylate (6-51): Methyl 3-(4-methoxyphenyl)-2-(2-phenyl-1H-indole-
1-carbonyl)acrylate (0.160 g, 0.390 mmol), In(OTf)3 (0.0223 g, 0.0400 mmol) and 1,2-
dichloroethane (13 mL) were combined according to the  general procedure to afford 6-51 
as a reddish orange solid (0.155 g, 97%) after 3 hours. (Rf = 0.33, 20% EtOAc/Hex) [m.p. 
108-110 °C] Diastereomeric ratio: (17.3:1). (trans-Diastereomer chemical shifts reported) 
1H NMR (300 MHz, CDCl3) ppm 8.16 - 8.22 (m, 1H), 7.71 - 7.76 (m, 1H), 7.16 - 7.45 
(m, 7H), 7.02 - 7.09 (m, 2H), 6.71 - 6.77 (m, 2H), 5.19 (d, J = 4.40 Hz, 1H), 4.05 (d, J = 
4.43 Hz, 1H), 3.86 (s, 3H), 3.73 (s, 3H). 13C NMR (75 MHz, CDCl3) ppm 168.0, 164.9, 
158.9, 139.4, 134.4, 132.0, 131.7, 130.5, 128.4, 128.4, 128.4, 127.0, 124.9, 124.5, 120.2, 
116.7, 114.3, 114.1, 63.0, 55.2, 53.3, 42.7. IR: 3056.9 (w), 2953.2 (w), 2837.9 (w), 1730.5 
(s), 1610.2 (s), 1511.9 (s), 1454.6 (s), 1392.4 (s), 1345.1 (m), 1305.2 (m), 1246.7 (s), 
1145.4 (s), 1103.0 (w), 1029.6 (s), 830.8 (m), 748.6 (s), 699.8 (s), 628.6 (m) cm-1. HRMS 




ij]quinoline-5-carboxylate (6-57): Methyl 2-(5-fluoro-2-methyl-1H-indole-1-carbonyl)-
3-(4-methoxyphenyl)acrylate (0.0750 g, 0.204 mmol), In(OTf)3 (0.0180 g, 0.0320 mmol) 
and 1,2-dichloroethane (7 mL) were combined according to the  general procedure to afford 
6-57 as a yellow solid (0.660 g, 88%) after 12 hours. (Rf = 0.40, 20% EtOAc/Hex) [m.p. 
106-108 °C] (Single Diastereomer Observed) 1H NMR (400 MHz, CDCl3) ppm 7.13 - 
7.18 (m, 2H), 7.01 (ddd, J = 0.63, 2.21, 8.96 Hz, 1H), 6.86 - 6.91 (m, 2H), 6.43 - 6.48 (m, 
1H), 6.37 - 6.39 (m, 1H), 4.92 (d, J = 10.79 Hz, 1H), 4.17 (d, J = 10.85 Hz, 1H), 3.81 (s, 
3H), 3.68 (s, 3H), 2.70 (d, J = 1.19 Hz, 3H). 13C NMR (101 MHz, CDCl3) ppm 168.8, 
163.7, 161.7, 159.3, 159.2, 138.7, 131.1, 130.3, 129.5, 128.1 and 128.0 (doublet), 124.0 
and 123.9 (doublet), 114.4, 109.2, 109.2, 109.1, 108.9, 104.7, 104.4, 58.5, 55.2, 52.7, 45.3, 
15.2. IR: 3001.9 (w), 2954.8 (w), 2838.9 (w), 1747.3 (s), 1709.5 (s), 1632.7 (m), 1610.7 
(m), 1513.3 (s), 1479.6 (s), 1435.4 (s), 1381.4 (s), 1327.8 (m), 1254.6 (s), 1210.5 (s), 
1156.7 (s), 1112.8 (s), 1031.8 (s), 961.2 (m), 852.7 (s), 832.2 (s), 741.1 (s), 714.0 (m), 
619.6 (m) cm-1. HRMS (ESI) M/Z+ Calc. 367.1220, Obs. 367.1227. 
6.7.5 Control Reactions for Pyrroloquinolines 
6.7.5.1 Trifluoromethanesulfonic Acid Reaction 
 To a mixture of trifluoromethanesulfonic acid (TfOH) (0.0010 g, 0.0068 mmol) in 
1,2-dichloroethane heated to a reflux, dissolved methyl 2-(2-methyl-1H-indole-1-
carbonyl)-3-(4-nitrophenyl)acrylate (0.250 g, 0.6866 mmol) was syringed into the reaction 
vessel. The reaction mixture was stirred at reflux for 16 hours. The reaction afforded only 
starting material as observed by crude 1H NMR. 
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6.7.5.2 1,8-Diazabicyclo[5.4.0]undec-7-ene Epimerization Reaction  
 The diastereomeric mixture of Methyl 2-methyl-6-(4-nitrophenyl)-4-oxo-5,6-
dihydro-4H-pyrrolo[3,2,1-ij]quinoline-5-carboxylate (0.06 g, 0.16478 mmol), DBU 
(0.0075 g, 0.0494 mmol) and 1,2-dichloroethane (3 mL) were combined and stirred at room 
temperature for 14 hours. The reaction afforded the trans isomer as a single observable 





 Glaucoma is a serious disease that can wreak havoc on one's quality of life and 
affects over three million Americans and 60.5 million individuals worldwide according to 
a 2010 study.378 Being an impairing ailment, glaucoma threatens the sense held most 
sacred...sight. Given the urgency for a cure, many studies have been conducted to 
understand the pathogenesis for open-angle and angle-closure glaucoma.379–387 Research 
has shown that mutations in the olfactomedin domain of myocilin are plausible causes for 
inherited open angle glaucoma.380,388,389 Mutations in the domain causes protein 
misfolding, promoting aggregation of myocilin protein in the trebecular meshwork, which 
is responsible for draining aqueous humor in the space between the lens and the cornea of 
the eye.380,390  The aggregation of mutant myocilin may predispose the host to increased 
intraocular pressure,391 which is a marker for glaucoma.392  Despite strides made in 
combating this disorder, myocilin remains a domain of unknown structure and function. 
Lieberman et al. sought to evaluate chemical probes to gain insight into the functional niche 
of myocilin and potentially identify targeted molecules to inhibit mutant myocilin 
aggregation. To this end, compounds were ordered and synthesized for screening.  
A.1. Chemical Probes for Myocilin Studies 
 Fourteen compounds were identified in our myocilin olfactomedin domain (myoc-
OLF) pilot screen by chemical assay for restabilization (CARS), which resulted in a 50% 
or better decrease in spyro orange (SO) fluorescence.  This study proceeded with eleven 
hit compounds, dismissing several compounds due to an increase in SO florescence 
because of interference with SO or destabilizing effects. The ligands were then evaluated 
for inhibition of myoc-OLF fibrillization, which is responsible for aggregation.  A 
fluorescence plate reader-based assay combined with atomic force microscopy was 
developed to evaluate the extent of fibrillization upon the addition of a compound. 
GW5074 bound to myoc-OLF stoichiometrically with micromolar affinity and was 
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determined to cause a decrease in myoc-OLF fibrillization in a dose dependent manner.  
Based on the results from surface plasmon resonance (SPR) and the fibrillization assay, 
several derivatives of GW5074 were synthesized. Of the derivatives, G5 was a potent 
inhibitor of amyloidogenesis in vitro.   
 Next, the ligands were evaluated with the use of a mutant myocilin cellular 
secretion assay which tested the ability of the ligand to rescue mutant myocilin secretion 
(1477 mutant myocilin represents one of the least stable glaucoma causing OLF variants) 
and prevent glaucoma associated HTM cell death.  The results indicated that GW5074 was 
not suitable because it precipitated when it was added to the aqueous cell media.  Second 
generation G2 and G5 both exhibited adequate solubility and a good cellular toxicity 
profile.  A dose dependent increase in 1477N mutant myocilin was found with G5 though 
G2 did not enhance secretion.  From this study, it was concluded that G5 has great promise 
for development into target molecules to reduce mutant myocilin aggregation. 
 
 
A.2. Research Participants 
All biological studies were conducted by Dr. Susan Orwig, Pamela Chi, Yuhong Du, Dr. 
Shannon E. Hill, Amrithaa Suntharalingam, Katherine Turnage, Chad Dickey, Haian Fu, 
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and Professor Raquel Lieberman. Compounds not commercially available were 
synthesized by Marchello Cavitt. This research was published in ACS Chemical Biology: 
Orwig, S. D.; Chi, P. V.; Du, Y.; Hill, S. E.; Cavitt, M. A.; Suntharalingam, A.; Turnage, 
K. C.; Dickey, C. A.; France, S.; Fu, H.; Lieberman, R. L. Ligands for Glaucoma-
Associated Myocilin Discovered by a Generic Binding Assay. ACS Chem. Biol. 2014, 9, 
517–525. 
A.3. Synthetic Methods 
Compounds were either purchased (GW5074, Sigma Aldrich), TCI chemicals, or 
synthesized as follows. All reactions were carried out in pre-dried glassware from the oven 
and any additional moisture was removed by flame-drying the reaction vessel under 
vacuum. Each reaction proceeded under a nitrogen atmosphere with anhydrous solvents, 
unless stated otherwise. Absolute ethanol was used. All other reagents were purchased 
from Acros, Sigma-Aldrich, Fluka, VWR, Merck, Alfa Aesar, TCI and Strem (for metal 
catalysts) and used without further purification.  
Chromatographic purification was performed as flash chromatography with 
Dynamic Adsorbents silica gel (32-65µm) and solvents indicated as eluent with 0.1-0.5 bar 
pressure. For quantitative flash chromatography, technical grades solvents were utilized. 
Analytical thin-layer chromatography (TLC) was performed on EMD silica gel 60 F254 
TLC glass plates. Visualization was accomplished with UV light, aqueous basic potassium 
permanganate (KMnO4) solution, iodine, aqueous acidic dinitrophenylhydrazine (DNP) 
solution, aqueous acidic p-anisaldehyde (PAA) solution, and an ethanol solution of 
phosphomolybdic acid (PMA) followed by heating. Melting points were determined by an 
Electrothermal Mel-Temp. Each yield refers to an isolated, analytically-pure material.   
Infrared (IR) spectra were obtained with a Shimadzu IR Prestige 21 FTIR 
instrument. The IR bands are characterized as weak (w), medium (m), and strong (s). 
Proton and carbon nuclear magnetic resonance spectra (1H NMR and 13C NMR) were 
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recorded on a Varian Mercury Vx 300 MHz spectrometer, a Varian Mercury Vx 400 MHz 
spectrometer, Bruker 400 MHz spectrometer, or Bruker 500 MHz spectrometer with 
solvent resonances as the internal standard (1H NMR: CDCl3 at 7.26 ppm or DMSO-d6 at 
2.50 ppm; 13C NMR: CDCl3 at 77.0 ppm or DMSO-d6 at 39.50 ppm). 
1H NMR data are 
reported as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, dd = 
doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, t = triplet, 
m = multiplet), coupling constants (Hz), and integration. Mass spectra were obtained using 
a VG-70SE instrument. Uncorrected melting points were measured with a digital melting 
point apparatus (DigiMelt MPA 160). Compounds synthesized and not reported in the 
literature until our publication are listed below. Some data may be missing because the 
compound(s) matched the data in the literature. Only new data that was not reported in 
the literature is shown below.  
 General Procedure: 2-Indolinone (1.0 equiv.), aldehyde (1.0-1.2 equiv.), piperidine 
(0.2-2 equiv.), and absolute ethanol (10 mL) were charged to a flask equipped with a 
condenser and stir bar. The mixture was heated to a reflux for 16 hours.  The resulting solid 
was filtered, washed repeatedly with low boiling petroleum ether, collected, and dried in 
vacuo overnight. Each sample was characterized, examined for purity by NMR, and 
compared to the data in the literature.  
 
(Z)-3-[4-(Dimethylamino)benzylidene]indolin-2-one (G1): The general procedure that 
was followed used indolin-2-one (415 mg, 3.12 mmol), 4-(dimethylamino)benzaldehyde 
(541 mg, 3.63 mmol), piperidine (517 mg, 6.07 mmol), and ethanol (15 mL). The reaction 
proceeded for 16 hours. 13C NMR (75MHz, DMSO-d6) δ ppm = 167.6, 151.7, 139.5, 138.0, 
 177 
134.7, 127.0, 126.1, 122.1, 120.6, 120.3, 118.4, 111.0, 108.9. The characterization of the 
compound was in accordance with reported data.393,394 
 
(E)-3-(4-Bromobenzylidene)indolin-2-one (G2): The general procedure that was 
followed used indolin-2-one (415 mg, 3.11 mmol), 4-bromobenzaldehyde (668 mg, 3.61 
mmol), piperidine (517 mg, 6.07 mmol), and ethanol (15 mL). The reaction proceeded for 
12 hours. The characterization of the compound was in accordance with the reported data. 
The 1H NMR matched the literature values for the E isomer. No Z isomer was initially 
detected. However, over the collection time of the carbon-13 spectrum, isomerization 
occurred. 13C NMR (101MHz, DMSO-d6) δ ppm = 168.4, 167.0, 143.1, 140.9, 135.2, 
134.3, 133.7, 133.1, 131.8, 131.7, 131.3, 131.3, 130.3, 129.3, 128.2, 127.5, 124.7, 123.8, 
122.8, 122.5, 121.2, 120.6, 119.9, 119.9, 110.2, 109.4, 105.5. The other characterization 
was in accordance with the reported data.395  
 
(E)-3-(3,4,5,-trimethoxybenzylidene)indolin-2-one (G3): The general procedure was 
followed with the use of indolin-2-one (301 mg, 2.26 mmol), 3,4,5-
trimethoxybenzaldehyde (488 mg, 2.49 mmol), piperidine (431 mg, 5.06 mmol), and 
ethanol (15 mL). The reaction proceeded for 12 hours. The characterization of the 
compound was in accordance with the reported data.396,397 
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3-(4-Methoxybenzylidene)indolin-2-one (G4):   [(E:Z ratio) = 6.3:1] The general 
procedure was followed with the use of indolin-2-one (499 mg, 3.75 mmol), 4-
methoxybenzaldehyde (615 mg, 4.52 mmol), piperidine (34 mg, 0.405 mmol), and ethanol 
(10 mL). The reaction proceeded for 6.5 hours. 13C NMR (75MHz, CDCl3) δ ppm = 170.8, 
168.4, 161.7, 161.0, 141.7, 139.5, 137.6, 137.5, 134.4, 131.5, 129.4, 128.2, 127.4, 127.1, 
126.0, 124.0, 122.7, 122.1, 121.6, 121.6, 118.8, 114.2, 113.8, 110.2, 109.5, 55.4. The other 
characterization was in accordance with the reported data.398,399 
 
3-(3,5-Dibromo-4-hydroxy-benzylidene)-1,3-dihydro-indol-2-one (G5): Indolin-2-one 
(302 mg, 2.27 mmol), 3,5-dibromo-4-hydroxybenzaldehyde (636 mg, 2.27 mmol), p-
toluenesulfonic acid monohydrate (51 mg, 0.269 mmol), and ethanol (15 mL) were heated 
to a reflux. The reaction proceeded for 16 hours. [(E:Z ratio) = 1:1.1] 1H NMR (300MHz, 
DMSO-d6) δ ppm = 10.66-10.60 (broad singlets, 3.54), 8.79 (s, 2.19), 7.90 (s, 2.00), 7.69 
(s, 1.10), 7.63 (d, J = 7.5 Hz, 1.16), 7.51 - 7.45 (m, 2.16), 7.27 - 7.16 (m, 2.26), 6.98 (t, J 
= 7.6 Hz, 1.15), 6.92 - 6.79 (m, 3.21), 3.63 (br s, 1.63). 13C NMR (75MHz, DMSO-d6) δ 
ppm = 168.5, 167.3, 152.5, 151.9, 143.1, 140.7, 136.1, 133.9, 133.2, 133.1, 130.3, 128.9, 




(Z)-3-(3,5-dibromo-4-methoxybenzylidene)-5-iodoindolin-2-one (G6): Piperidine 
(0.091 mmol, 7.7 mg), 3,5-dibromo-4-methoxybenzaldehyde: (0.49 mmol, 0.145 mg), 5-
iodoindolin-2-one (0.45 mmol, 0.118 mg), and ethanol (10 mL) were charged to a flask 
with a condenser. The mixture was heated to a reflux for 16 hours. The orange solid was 
collected and washed repeatedly with petroleum ether and afforded 0.1509 g (62%) of the 
desired product. (Rf = 0.73, 1% MeOH/DCM) [(E:Z ratio) = 1:2.8] [m.p. 273-275 °C] (Z 
isomer NMR data) 1H NMR (500MHz, DMSO-d6) δ ppm = 10.83 (s, 1 H), 8.78 (s, 2 H), 
8.04 (d, J = 1.7 Hz, 1 H), 7.85 (s, 1 H), 7.55 (dd, J = 1.7, 8.1 Hz, 1 H), 6.68 (d, J = 8.1 Hz, 
1 H), 3.86 (s, 3 H). 13C NMR (126MHz, DMSO-d6) δ ppm = 166.5, 154.8, 140.5, 137.5, 
136.2, 134.5, 132.9, 128.4, 127.1, 126.8, 117.1, 112.0, 84.2, 60.7. IR: 3149.8 (m), 3080.3 
(w), 3024.4 (w), 2866.2 (w), 1701.2 (s), 1604.8 (s), 1525.7 (m), 1475.5 (m), 1465.9 (m), 
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